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Chapter I 
Statement of the Problem 
Over the past two decades substance abuse in females has 
reached epidemic levels in America (Clark & McClanahan, 
1998; Clark, McClanahan, & Sees, 1998; Substance Abuse and 
Mental Health Services Administration [SAMHSA], 1997; 
National Institute on Drug Abuse [NIDA], 1997). In fact, 
recent morbidity data indicate that an estimated 200,000 
females will die annually of substance-related illness 
more than four times the number who will die of breast 
cancer (Blumenthal, 1998) 
Accumulating evidence indicates that there are 
differences in both the etiology and the epidemiology of 
male and female substance abuse. For instance, 
neurochemical research indicates that females are more 
sensitive than males to the rewarding effects of 
substances. This corroborates data that indicates that 
females proceed more rapidly to drug abuse and addiction 
than males after initial drug use, and that substance abuse 
has more severe medical implications for females than males 
(Leshner, 1998). Medical data reveals that female emergency 
room admissions for methamphetamine and other stimulants, 
tranquilizers, and sedatives exceed those of males (SAMHSA, 
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1998b) . Females also have significant numbers of admissions 
for cocaine/crack, non-smoked cocaine, and heroin (SAMHSA, 
1998b) . These differences indicate that treatment 
approaches for each gender should also be different 
(Leshner, 1998). 
While epidemiological data indicates an obvious need, 
treatment for substance abuse has predominately focused on 
male clients (Hatsukami et al., 1997). This is compounded 
by the fact that the traditional therapeutic community 
approach to drug and alcohol treatment uses behavioral 
techniques that tend to be confrontational and may not be 
appropriate for female substance abusers (Hatsukami et al., 
1997). In fact, current research suggests that the optimal 
treatment approach for females may be to focus on the 
process of negative emotions and interpersonal relations 
that are more typical relapse indicators for female 
substance abusers (Stocker, 1998). 
Another issue in the treatment of substance abuse in 
females is the fact that females have been hesitant to seek 
out treatment. Research indicates that females under 
utilize mental health services because of fear of personal 
safety and various other reasons (Coletti, 1998). Females 
also report that they are hesitant to seek out traditional 
drug treatment due to issues of safety, a lack of knowledge 
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about women and drug abuse on the part of treatment 
providers, transportation, long waiting lists, lack of 
youth specific services such as day care, distrust of the 
system (e.g., fear of children being taken from them), and 
being more reluctant than males to accept random assignment 
in a research protocol (NIDA, 1998) . 
The barriers previously mentioned have contributed to an 
under representation of females in clinical trials. Other 
studies (Carroll, Rounsaville, Nich, Gordon, & Gawain, 
1995; Hall, Munoz, & Reus, 1994; Hollon & Beck, 1994; 
Ojehagen, Berglund, & Hansson, 1997; Woody et al., 1983) 
have included females in their clinical samples, but failed 
to analyze treatment outcome by gender. Traditional 
approaches such as Cognitive-Behavioral Therapy (Beck et 
al., 1991) and psychodynamic derivatives (Lubarsky, 1984) 
have been reported as being effective, but specific outcome 
data by gender is lacking. Thus, there is a need to 
evaluate these treatments specifically among women who 
abuse substances. 
The Cognitive-Behavioral Treatment (CBT) in this study 
draws from the principles of Beck (1979), Ellis (1962, 
1986), and Meichenbaum (1977). The CBT principles (Carroll, 
1998) diverge from the traditional behavioral approach of 
the therapeutic community treatment that is typically 
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applied to substance abuse, and includes a functional 
analysis of the substance abuse and individualized training 
related to the substance abuse. It is also more client-
centered in its approach than previous CBT models. The 
client-centered aspects are designed to develop rapport and 
trust between the client and therapist. 
The Insight-Oriented Psychotherapy (IOP) condition is 
based on contemporary psychodynamic theory espoused by 
Khantzian's (1985, 1986, 1988, 1990) self-medication 
theory, which posits that when some people experience 
intrapsychic pain they turn to mood altering substances to 
alleviate that pain. This intrapsychic pain or distress is 
manifested in females as depression, anxiety, low ego 
integration, and obsessiveness (Brook, Whiteman, & Cohen, 
1998). 
The literature suggests that aspects of both CBT and IOP 
may be effective in the treatment of female substance 
abuse. For instance, learning theory suggests that 
educating an adult regarding the topic facilitates clinical 
work. Thus, psychoeducational techniques such as those in 
the CBT treatment of this study have proven effective with 
adults previously and should provide similar results with a 
female population. Similarly, the literature suggests that 
the process orientation of the IOP treatment of this study 
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should also provide efficacious treatment for females who 
abuse substances. This approach may be effective with 
females who turn inward and abuse substances to relieve 
intrapsychic pain. The efficacy of this approach may be a 
function of providing a forum for the females to discuss 
their pain rather than seeking a self-soothing action such 
as abusing substances. 
While both of these treatment conditions have been 
successfully applied to substance abuse with predominantly 
male subjects, females have been underrepresented and no 
study has reported their individual effectiveness with 
females who abuse substances. Thus, the purpose of this 
study was to determine which treatment approach, Cognitive 
Behavioral Therapy or Insight Oriented Psychotherapy, is 
more effective in the treatment of female substance abuse. 
Background and Need for the Study 
Using substances to alter one's mind is nothing new to 
humans. Alcohol and tobacco are the most prevalent 
substances that modern age humans abuse, however, these two 
substances are relative newcomers to the arena of substance 
abuse - - anthropological digs have discovered that humans 
have used substances to alter mood states for thousands of 
years. Papaver somniferurn (opium poppy) and Cannabis sativa 
(hemp) were cultivated by stone-age farmers (Rudgley, 
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1995). In fact, recent excavations have discovered that 
opium poppy was domesticated in Mediterranean areas as 
early as the sixth millenium BC; charred hemp (which 
indicates that it was burned and resulted in mood altered 
states), opium poppy, and even Amanita muscaria (fly-agaric 
mushroom hallucinogenic) are common references in 
palaeoethnobotanical literature. The oldest recorded 
prehistoric use of substances was found in Spain where 
burial sites that date to 4200 BC revealed opium capsules. 
Similar archeological digs have unearthed hashish, 
marijuana, and hallucinogens in other European sites. Never 
before, however, has substance use been so prolific in 
societies around the world, and especially within the 
American society. 
Patterns of Substance Use and Abuse in Females 
Substance use has reached pandemic proportions in 
America during the twentieth century (Clark & McClanahan, 
1998; NIDA, 1998; SAMHSA, 1998a). Substance abuse is 
generally considered a male phenomenon and has been at 
epidemic proportions since the 1960s. Medical evidence, 
however, reveals that females have abused substances longer 
than males. For instance, females accounted for 60-75 
percent of opium-morphine addicts in the 1800s (Blumenthal, 
1998) . 
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Recent data from the National Household Survey on Drug 
Abuse, conducted annually since 1979, reports that in 1997 
there were 111 million Americans age 12 and older (51 
percent of the general population) who were current users 
of alcohol (SAMHSA, 1998a) . This number represents 58 
percent of the male population and 45 percent of the female 
population. 
Of the thirty-two million Americans who engaged in binge 
drinking (5 or more drinks on at least one occasion during 
the past 30 days), females represent 8.1 percent (SAMHSA, 
1998a) . Of the 11 million heavy drinkers (5 or more drinks 
per occasion on 5 or more days during the past 30 days) , 
females represent 2.1 percent (SAMHSA, 1998a). 
SAMSHA (1998a) also reports that there were an estimated 
64 million Americans who were current smokers in 1997. 
Females more than males (20.7 percent versus 19.1 percent) 
are more dependent on tobacco and have a higher risk of 
becoming addicted to psychotherapeutic medications being 
used non-medically (Kandel, 1998). 
Illicit drug use is equally at epidemic proportions. For 
instance, in 1997 an estimated 13.9 million Americans were 
current illicit drug users, which included 1.5 million 
current cocaine users and 171,000 new heroin users (an 
increase of 25 percent from the 1996 level) (SAMHSA, 
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1998a) . New heroin use is typically used as a barometer of 
the severity of new drug use and as a general indicator of 
hard drug use. Although males (8.5 percent) report a higher 
current illicit drug use than females (4.5 percent), the 
current illicit drug use in females extrapolates to 
approximately 4.5 million females (SAMHSA, 1998a). 
The pattern of male substance use and abuse is more 
prolific for most classes of illicit substances than for 
females. However, female usage is equal to or exceeds that 
of males in certain classes -- female admissions to the 
emergency room for methamphetamine and other stimulants, 
tranquilizers, and sedatives exceed those of males (SAMHSA, 
1998b) . 
Prevalence of Comorbid Psychiatric Illness 
The use of illicit drugs often occurs with comorbid 
psychiatric conditions. The landmark Epidemiologic 
Catchment Area study (ECA; Reiger et al., 1990) reports 
that over 53% of individuals who have a lifetime diagnosis 
of a drug use disorder have a co-occurring psychiatric 
diagnosis. Two-thirds of individuals with a cocaine or 
opiate use disorder will have at some point in their lives 
a comorbid psychiatric condition. 
The National Comorbidity Survey (NCS; Kessler et al., 
1996) report similar comorbid psychiatric and substance 
9 
abuse disorders. For instance, the NCS data indicates that 
51% of those with a lifetime addictive disorder will have a 
lifetime mental disorder (Kessler et al., 1996). While the 
NCS study reported that drug dependence was more prevalent 
in males than females in general, females are more likely 
to have a comorbid anxiety and substance use disorder than 
males. Comorbid depression and substance abuse is also more 
prevalent in females than males (Kessler et al., 1996). 
When substance use and abuse, both licit and illicit, is 
combined with comorbid psychiatric conditions, the 
magnitude of the problem is exponentially compounded, and 
the resultant pressure on the individual, families, and 
American society is also exponential. For instance, the 
Center for Substance Abuse Treatment (CSAT; 1998) reports 
that the economic cost of alcohol and other drug abuse in 
1992, the most recent year studied, was $246 billion. Of 
this $246 billion, $148 billion was attributed to alcohol 
abuse and $98 billion was attributed to the abuse of other 
drugs. Costs associated to alcohol abuse was illness (47%), 
premature death (21%), health care costs (13%), crime (9%), 
and unidentified other costs (11%) . This is compared to the 
cost associated to other drug abuse, such as crime (59%), 
premature death (15%), illness (16%), and health care 
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(10%). These figures highlight the magnitude of the 
negative effect that substance use has on American society. 
Traditional Treatment 
Traditionally treatment providers have maintained the 
view that recovery from substance abuse or addiction is a 
process. For some individuals, this process may be life 
long with relapse being a part of that recovery process. 
The recovery process is viewed as another symptom of 
addiction, and can be broken down into a rule of thirds: 
one-third of clients achieve permanent abstinence through 
their first attempt at recovery; another one-third have a 
period of brief relapse episodes that eventually result in 
long-term abstinence; and, the last one-third have chronic 
relapses that result in eventual death as a result of their 
addiction (Gorski, Kelley, Havens, & Peters, 1995). 
Relapse is often predicated by individual triggers 
(cues), high-risk situations, or associations which set in 
motion the road of relapsing to substances (Gorski et al., 
1995) . Treatment is predicated on the notion that once the 
individual's particular events that lead to relapse are 
identified, treatment should focus to help the individual 
overcome these threats through strategies designed to 
increase self-awareness, strengthen resistance, and create 
positive coping options. 
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Substance abuse treatment has predominately served male 
clients (Hatsukami et al., 1997) with females being 
underrepresented in clinical trials. This practice 
continues even though there is growing evidence of 
significant differences between males and females in 
patterns of substance use and abuse and psychological 
illness (Hatsukami et al., 1997). Furthermore, conclusions 
from studies with only male clients lead to threats of the 
generalizability of results to a female population 
(Hatsukami et al., 1997). 
Gender Specific Treatment 
Research indicates that females under utilize mental 
health services because of a variety of reasons (Coletti, 
1998) . This may also account for some of the under 
representation of females in empirical clinical trails. 
Additionally, the traditional approach to drug and alcohol 
treatment is a behavioral approach that tends to be 
confrontational (Coletti, 1998). This contrasts to the view 
that the optimal treatment approach for females may be to 
focus on process and to utilize techniques that call upon 
the therapeutic relationship in order to promote the 
necessary motivation in the client to change their behavior 
(Blumenthal, 1998; Geshshan, 1993; Hatsukami et al., 1997; 
Kandel, 1998; Leshner, 1998; Moras, 1998b). Another 
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complication is the fact that treatment research that 
examines comorbid psychiatric conditions is not prevalent 
in the professional literature (Onken, Blaine, Genser, & 
Horton, 1997) . There is a similar dearth of efficacy 
research with female clients who have comorbid substance 
abuse (Clark, McClanahan, & Sees, 1998) . 
Given the fact that females use and abuse different 
substances and that those substances (including alcohol and 
tobacco) affect females differently, the fundamental 
question is: "Do female substance abusers require gender-
specific therapies?" (Moras, 1998b). Because females are 
socialized differently than males, females present with 
different problems than male substance abusers. For 
instance, female substance abusers present with lower self-
esteem and late entry into treatment (Coletti, 1998). These 
issues may corroborate the view that treatment services for 
substance-abusing females should be different than those 
for males (Coletti, 1998). As an example, CBT focuses on 
content and problem solving and has proven highly effective 
for substance-abusing males (Becket al., 1991; Clark & 
McClanahan, 1998; Liese & Najavits, 1997; O'Brien et al., 
1995; Onken et al., 1997; Woody et al., 1983). However, 
negative emotions (depression and anxiety) and 
interpersonal relations (lack of social support) are more 
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typical relapse indicators for females and may be more 
appropriate as the focus of treatment for females. 
The most significant issue with regard to gender 
specific treatment is the lack of empirical studies that 
have examined female substance abuse. Several studies have 
included females in their study sample (Carroll et al., 
1995; Hall, Munoz, and Reus, 1994; Kadden, Cooney, Getter, 
and Litt, 1989; Lubarsky, 1984), however, outcome by gender 
was not reported. 
Principles of CBT and IOP Treatment 
The Cognitive-Behavioral Treatment in this study 
diverges from the traditional behavioral approach 
(Hatsumakmi et al., 1997) that is typically applied to 
substance abuse in a therapeutic community treatment 
paradigm. Instead, the CBT approach espoused by Carroll 
(1998) includes: focusing on a functional analysis of the 
substance abuse, individualized training in recognizing and 
coping with cravings, examining the client's cognitive 
processes related to substance abuse, examining high-risk 
situations, encouraging extra-session skills, and 
practicing of skills within session. 
The Insight-Oriented Psychotherapy (IOP) condition in 
this study draws primarily from contemporary psychodynamic 
theory espoused by Khantzian. Khantzian's (1985, 1986, 
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1988, 1990) Self-Medication theory states that when some 
people experience intrapsychic pain, they attempt to 
alleviate that pain with mood altering substances. The goal 
of the insight-oriented treatment condition is to develop 
defenses that would remove the underlying basis for 
continued substance abuse (Khantzian, 1990). The 
fundamental dynamic that fosters this change in behaviors 
is the therapeutic relationship (therapeutic alliance) that 
the client develops toward the therapist. This alliance is 
developed through the use of interpretation, clarification, 
empathy, involvement, and support that the therapist 
provides during treatment. The relationship allows the 
client to trust the therapist and to gain the intrapsychic 
insight necessary to discontinue the substance abuse. 
While both of these treatment conditions have been 
successfully applied to substance abuse, females have been 
underrepresented and no study has examined the 
effectiveness of either approach with only female subjects. 
Thus, the objective of this study was to determine which 
treatment approach, Cognitive Behavioral Therapy or Insight 
Oriented Psychotherapy, was more effective in the treatment 
of female substance abuse. 
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Purpose of the Study 
The purpose of this study was to determine whether 
Cognitive Behavioral Therapy (CBT) that focused on 
psychoeducational interventions was more effective than 
Insight-Oriented Psychotherapy (IOP) which focused on 
intrapersonal issues in increasing psychosocial functioning 
and reducing substance abuse in females. 
Psychosocial functioning is the ability of the 
individual to interact with the environment in an adaptive 
manner. Domains that are associated with psychosocial 
functioning include: employment, family relations, and 
social relations. Other areas may also indicate problematic 
functioning. For instance, if a person has legal action 
taken against them (i.e., on parole, probation) then their 
functioning is likely to be impaired. Similarly, if a 
person manifests certain medical conditions, these too may 
be a result of impaired functioning. 
Outcome variables (dependent variables) included: the 
reduction in substance use and/or abuse, depression, and 
anxiety; and, increased psychosocial functioning. 
Instruments that measured the outcome variables were: (a) 
the Addiction Severity Index, Female Version (ASI-F), and 
(b) the Profile of Mood States (POMS) . 
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Theoretical Framework for the Study 
This study draws from two theoretical frameworks: 
Cognitive Behavioral Therapy and Psychodynamic 
Psychotherapy. While each of the treatment regimens is 
based upon the traditional theories, each has incorporated 
principles of contemporary practice. 
Cognitive Behavioral Therapy 
The three preeminent theorists that pioneered the 
development of Cognitive-Behavioral Therapy are Meichenbaum 
(1977), Beck (1979), and Ellis (1962, 1986). Meichenbaum 
(1977) developed Cognitive Behavior Modification (CBM); 
Beck (1979) developed Cognitive Therapy (CT); and, Ellis 
(1962, 1986) developed Rational Emotive Therapy (RET). 
Cognitive Behavior Modification. Cognitive restructuring 
is the central theme of Meichenbaum's (1977) Cognitive 
Behavior Modification. According to Meichenbaum (1977), 
negative self-statements are as detrimental as derogatory 
statements made by another person. In order for change to 
occur the individual must be able to perceive how they 
think, feel, behave, and be cognizant of the impact that 
they have on others. Thus, CBM treatment is a self-
instruction model wherein behavioral change occurs through 
a sequence of mediating processes that involves the 
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interaction of inner speech (self-deprecating statements), 
cognitive structures, and behaviors. 
CBM treatment is a three-phase process of change that 
integrates the interaction of thinking, feeling, and 
perceiving. Phase 1, self-observation, is where the 
individual learns to observe their own behavior. Phase 2, 
starting a new internal dialogue, begins once the client 
can observe their own behaviors, but where more adaptive 
behavioral alternatives are developed that lead to 
behavioral, cognitive, and affective changes. Phase 3, 
learning new skills, consists of teaching the individual 
more effective coping skills, which are practiced in vivo. 
Cognitive Therapy. Beck's approach to Cognitive Therapy 
is based on the rationale that what a person feels and how 
he or she behave is determined by the manner in which they 
structure their experience (Corey, 1991). Beck posits that 
cognitive therapy attempts to reduce excessive emotional 
reactions and self-defeating behavior by modifying the 
faulty or erroneous thinking and maladaptive beliefs that 
underlie these reactions (Becket al., 1991). Beck (1979) 
states that in order to understand the nature of an 
emotional disturbance, it is essential to focus on the 
cognitive content of an individual's reaction to the event 
or stream of thoughts. Beck drew from his training in 
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psychoanalysis and employed many of the client-centered 
techniques of that theoretical paradigm. For instance, Beck 
(1979) states that cognitive techniques are most 
appropriate for individuals who have the capacity for 
introspection and for reflecting on their own thoughts and 
fantasies both of which are central to insight oriented 
therapy. 
Beck (1979) posits that distortions in processing 
information lead to faulty assumptions and misconceptions. 
Arbitrary inferences are formed without sufficient and 
relevant evidence (neurotic anxiety) . Selective 
abstractions are conclusions that are based on an isolated 
detail of an event and therefore misses the overall 
context. Overgeneralization is a process of holding extreme 
beliefs on the basis of a single incident. Magnification 
and exaggeration consists of overestimating the 
significance of negative events. Personalization is a 
tendency for people to relate external events to 
themselves, even when there is justification for doing so, 
and polarized thinking involves thinking in an all-or-
nothing paradigm. 
Rational Emotive Therapy (RET) . Ellis' (1962) Rational 
Emotive Therapy (RET) is based on the assumption that 
cognitions, emotions, and behaviors interact significantly 
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and have a reciprocal cause-and-effect relationship. RET is 
a school of psychotherapy that provides clients with the 
tools to restructure their philosophical and behavioral 
styles (Ellis & Yeager, 1989). The fundamental premise of 
RET is that emotions stem primarily from personal beliefs, 
evaluations, interpretations, and reactions to life 
situations (Corey, 1991). Ellis states that ucoulds", 
ushoulds", and "musts" are the reasons that individuals 
react to their environment in maladaptive ways (personal 
communication, August, 1998). In other words, an activating 
event (A) leads to the interjection of a personal belief 
(B) , which leads to an emotional and behavioral consequence 
(C) . Ellis (1986) expanded on this early theory by stating 
that often there is a disputing intervention that 
challenges the personal belief (D) that results in the 
creation of a new feeling (E). Thus, the expanded A-B-C-D-E 
theory of RET (Ellis, 1986) . 
Techniques of RET include: disputing irrational beliefs, 
assigning cognitive homework (i.e., lists of problems, 
beliefs surrounding those problems), changing one's 
language, using rational-emotive imagery, role playing, 
shame-attacking exercises, and using force and vigor in the 
session (a way of going from the intellectual to the 
emotional level). 
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Cognitive Behavioral Therapy (CBT) . The Cognitive 
Behavioral Therapy model espoused by Carroll (1998) draws 
from each of these three pioneers of cognitive therapy. 
Carroll's model is similar to Beck's Cognitive Therapy in 
that it emphasizes a functional analysis and identifies 
cognitions associated with the behavior. The Carroll (1998) 
model differs from Cognitive Therapy in terms of 
identifying, understanding, and changing underlying beliefs 
of the self and the self in relation to substance abuse. 
The initial emphasis of the Carroll CBT model is on 
learning and practicing a variety of coping skills, of 
which only some are cognitive. 
Initial CBT strategies involve behavioral aspects of 
coping (i.e., avoiding high-risk situations) rather than 
the cognitions associated with a high-risk situation. In 
Beck's Cognitive Therapy, a reduction in substance abuse is 
brought about by changing the cognitions associated with 
the substance abuse. In CBT, a reduction in substance abuse 
is brought about by first changing behavioral patterns 
(i.e., avoiding high-risk situations) and then addressing 
the cognitions. 
The Cognitive Behavioral Therapy of this study (Carroll, 
1998) focused on the following treatment interventions: (1) 
functional analyses of substance abuse, (2) examination of 
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the client's cognitive processes related to substance abuse 
(i.e., managing thoughts associated with substance abuse, 
problem solving, planning for emergencies, and refusal 
skills), (3) identification and debriefing of past and 
future high-risk situations, (4) encouragement and review 
of extra-session implementation of skills, and (5) practice 
of skills within session. 
Specific topics covered in the sessions included: (1) 
introduction to treatment and CBT, (2) coping with craving, 
(3) shoring up motivation and commitment to stop, (4) 
refusal skills and assertiveness, (5) seemingly irrelevant 
decisions, (6) coping plan, (7) problem solving, (8) case 
management, (9) HIV risk reduction, (10) significant other 
discussion, and (11) termination (Carroll, 1998). 
Curative Factors of Cognitive Behavioral Therapy. There 
are many parallels between the three founding theorists of 
CBT. For instance, each of the theorists posits that there 
is an activating event (A) in the environment that causes a 
reaction of some sort in the individual (B) that results in 
a behavior (C) . Each of the theories includes self-
deprecating statements that are harmful to the individual. 
Each theory also includes a component where the individual 
must learn how to change themselves. Cognitive Therapy 
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helps to ~cure" a person by restructuring cognitions 
associated with a particular behavior. 
Cognitive Behavioral Therapy (CBT) is based on the 
premise that cognitions are the primary pathway in which an 
individual distorts their environment (Becket al., 1991). 
These cognitive distortions encumber the individual's 
ability to cope with stress in the environment. Thus, the 
individual turns to alternative methods of coping, such as 
substance abuse. 
Several features of CBT make it a promising approach to 
treatment for substance abuse. For instance, CBT is short-
term which makes it well suited for the limited resources 
of most clinical programs. CBT has been extensively 
evaluated in clinical trials and evidence indicates that it 
is an efficacious treatment for a variety of issues (Beck 
et al., 1991; Clark & McClanahan, 1998; Liese & Najavits, 
1997; O'Brien et al., 1995; Onken et al., 1997; Woody et 
al., 1983). CBT is structured, goal-oriented, and focused 
on the immediate problems that substance abusers face in 
their recovery process (NIDA, 1998) . 
Insight-Oriented Psychotherapy (IOP) 
The second theoretical foundation, Insight-Oriented 
Psychotherapy, is ultimately based on the extensive works 
of Freud. However, much of Freud's work has been criticized 
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and contemporary theorists and researchers have revised his 
early formulations. For instance, contemporary insight-
oriented psychotherapies focus on the ability of the 
individual to maintain interpersonal relations. One of 
these contemporary theories that espouses a relational view 
is the Time-Limited Dynamic Psychotherapy (TLDP; Levenson, 
1995) . 
Another contemporary theorist and researcher is 
Khantzian. Khantzian's extensive work with persons addicted 
to substances led to the development of the Self-Medication 
Model of addiction (Khantzian, 1985; 1986; 1988; 1990), 
which suggests that a person chooses a substance based on 
the psychotherapeutic effects of that particular substance. 
Time-Limited Dynamic Psychotherapy (TLDP) . Levenson 
(1995) posits that there are seven basic conditions that 
apply to the situation of an individual who has 
difficulties in interpersonal relationships. These seven 
fundamental conditions are: (1) the client's problems stem 
from disturbed interpersonal relationships, (2) 
dysfunctional styles were learned in the past, (3) 
dysfunctional styles are being maintained in the present, 
(4) the client will reenact interpersonal difficulties with 
the therapist, (5) the therapist can and will function as a 
participant observer, (6) the therapist will help the 
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client reenact difficulties, and (7) that there is one 
identifiable, problematic relationship problem. 
According to Levenson (1995), the basic principles of 
TLDP reflects a larger paradigm shift that is occurring 
with psychoanalytic theory and practice. This relational 
view contrasts with the traditional psychodynamic view of 
drive theory, which emphasizes predetermined mental 
constructs to deal with conflicts between gratification and 
social constraints (Levenson, 1995) . 
The Self-Medication Model. Khantzian (1985; 1986; 1988; 
1990) posits that addiction is an individual's attempt to 
reach homeostasis. In essence, the individual self-
medicates in an attempt to alleviate emotional suffering. 
This emotional crisis or problem is the result of 
dysfunctional coping mechanisms. For instance, a functional 
approach to a crisis situation is to problem solve 
alternatives or solutions to the situation. In an 
individual that abuses substances, this problem-solving 
function either does not begin or is abandoned during the 
process and the individual copes with the crisis situation 
by escaping from it through a self-soothing technique of 
using substances. Over time this self-soothing or self-
medication becomes the preferred manner to avoid 
intrapersonal conflict or turmoil. 
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According to the Self-Medication Model, substance 
abusers do not choose their drugs of choice by mere 
coincidence. They choose them because of the specific 
psychopharmacological action of the substance that helps 
the individual return to a state of homeostasis (Khantzian, 
1986; 1988; 1990). For instance, the pain relieving 
properties of opiates modulate feelings of rage that many 
victims or perpetrators experience. The hypnotics have 
sedating properties, which are attractive to the tense, 
emotionally restricted individual to help them overcome 
their fears surrounding intimacy and dependency. Cocaine 
appeals to both high- and low-energy individuals because of 
its activating properties it can help overcome the 
feelings of boredom, fatigue, or low self-esteem. 
According to Khantzian (1988), individuals self-medicate 
because of deficiencies in their ability to self-regulate. 
The self-regulatory deficiencies include: deficits in self-
care, self-development and self-esteem, self-object 
relationships, and affects. Khantzian (1988) believes that 
interventions which he labels as the four "C's": control, 
containment, contact, and comfort are essential to treating 
substance abuse. 
Control is more correctly defined as loss of control 
around substances or maintaining boundaries. Through the 
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empathic interaction with the drug user/abuser, the 
therapist builds trust and fosters the therapeutic 
alliance. The client's insight into their inability to 
self-regulate their feelings and subsequent problems is 
essential to effective treatment. 
Containment refers to the ability of the client to rely 
on the belief that the therapist can contain and ultimately 
maintain appropriate stability of the client. Support and 
empathy are interventions that allow this to be manifestly 
true. 
Contact and Comfort are human solutions that Insight 
Oriented Psychotherapy provides to the alcoholic or drug-
abusing client who has become isolated from family and 
society through their use and abuse of substances 
(Khantzian, 1988) . The therapeutic relationship allows for 
both the substance-abusing client and the therapist to 
appreciate the extent of emotional suffering that has 
contributed to the substance abuse. 
The Curative Factors of Insight-Oriented Therapy. The 
primary principles that foster a "cure" of the client in a 
psychodynamic or insight-oriented therapy is the 
therapeutic alliance, support from the therapist, and a 
venue for expression of feelings. When a person introjects 
the feeling of anxiety or depression, the feeling will be 
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projected and manifested through acting out, which in the 
case of substance abusers would be the use of a substance. 
The goal of the Insight-Oriented Psychotherapy treatment 
condition is to instill and build normal defenses that 
remove the underlying basis for continued substance abuse 
(Khantzian, 1990). The fundamental dynamic that fosters 
this change in behaviors is the therapeutic relationship 
(therapeutic alliance) that the client develops toward the 
therapist. This therapeutic alliance is fostered by the 
therapist through the use of empathy, support, 
interpretation, clarification, and involvement. This 
relationship enables the client to trust the therapist and 
to gain the intrapsychic insights into how behaviors are 
adversely affecting them, either inter- or intra-
personally. 
Research Questions 
This study addresses: 
1. Is Cognitive Behavioral Therapy (CBT) or Insight-
Oriented Psychotherapy (IOP) more efficacious in the 
treatment of substance use/abuse in females as measured by 
the Drug Status and the Alcohol Status subscales of the 
Addiction Severity Index, Female Version? 
2. To what extent does CBT and IOP increase overall 
psychosocial functioning of females who abuse substances as 
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measured by the Employment Status, Legal Status, 
Family/Social Relationship, and Psychological Status 
subscales of the Addiction Severity Index, Female Version? 
3. To what extent does CBT and IOP reduce the frequency 
and amount of substance use as measured by the Alcohol- and 
Drug-Status subscales of the Addiction Severity Index, 
Female Version? 
4. To what extent does CBT and IOP reduce feelings of 
depression in females who abuse substances as measured by 
the Depression-Dejection subscale of the Profile Of Mood 
States? 
5. To what extent does CBT and IOP reduce feelings of 
anxiety in females who abuse substances as measured by the 
Tension-Anxiety subscale of the Profile Of Mood States? 
Definitions of Ter.ms 
Addiction is a disease caused by the continued use of 
drugs that produce biological, psychological, and social 
changes in an individual (APA, 1994) . 
Adaptive behavior is an appropriate response to a given 
situation, that helps the individual interact more 
effectively with his or her environment (Chaplin, 1985). 
Route of ingestion is the means of consuming a substance 
(e.g., oral, intravenous injection, smoking, intranasal). 
Substance(s) include both licit (alcohol, tobacco, 
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prescription medications) and illicit (sedatives, opiates, 
stimulants, tranquilizers, and hallucinogens) drugs. 
Substance abuse is a maladaptive pattern of substance 
use that results in recurrent and significant adverse 
consequences related to the repeated use of substances 
(APA, 1994) . 
Substance dependence is a maladaptive pattern of 
substance use leading to clinically significant impairment 
or distress as manifested by three of the following 
criteria: tolerance; withdrawal; the substance is taken in 
larger amounts or over a longer period than was initially 
intended; a persistent desire or effort to cut down or 
control the substance use; a great deal of time is spent in 
the pursuit of the substance; social, occupational, or 
recreational activities are given up or reduced because of 
the substance use; or, the substance use is continued 
despite knowledge of negative consequences (APA, 1994) 
Substance use is the consumption of licit or illicit 
drugs in a manner that is not maladaptive (e.g., does not 





The review of the literature can be summarized into 
three general categories: (a) components of Cognitive-
Behavioral Therapy (CBT) and Insight Oriented Psychotherapy 
(IOP) in the treatment of addiction, (b) psychosocial 
functioning and substance abuse treatment, and (c) 
Cognitive Behavioral Therapy and Insight Oriented 
Psychotherapy comparative studies. 
A significant difficulty in reviewing the literature is 
the fact that there are hundreds of substances or their 
derivatives, with a plethora of techniques that have been 
applied to the treatment of them. The majority of the 
studies, however, report equivocal or contradictory results 
and virtually no study has examined the efficacy of 
treatment on substance abuse in females. Therefore, for the 
purposes of this study, components of the two treatment 
conditions were included in the review and results have 
been extrapolated for implications to this study. 
Components of CBT and IOP in the Treatment of Addiction 
Several components of both CBT and IOP have been 
investigated in the amelioration of symptoms related to 
substance abuse. For instance, the therapeutic alliance 
(IOP) has been examined in numerous studies (Hentschel, 
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Kiessling, & Rudolf, 1997; Horvath & Luborsky, 1993; 
Ojehagen, Berglund, & Hansson, 1997). Components of 
cognitive behavioral therapy (thought restructuring) have 
also been investigated in the treatment of negative 
symptoms that often result or are comorbid with substance 
abuse, such as depression (Hall, Munoz, & Reus, 1994). 
Therapeutic Alliance. Horvath and Luborsky (1993) 
postulate that the therapeutic alliance should be viewed 
under four categories: the relation between a positive 
alliance and success in therapy, the path of the alliance 
over time, an examination of the variables that lead an 
individual to develop an alliance, and the exploration of 
the in-therapy factors that foster the development of a 
positive alliance. 
Luborsky's (1984) work on the Penn Psychotherapy Project 
indicated that there were two types of therapeutic 
alliance: Type I, which is more evident in the early stages 
of therapy where the client views the therapist as 
supportive, and Type II which is more typical of later 
stages of therapy where there is a sense of working 
together in an effort to alleviate the impediment of the 
client. 
In an extensive review of the literature, Horvath and 
Luborsky (1993) found that the impact of the therapeutic 
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alliance has been examined in the context of behavioral 
therapy, cognitive therapy, gestalt therapy, and 
psychodynamic therapy. In each of these studies "a strong 
alliance appears to make a positive contribution in all of 
these therapies" (p. 565). 
In an attempt to evaluate the effects of the helping 
alliance and treatment outcome, Ojehagen, Berglund, and 
Hansson (1997) conducted a study using outpatient treatment 
for the abuse of alcohol. The patients were randomly 
assigned to two treatment conditions: multi-modal 
behavioral therapy (MBT) and psychiatric treatment (PT) 
based on a psychodynamic approach. Seventy-two patients, 60 
males and 12 females, were selected for inclusion in the 
two treatment conditions. Due to numerous factors, such as 
not completing treatment, moving out of the area, and 
death, only 35 subjects were included in the final analysis 
(MBT, n=17; PT, n=18). Of these 35 participants, three 
participants in the MBT and one in the PT treatment were 
females. The mean number of treatment sessions were 24.7 
(SD=1.7) for MBT and 24.6 (SD=1.7) for PT. 
The MBT treatment was based on Lazarus's (1981) 
Multimodal Therapy. The primary principles of MBT were 
based on Lazarus' BASIC ID - Behavior, Affect, Sensation, 
Imagery, Cognition, Interpersonal relationships, and Drugs 
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or biology. The PT model was based on Lubarsky's (1984) 
Supportive-Expressive therapy that espouses the Core 
Conflictual Relationship Theme (CCRT) . Luborsky posits that 
supportive techniques such as supportive relationships can 
foster the therapeutic alliance, which will alleviate the 
intrapsychic pain that the client experiences. Luborsky 
also believes that expressive techniques, such as listening 
and understanding, can also foster this curative process. 
Ojehagen, Berglund, and Hansson (1997) reported no 
significant outcome differences between the two treatment 
regimens during the course of treatment or in the third 
year of follow-up. The authors assessed the magnitude of 
the helping alliance and the outcome on treatment, and 
reported that multi-modal therapy had significantly better 
early therapist alliance in comparison with the psychiatric 
treatment according to the Mann-Whitney U-test (MBT, M 
67.2; PT, M = 61.3). An ANOVA showed no differences in 
early therapist or patient alliance with regard to length 
of therapy. With each of the treatment conditions, there 
were significant correlations (p < .001) between early 
patient and therapist alliance (MBT and PT, rs=0.81). 
Neither treatment condition was correlated to demographic 
data. The most significant finding, however, was that there 
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were no significant positive correlations between early 
alliance and drinking outcome for either treatment. 
The authors state that the small sample size places 
limitations on the conclusiveness of their findings, and 
several methodological issues also limit the 
generalizability of their findings. For instance, the 
therapist factor was not standardized, neither treatment 
condition was manualized, and the number of therapists 
differed between the two treatment conditions. The 
therapist effects included the fact that only one therapist 
provided the MBT treatment whereas several therapists 
conducted the PT treatment - - therapist effects on the 
outcome data were not reported. 
The implications of these results on the current study 
include the fact that the helping alliance can be measured 
and is a curative factor. As Ojehagen, Berglund, and 
Hansson (1997) state, the helping alliance depends upon the 
style of the therapist and the structure of the treatment. 
Each of these factors were incorporated into the research 
design of the current study. For instance, one therapist 
provided both treatment regimens in the proposed study. 
Additionally, both treatment regimens in this study were 
manualized and cross-checked for adherence to treatment 
principles. 
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Thought Restructuring. Hall, Munoz, and Reus (1994) 
examined the effect of a cognitive behavioral mood 
management intervention on smokers with a history of Major 
Depressive Disorder (MDD). 
One-hundred and forty-nine subjects were randomly 
assigned to either a Mood Management condition (n = 79) or 
a standard treatment condition (n = 70) . Of the 149 
subjects, 71 were male and 46 were female. The mean age of 
the sample was 40.6 years (SD 9.2), 131 were Caucasian, 
40 had advanced degrees, 49 had completed an undergraduate 
degree, and only 14 had less than a high school education. 
Subjects reported smoking an average of 24.9 cigarettes per 
day (SD = 10.9), and reported a regular smoking pattern for 
a mean of 22.1 years (SD = 9.5), and a majority reported 
multiple previous attempts to quit (n = 128). Forty-six 
subjects (31%) were diagnosed as having a history of MDD at 
baseline. 
The standard treatment condition used group support and 
nicotine gum (2 mg) to aid in quitting smoking. The 
standard treatment condition consisted of five sessions 
over a period of 8 weeks. The sessions provided information 
about smoking cessation and group support for planning 
individualized strategies for quitting smoking. 
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The Mood Management treatment condition met for ten two-
hour sessions over an 8-week period (twice a week for the 
first two weeks, and once a week thereafter). Specific 
cognitive behavioral methods included monitoring of 
thoughts, daily activities, interpersonal contacts, and 
mood. The treatment emphasized the impact of thoughts, 
activities, and interpersonal contacts on mood. The 
treatment also focused on thoughts and activities so that 
those thoughts related to healthy mood were increased and 
those that were related to negative mood and smoking were 
decreased. Specific techniques included social skills 
training to increase pleasant social contacts, relaxation 
training, and linking maladaptive thoughts to cigarette 
smoking. 
Hall, Munoz, and Reus (1994) reported that the cognitive 
behavioral method enhanced treatment outcome for subjects 
with a history of MDD (X2 (2, N=46)=12.795, p=.0017). 
Subjects without a history of depression were more likely 
to be abstinent in the control condition (13 of 53, 24%) 
than in the cognitive-behavioral condition (8 of 51, 16%). 
The cognitive behavioral treatment condition (POMS 
Depression score, M = 53.57) achieved the best abstinence 
rates of the treatment conditions (POMS Depression score, 
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M = 36.00) at assessment in week 52. Outcome data was not 
provided by gender. 
The authors postulate that several factors provided the 
cognitive behavioral treatment condition with the more 
positive outcome. First, the cognitive behavioral treatment 
condition provided "tools to rethink risky situations and 
to endure bouts of poor mood ... " (p. 145) . The authors 
further state that the cognitive behavioral techniques that 
target mood-related problems are effective with substance 
abusers that have a history of MDD. 
While this study involved a licit substance, tobacco, it 
did investigate two variables that are germane to this 
study. The first variable is the cognitive behavioral 
technique of cognitive restructuring which Carroll (1998) 
uses. The second variable is negative emotions such as 
depression and anxiety, both of which are common symptoms 
associated with substance use (i.e., cocaine and alcohol). 
Psychosocial Functioning in Substance Abuse Treatment 
Woody et al. (1983) examined the effectiveness of drug 
counseling, cognitive-behavioral therapy, and supportive-
expressive therapy with 100 male methadone clients. The 
subjects were randomly assigned to either drug counseling 
alone, or to counseling plus six months of either 
supportive-expressive or cognitive-behavioral 
38 
psychotherapy. The cognitive-behavioral (CB) therapy relied 
on a directive, time-limited approach that focused on 
making lists, homework, role-playing, and identifying 
underlying thoughts. The CB treatment also focused on 
uncovering and understanding the relationship and influence 
of automatic thoughts and underlying assumptions on 
problematic feelings and behaviors. Drug counseling (DC) 
focused on monitoring current problems, advice giving, and 
on providing external services (i.e., liaison with 
physicians, courts, and social service agencies) rather 
than intrapsychic processes. The supportive-expressive (SE) 
therapy was analytically oriented, non-directive, and 
focused on helping the client identify and work through 
problematic relationships. 
Subjects assigned to the supportive-expressive treatment 
condition kept an average of 12 sessions with their 
therapists and 12 sessions with their counselors: subjects 
assigned to the cognitive-behavioral treatment condition 
kept an average of 9.5 sessions with their therapists and 
12 sessions with their counselors. The authors report that 
85% of sessions lasted 30 minutes or longer. 
While specific data are not presented, Woody et al. 
(1983) state that, uthe clear overall result was that 
patients in all three groups showed improvement in many 
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outcome measures, including lessened drug use, crime days, 
and illegal income and improved psychological function" (p. 
643) . 
The authors report that both the cognitive-behavioral 
and the supportive-expressive groups were more effective 
than drug counseling in the reduction of heroin use and 
other illicit drugs. For instance, the mean methadone 
hydrochloride dose for the drug counseling alone group went 
from a dose of 30mg at baseline to 40mg at week 25; the 
supportive-expressive group went from 37mg at baseline to 
32mg at week 25; and the cognitive-behavioral group went 
from an initial dosage of 39mg at baseline to 30mg at week 
25 (Woody et al., 1983). Urine samples indicated that 
subjects assigned to all groups showed a significant 
decrease in positive results over the course of the study 
(F = 8.41, p < .05), but there were no significant 
differences between groups (p < .1) (Woody et al., 1983). 
The authors also reported a separate analysis of opiate-
positive urine samples that revealed that all three groups 
showed a significant decrease in substance use over the 
course of the study (F = 11.81, p < .01). However, subjects 
who were assigned to either the SE or the CB group showed 
significantly less use of opiates than the subjects who 
received DC alone (p < .05). The authors report that 
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subjects in the SE group had only an 8% rate of urine test 
results positive for opiates during the latter part of the 
six-month study. 
Additional findings revealed that the cognitive-
behavioral group showed more improvement with legal 
problems, while the supportive-expressive group had more 
improvement in psychological functioning and employment 
(Woody et al., 1983). Woody et al. report that subjects in 
the SE treatment condition had more stable work performance 
and lower levels of residual psychopathology. 
The implications of these findings are that both the lOP 
and the CBT approaches of the current study may yield 
similar results in enhancing psychosocial functioning. 
However, the subjects in the Woody et al. (1983) study were 
all male, whereas the subjects in the current study were 
all female. Thus, extrapolating the Woody et al. results to 
the current study may have limited utility. 
McKay, Alterman, Cacciola, O'Brien, Koppenhaver, and 
Shepard (1999) examined the treatment effects on subjects 
assigned to standard group counseling versus individualized 
relapse prevention. Outcome variables included days of drug 
use, days of alcohol use, and six psychosocial variables as 
measured by the Addiction Severity Index (AS!; McLellan, 
Lubarsky, Woody & O'Brien, 1980). 
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The subjects consisted of 132 male veterans who were 
diagnosed with cocaine dependence (lifetime) and who had 
used cocaine in the prior six months. The subjects were 
referred for inclusion in the McKay et al., (1999) study 
following a 4-week intensive outpatient program. Subjects 
were randomly assigned to either the standard treatment 
(STND) or an individualized relapse prevention (RP) 
treatment condition, with each treatment lasting for a 
period of five months. 
The STND group condition was designed as the control 
group and consisted of group sessions with an 
interactional, 12-step focus. The authors state that this 
treatment regimen was the "treatment as usual" model in the 
Veterans Affairs (VA) clinic where the study was conducted. 
The STND treatment consisted of two group therapy sessions 
per week. The RP treatment condition consisted of one 
individual structured cognitive-behavioral relapse 
prevention session and one group session per week. The 
individualized RP treatment was designed for the treatment 
of substance abusers in the maintenance phase of recovery. 
Assessments were conducted at 6, 12, 18, and 24 months and 
took approximately 90 minutes to complete. 
The authors state that they used mixed-effect regression 
models for the longitudinal analyses of the ASI data. The 
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authors state that they chose the mixed-effect regression 
model because that approach allows for the modeling of both 
group and individual differences over time and the 
interaction of effects of the individual's data. The 
analyses included independent variables (e.g., treatment 
condition, current psychiatric diagnoses, and abstinence 
commitment), all two- and three-way interactions between 
these variables, a time factor, and interaction between 
time and other variables. 
The authors reported that significant time effects (p < 
.05) were observed on the drug, psychiatric, employment, 
and medical composites of the AS!. The RP produced a 
significant group effect on the medical composite score of 
the AS!. Similar results were observed on t tests with the 
RP treatment condition producing significant differences 
over the STND treatment with regard to medical outcomes at 
months 6 and 18. The subjects who received the RP treatment 
condition had better cocaine use outcomes if they were 
committed to absolute abstinence on entering the study, but 
subjects who received the STND treatment had better cocaine 
use outcomes if they had a less stringent abstinence goal. 
According to McKay et al. (1999), subjects who received the 
RP treatment program reported fewer heavy drinking days 
(more than five drinks) in the second year and that overall 
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treatment main effects favored RP over STND in the second 
year. 
McKay et al., (1999) concluded that their results reveal 
that RP is the treatment of choice for continuing care for 
individuals who are committed to absolute abstinence. 
However, STND is the treatment of choice for individuals 
who have less stringent abstinence goals. There are, 
however, several limitations to their study. For instance, 
87% of the subjects were African-American, the mean number 
of years of education was 12.81 (SD = 1.55), and all 
subjects reported being of lower socioeconomic status. 
Thus, the findings of this study may not generalize to the 
general population, however, the demographics of this study 
match very closely with those of the McKay et al. sample. 
There are several implications to the current study. For 
instance, with the exception of the gender of the subjects, 
the demographic variables parallel those of the current 
sample. In addition to the homogenous study sample, the RP 
treatment regimen was manualized and was based on tenets 
similar to those of the CBT group in the current study. The 
McKay et al. (1999) study also used the ASI to measure 
psychosocial outcomes which this study also used. The 
conclusions drawn by McKay et al. indicates that aspects of 
a cognitive-behavioral model is the most efficacious if the 
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subjects are committed to total abstinence. This stringent 
goal, however, may be too high for most people who have a 
lengthy history of substance abuse but a short history of 
abstinence, both of which apply to the current sample. 
CBT and lOP Comparative Studies 
There is a body of literature that has compared 
cognitive-behavioral therapy with derivatives of a 
psychodynamic therapy model in the treatment of substance 
abuse. Many of these studies have been conducted in medical 
settings and compare various treatment conditions with a 
psychotropic medication. 
According to Onken, Blaine, and Boren (1995), substance 
abuse is a behavioral problem and should be treated in 
behavioral therapy. Their definition of behavioral therapy 
includes behavior therapy, psychotherapy, and counseling. 
In some cases pharmacotherapy may be the treatment of 
choice, however, in other cases it may not be possible, 
practical, or necessary (Onken et al., 1995). 
Carroll et al., (1995) studied the effectiveness of 
psychopharmacology, cognitive behavioral therapy, and 
clinical management in the treatment of cocaine dependence. 
Each of the treatment conditions were manual guided and 
delivered to 139 patients over 12 weeks, where each session 
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was videotaped and evaluated for continuity with the 
manual. A breakdown of subjects by gender was not reported. 
The pharmacological agent was desipramine, and was 
administered in a 200mg per day dose. A placebo was used in 
order to evaluate the effects of the active medication. The 
cognitive behavioral treatment was an adaptation of Marlatt 
and Gordon's (1985) model that focused on implementing 
effective coping strategies. The coping strategies included 
exploration of positive and negative effects of cocaine 
use, self-monitoring for the identification of high-risk 
situations for relapse, and problem-solving for avoiding 
craving and high-risk situations. The clinical management 
condition included medication management, a supportive 
doctor [physician]-patient relationship, and medication 
compliance. 
The mean number of sessions completed was 7.2 (SD = 
3.6), and only 49 subjects completed treatment (12 weeks or 
12 sessions) . The desipramine group had the highest number 
of treatment completers with 49%. While each of the groups 
showed significant improvements in the reduction of cocaine 
use, outcomes failed to demonstrate significant main 
effects for psychotherapy, pharmacotherapy, or their 
interaction (Carroll et al., 1995). 
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The results of this study indicate that cognitive 
behavioral techniques were effective in the reduction of 
substance use. However, gender specifics were not provided 
and therefore may not be replicated in a study of substance 
abuse in a female sample. 
Kadden, Cooney, Getter and Litt (1989) investigated the 
effects of coping skills training, based on a cognitive-
behavioral treatment paradigm, versus an interactional 
therapy approach based on a psychodynamic paradigm. The 
study included a sample of 96 subjects who had a mean age 
of 39.1 years (SD = 13.5), 44% were married, 53% were high 
school graduates, and 30% had college degrees. Eighty-four 
percent met the DSM-III criteria for alcohol dependence and 
16% for alcohol abuse. Subjects reported a mean number of 
45 days of heavy drinking out of the most recent 90 days. 
Gender specific information was not reported. 
The coping skill training group was a highly structured 
group designed to foster the acquisition of skills such as 
problem solving, interpersonal skills, relaxation, and 
skills for coping with negative moods and urges to drink. 
Homework and in-session practice were used to teach the 
skills. The interactional group therapy was an adaptation 
of Yalom's group therapy model and was designed to explore 
participants' interpersonal relationships and pathology in 
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the "here-and-now". This group encouraged expression of 
immediate feelings, self-reflection, and exploration of the 
meaning of experiences as they occurred in the session. 
The use of the Addiction Severity Index (ASI; McClellan, 
Lubarsky, Woody, & O'Brien, 1988) provided both psychiatric 
diagnosis as well as patterns of drug and alcohol use. The 
ASI was also used to evaluate the success of the substance 
abuse treatment. 
The authors report that a MANOVA analysis indicated that 
there were no significant pretreatment differences between 
the two treatment groups on alcohol consumption, social 
functioning, psychological functioning, or 
neuropsychological status (Kadden et al., 1989). The MANOVA 
analysis yielded no significant differences in outcomes 
(heavy drinking days, ASI Psychiatric Status, ASI 
Employment) attributable to a therapist effect (p < .10). 
The authors state that coping skills training and 
interactional group therapy were equally effective over the 
course of a 6-month aftercare period. However, coping 
skills training was found to be more effective for subjects 
with higher levels of psychopathology (ASI Psychiatric 
Status score > 0.29), and the interactional group therapy 
was more effective for subjects lower in psychopathology. 
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The implication of these results is that both treatment 
conditions in the current study should be effective in the 
treatment of substance abuse. The fact that this study did 
not control for gender causes one to be cautious in making 
a hypothesis as to which treatment, if either, could be 
more efficacious in treatment outcome. 
Khantzian, Halliday, and McAuliffe (1990) describe an 
empirical study in their treatment manual where they 
investigated the effectiveness of two short-term, six-
month, group approaches versus a no-group control 
condition. The first group condition was a self-help 
condition based on a cognitive-behavioral model. The second 
condition was a modified dynamic group therapy, which was a 
supportive-expressive psychodynamic model adapted for 
cocaine abusers. The study evaluated the effects of 
treatment on psychological functioning and substance use. 
The sample consisted of 214 cocaine-dependent persons from 
the greater Boston area. Retention, which is usually 
problematic with any substance abuse clinical trial, was at 
70% for the entire length of treatment. The authors state 
that preliminary results indicate that short-term 
psychodynamic treatment was effective in reducing substance 
abuse and improving psychological health. 
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The implications of these results is that treatment 
based on a psychodynamic paradigm, whether it is 
supportive-expressive or insight-oriented therapy, may be 
effective in both the reduction of substance abuse as well 
as increasing psychosocial functioning. Additionally, the 
senior investigator in this study developed the principles 
of the insight-oriented model that provide the basis for 
the current study. 
Summary 
Efficacy studies in the treatment of substance abuse are 
prolific, however, the results are often equivocal and 
studies that have investigated female substance abuse are 
virtually nonexistent. 
There is a growing literature that postulates that 
females respond differently to drug treatment that was 
developed for use with male substance abusers (Moras, 
1998a); interventions that emphasize increasing a female's 
self-esteem and choosing more positive lifestyles may be 
more effective in the treatment of females. It should be 
noted, however, that the majority of studies indicate that 
no treatment approach is superior to all others across 
psychological conditions or treatment populations (Garfield 
& Bergin, 1994). 
50 
Several tenets of IOP treatment have been empirically 
evaluated. For instance, Horvath and Lubarsky (1993) report 
that the central principle in psychodynamic therapies, the 
therapeutic alliance, can foster positive outcome. To this 
end, Ojehagen et al. (1997) reported that a multi-modal 
behavioral therapy and psychiatric therapy based on a 
psychodynamic paradigm were equally effective in reducing 
alcohol use. The multi-modal therapy, however, had 
significantly better early therapist alliance in comparison 
with the psychiatric treatment. 
Cognitive behavioral techniques such as thought 
restructuring and teaching new coping skills have also 
proven effective in the reduction of substance use as well 
as depression. Hall, Munoz, and Reus (1994) found that 
cognitive behavioral techniques that focused on thought 
restructuring, relaxation training, social skills training, 
and identifying maladaptive thoughts were significantly 
more effective than a standard treatment in achieving 
longer periods of abstinence and reduced feelings of 
negative emotions. 
Studies have also evaluated treatment outcome on 
psychosocial variables. For instance, Woody et al. (1983) 
reported that cognitive behavioral therapy was as effective 
as supportive expressive therapy in the reduction of 
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substance use. However, supportive expressive therapy was 
more effective in enhancing psychological functioning and 
employment. Thus, it seems that while each treatment is 
effective, they differ in the aspects of the treatment 
approach that is more effective with outcomes, as well as 
in terms of outcomes they impact. 
McKay et al. (1999) also found equivocal and 
inconclusive results in evaluating treatment on 
psychosocial variables, but reported that a cognitive-
behavioral program was the treatment of choice for 
continuing care for individuals who are committed to 
absolute abstinence. For individuals who have less 
stringent abstinence goals, standard 12-step relapse 
maintenance produced better treatment outcome. 
Several studies have also compared treatment programs 
based on cognitive-behavioral principles with those based 
on psychodynamic principles. Kadden et al. (1989) found 
that coping skills training was more effective at reducing 
substance use than an interactional therapy condition in 
patients with high levels of pretreatment psychopathology. 
Khantzian, Halliday, and McAulfie (1990) compared a self-
help group approach with a modified psychodynamic group 
approach. These investigators report that the modified 
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dynamic approach has produced positive results for 
substance use. 
The major objective of this study concerns which 
treatment is more efficacious in the treatment of substance 
abuse in females. This is of importance because empirical 
studies previously mentioned evaluated treatment with 
primarily male subjects. These studies yielded equivocal or 
contradictory results with respect to treatment outcomes 
and did not identify specific aspects of treatment that 




Restatement of the Problem 
The purpose of this study was to determine if Cognitive 
Behavioral Therapy (CBT) or Insight-Oriented Psychotherapy 
(IOP) was more effective in the treatment of anxiety, 
depression, and substance abuse in females. Treatment 
effects were evaluated on three domains: level of 
psychosocial functioning, level of drug use (frequency and 
amount), and level of affective state. These domains were 
measured by (a) the Addiction Severity Index - Female 
Version (ASI-F) and (b) the Profile of Mood States (POMS). 
Research Design 
This study employed a pretest-posttest comparative 
experimental design to evaluate the two interventions in 
the treatment of substance abuse in a female population 
(see Appendix A) . 
A comparative study evaluates two or more treatments 
without conceptualizing either as being a standard control 
group (Basham, 1986) . This type of methodology is designed 
to specifically highlight that between-group outcome 
differences are caused by differences in the magnitude of 
the two individual treatment effects (Basham, 1986). In 
choosing the comparison groups the investigator often 
54 
chooses the "standard treatment" and compares that 
treatment to one that the research literature hypothesizes 
might be more effective for the given problem or sample 
population (Kazdin, 1992). 
Kazdin (1986) outlines several advantages to using a 
comparative research design. First, the clinical question 
of which treatment is best under what condition is 
answered. Second, this type of study offers a comparison of 
treatment processes (similarities and differences in how 
treatments are executed) . Third, a comparative design is 
often more desirable than traditional methodologies because 
the primary focus is on the forms of treatment rather than 
between treatment and control procedures. Finally, 
comparative studies highlight and crystallize differences 
between alternative treatments. 
Clinical research raises special issues that the 
researcher must address. In clinical trials, it is often 
unethical to deny or delay treatment to subjects --
comparative studies addresses this problem by providing 
treatment to all participants who are included in the study 
(Basham, 1986; Kazdin, 1986; Kazdin, 1992). 
A comparative study does, however, have some 
limitations. For instance, often the most significant 
limitation to a comparative design too general of a 
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research question such as uwhich treatment is best?" 
(Kazdin, 1986). However, this limitation can be reduced 
when specific clinical problems are addressed with specific 
assessment criteria and when the intervention is applied 
under rigorous conditions (Kazdin, 1986) . Each of these 
issues were addressed in this study. For instance, specific 
outcome variables were identified and assessed through the 
use of well-accepted, standardized instruments. 
Additionally, the use of treatment manuals helped to 
standardize the treatments and the Principal Investigator, 
who facilitated both treatment conditions, has received 
extensive training in each of the treatment approaches. 
Crits-Christoph and Mintz (1991) state that therapist 
effects should be controlled for when there are numerous 
therapists. The reason that multiple therapists should be 
controlled for is due to the fact that a therapist may 
effect client outcomes. When there is only one therapist, 
however, each group should be effected by the same 
therapist effects. The issue of therapist effects was 
addressed in the current study with the Principal 
Investigator administering both treatment conditions. 
Characteristics of the Study Sample 
The sample for this study was recruited from an 
outpatient community-based mental health clinic in Oakland, 
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California. As individuals sought out treatment at the 
clinic, they were referred to the Principal Investigator 
for screening for inclusion in the current study. Flyers 
(Appendix B) were also posted in the clinic and were 
designed to recruit individuals who were currently or had 
recently experienced a number of problems associated with 
substance use. Following the conclusion of the study, the 
subjects were referred back to the mental health clinic for 
inclusion in an outpatient day treatment program. 
Inclusionary Criteria 
Criteria necessary to participate in this research 
project included: (1) subjects had to be female; (2) be 
within the ages of 18 to 44; and, (3) have a diagnosis of 
substance abuse or dependence according to the DSM-IV. 
Exclusionary Criteria 
Criteria used to exclude an individual from treatment in 
this research protocol included: (1) being male or 
transgender; (2) not having a diagnosis of substance abuse 
or dependence according to the DSM-IV; (3) presence of an 
active psychosis; or, (4) planning on leaving the area 
prior to completion of the treatment. 
Sample Population 
Twenty-four adult females were recruited and screened 
for participation in the current study. Fiveindividuals 
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were excluded from participating in the study: four had a 
diagnosis of sustained full remission from substance 
dependence and one individual had a medical condition that 
precluded her participation. Thus, the sample for this 
study consisted of 19 participants, who were randomly 
assigned to the two treatment conditions via a table of 
random numbers. Ten individuals were assigned to Insight-
Oriented Psychotherapy (IOP) treatment condition and nine 
individuals were assigned to the Cognitive-Behavioral 
Therapy (CBT) treatment condition. Two individuals, one 
from each treatment condition, did not complete the study, 
and their data were not included in the data analysis. 
Thus, the final sample was comprised of 17 individuals, 9 
in the IOP treatment condition and 8 in the CBT treatment 
condition. 
Demographic data consisted of variables such as age, 
race, level of education, and psychiatric diagnosis. The 
chi-square test is used to determine if there are 
statistically significant differences with nominal or 
categorical data. If significant differences are found, the 
implication is that the independent variable may not have 
caused the change but that the change may have been due to 
the pre-existing differences in the sample. 
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Table 1 
Demographic Characteristics at Intake 
IOP (n = 9) CBT (n = 8) 
Variable M SD n % M SD n % 
Age (years) 35.2 2.2 34.9 4.2 
Education (years) 11.9 1.8 11.8 0.9 
Months Clean 4.1 2.9 3.5 1.6 
Ethnicity: 
African-American 8 89% 5 63% 
Caucasian 0 0% 1 13% 
Other 1 11% 1 13% 
Sub-Related Disorder: 
Alcohol, Current 1 11% 0 0% 
Cocaine, Current 8 89% 7 88% 
Amphet., Current 0 0% 1 12% 
Table 1 presents specific demographic data by treatment 
condition. Chi-square analysis revealed no statistically 
significant differences between the two treatment 
conditions for age [X2 (1, n=17)=.73, p=.12], years of 
education [X2 (1, n=17)=.67, p=.19], ethnicity [X2 (1, 
n=17)=.95, p=.Sl], substance-related psychiatric diagnosis 
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[X2 (1, n~17)~.86, p~.03], or length of time since the last 
substance use [X2 (1, n=17)~.92, p~.01]. 
The average age for the IOP participants was 35.22 (SD ~ 
2.17) and 34.87 (SD ~ 4.19) for the CBT participants. Both 
treatment conditions had comparable levels of education, 
with the IOP treatment condition having a mean of 11.89 
years (SD ~ 1.76) and the CBT treatment condition having a 
mean of 11.75 years (SD ~ .89). Participants in both 
treatment conditions also had similar ages of first 
substance use with the IOP treatment condition reporting a 
mean of 14.67 years (SD ~ 8.97) and the CBT treatment 
condition reporting a mean of 14.63 years (SD ~ 2.56). 
Participants reported similar patterns in the number of 
months since their last substance use with the IOP 
treatment condition having a mean number of months since 
their last substance use of 4.11 (SD ~ 2.93) and the CBT 
treatment condition having a mean number of months since 
their last substance use of 3.50 (SD ~ 1.60). 
As Table 1 indicates, African-Americans (n ~ 14) 
comprised 82% of the total sample (n ~ 17). American Indian 
(n = 1), Asian of the Pacific Islands (n = 1), and 
Caucasians (n = 1) comprised the remaining 18% of the total 
sample. The majority of the sample (88%) had a diagnosis of 
Cocaine Dependence, Early Partial Remission. One subject in 
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the IOP treatment condition was diagnosed with Alcohol 
Dependence, Early Partial Remission and one subject in the 
CBT treatment condition was diagnosed with Amphetamine 
Dependence, Early Partial Remission. 
Procedures 
Two methods were used for data collection with this 
study, both of which relied on self-report by the 
participants of the study. The first method used to collect 
data was the use of structured interviews (i.e., the 
Structured Clinical Interview using the DSM and the 
Addiction Severity Index, Female Version) . The second 
method was the use of questionnaires (i.e., the Profile Of 
Mood States) . The Principal Investigator administered each 
of the assessment instruments to all study participants. 
In designing this study, the Principal Investigator had 
two primary concerns. The first was the recruitment of 
subjects into substance abuse treatment, which has proven 
problematic for reasons previously outlined. The second 
concern dealt with the complexity of the assessment and the 
implementation of the treatment regimens. 
In order to make the prospect of treatment more 
appealing several incentives were built into the design of 
the study. First, the treatment was conducted at a 
reputable substance abuse program centrally located with 
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nearby public transportation. Another item incorporated 
into the study was reimbursement, which was graduated and 
disbursed on a pay-as-you-go schedule. 
The second concern, the complexity of the design and 
implementation of the treatments, required significant 
training and expertise. An effort to recruit additional 
therapists proved to be unsuccessful due to two factors: a 
lack of competency of the additional therapists and the 
time requirement of the study that the additional 
therapists would not commit. Thus, the principal 
investigator conducted the study as a sole investigator. 
The research protocol was administered in the following 
manner: (a) prospective participants telephoned the 
Principal Investigator who gave them a brief overview of 
the study (see Appendix C), (b) if the caller was 
interested, they were asked some brief questions to 
determine if they met certain conditions which would 
exclude them from the study (see Appendix D) , (c) if the 
caller remained interested an appointment was set up where 
the informed consent was conducted (see Appendix E) , (d) if 
the individual signed the informed consent, then the pre-
test and diagnostic assessment were administered and the 
participant was scheduled for their weekly group treatment. 
Treatment used a group format with each session lasting 90 
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minutes and ran for eight weeks. At the conclusion of the 
last treatment session, a post-test appointment was 
conducted. 
Telephonic Pre-Screening 
The first stage in the assessment process was conducted 
via the telephone in order to pre-screen the prospective 
participant. The prospective subjects were read a 
background statement concerning the study (e.g., rationale 
of the study, length of treatment) (see Appendix C) by the 
Principal Investigator. If the subject remained interested 
in participating in the study, they were asked a series of 
questions that might prohibit them from participating in 
the study (see Appendix D) . 
Specific items were chosen due to the nature of 
potential problems that they might uncover. For instance, a 
person who has a history or is currently experiencing a 
psychosis would be inappropriate for inclusion in either 
group treatment (Yalom, 1985), and would have been excluded 
from participating in the study. 
Informed Consent 
The informed consent included potential risks, benefits, 
the right to withdraw from treatment, and emergency contact 
procedures (see Appendix E) . After the informed consent was 
executed, the pretest assessment was conducted and the 
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participant was scheduled for their first treatment 
session. If the individual decided not to participate, they 
were given a list of community-based agencies that provide 
treatment for substance abuse. The referrals included 
treatment within the referring mental health clinic as well 
as other agencies that specialized in substance abuse and 
mental health services. 
Pre-test and Diagnostic Assessment 
Pretest assessment consisted of the administration of 
the Structured Clinical Interview using the DSM (SCID; 
Spitzer et al., 1990), the Addiction Severity Index, Female 
Version (ASI-F; SAMHSA, 1997), and the Profile Of Mood 
States (POMS; McNair, Lorr, & Droppleman, 1961/1981). The 
SCID is a diagnostic instrument and was used as such. The 
ASI and POMS have been used extensively in the assessment 
and treatment of alcohol and drug abuse treatment and are 
viewed as standard assessment instruments (Clark, 
McClanahan, & Sees, 1998) . Due to the varying length of 
time necessary to administer the assessment instruments, a 
two- to three-hour appointment was scheduled for the 
initial assessment interview. 
Assignment to Treatment Condition 
Study participants were randomly assigned to the two 
treatment conditions (CBT or IOP) via a table of random 
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numbers. Thus, each participant had an equal chance of 
being assigned to either treatment condition. Each 
treatment condition contained a similar number of 
participants and ran for eight sessions. Weekly therapy 
appointments involved group counseling that used either 
Cognitive Behavioral Therapy (CBT) or Insight Oriented 
Psychotherapy (IOP) . Each group counseling session lasted 
for 90 minutes and was conducted at the referring mental 
health clinic. The Principal Investigator facilitated each 
group condition. 
Cognitive-Behavioral Treatment Approach. The Cognitive-
Behavioral Therapy developed by Carroll (1998) originally 
consisted of 12 sessions. For the purposes of this study, 
however, the treatment was reduced to eight sessions which 
consisted of the following topics: Session 1, introduction 
to treatment and coping with feelings of craving a 
substance (distraction, talking about the craving, going 
with the craving instead of fighting them, recalling the 
negative consequences of substance abuse, and using self-
talk); Session 2, shoring up motivation and commitment to 
stop (addressing readiness for change, current position 
toward abstinence, identifying treatment goals); Session 3, 
developing refusal skills and assertiveness (how to handle 
suppliers, developing appropriate refusal skills); Session 
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4, seemingly irrelevant decisions (identifying personal 
examples, practicing safe decision making); Session 5, 
developing a coping plan (emergency phone numbers, 
recalling negative consequences of substance use, 
developing positive thoughts to use in high-risk 
situations, developing a list of safe places to go in a 
crisis; Session 6, introduction to the problem solving 
model (i.e., identifying the problem, brainstorming 
solutions, generating advantages and disadvantages of each 
solution, choosing the best solution); Session 7, HIV risk 
reduction (assessment of risk, build motivation to change, 
establish goals, problem solve barriers); and, Session 8, 
termination (Carroll, 1998). 
Insight-Oriented Psychotherapy. The IOP treatment 
approach used in this study also consisted of eight 
sessions and included: Session 1, introduction to treatment 
(developing relationships with other group members) ; 
Session 2, setting treatment goals (explanation of the 
treatment process and setting realistic goals of 
treatment); Session 3, establishing a relationship of trust 
and rapport (listening, understanding, responding, and 
returning to listening); Session 4, understanding and 
responding to the client's problems (hidden meanings, 
client's symptoms, matching goals to alleviate the 
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symptoms); Session 5, identifying the importance of and 
developing supportive relationships; Session 6, evaluating 
and developing the helping alliance (helping the client 
trust the therapist, developing understanding by the 
therapist, developing optimism); Session 7, evaluating the 
core conflictual relationship theme (evaluate current in-
treatment relationship, current out-of-treatment 
relationships, past relationships) to determine patterns 
and linkage to maladaptive coping mechanisms; and, Session 
8, termination. 
Posttest Assessment 
At the end of their eight-week treatment, a final 
assessment was conducted using the POMS and the ASI-F. The 
final assessment interview took between 1 and 2 hours to 
complete. This time requirement was less than the initial 
appointment because the SCID was not administered during 
this final interview. 
Reimbursement 
Treatment was provided free of charge to the clients and 
subjects were reimbursed for their time while participating 
in the study. Subjects were paid $10 for completing the 
pretest assessment, $5 for each therapy session, $10 for 
the posttest assessment, and a $10 bonus for completing 
each requirement of the study (see Appendix F) . Thus, the 
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total reimbursement possible was $70 if the participant 
completed each requirement. Subjects were reimbursed at 
each stage of the study in which they completed. For 
instance, each subject was reimbursed following: the intake 
assessment, each therapy session, and the posttest 
assessment. The bonus was paid after the post test 
assessment to each subject that completed all study 
requirements. 
Protection of Human Subjects 
Prior to client contact, the University of San 
Francisco's Institutional Review Board for the Protection 
of Human Subjects (IRBPHS) reviewed and approved this 
study. 
To ensure the protection of the rights of human 
subjects, this research project adhered to the American 
Psychological Association's Ethical Principles and Code of 
Conduct (American Psychological Association [APA], 1992). 
The participants were thoroughly briefed concerning the 
nature of the study, their rights to treatment, rights to 
not participate, potential risks, potential benefits, right 
to withdraw from treatment, time required for assessments, 
and reimbursement for being in the research project 
(Appendix F) . 
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Subjects' confidentiality was protected through the use 
of numbers, which each participant agreed to, on charts, 
instruments, and notes. All study materials were kept in a 
locked filing cabinet which only the Principal Investigator 
had access. 
Instrumentation 
The Structured Clinical Interview using the DSM-IV 
(SCID; Spitzer et al., 1990) and the Addiction Severity 
Index Female Version (ASI-F; Substance Abuse and Mental 
Health Services Administration, 1997) were utilized in this 
study to obtain a history of substance use, abuse, and 
addiction in order to develop a psychiatric diagnosis. The 
ASI-F was also used to obtain information on psychosocial 
functioning. The Profile of Mood States (POMS; McNair, 
Lorr, & Droppelman, 1961/1981) was used as an outcome 
measure for treatment effects on anxiety and depression. 
Each of the assessment instruments is discussed separately. 
The assessment instruments were selected based on the 
four criteria espoused by Patterson and McClanahan (1999) : 
(1) appropriateness or goodness of fit, (2) empirically 
based psychometric principles (i.e., normative criteria, 
reliability and validity), (3) preponderance of research 
literature that utilizes the instrument, and (4) 
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practicalities (e.g., availability, ease of administration 
and scoring) . 
Qualifications of the Principal Investigator 
The Principal Investigator administered, scored, and 
interpreted each of the data collection instruments. The 
Principal Investigator has specific training which 
demonstrates his competence, and includes: administration, 
scoring, and interpretation of 169 SCIDs; administration, 
scoring and interpretation of 29 POMS; three years of 
experience in the application of Cognitive-Behavioral 
Therapy with substance abusers; completion of a graduate 
degree in Clinical Psychology specializing in Psychodynamic 
Psychotherapy; three years of experience in the application 
of psychodynamic theory with substance abuse; and, at the 
time of treatment the Principal Investigator was a doctoral 
candidate (successful completion of coursework, written and 
oral comprehensive examinations, and defense of the 
dissertation proposal) in Counseling Psychology. 
Structured Clinical Interview using the DSM-IV (SCID) 
The Structured Clinical Interview using the DSM (SCID; 
Spitzer et al., 1990) is a series of questions contained 
within specific modules (e.g., psychotic screen, PTSD, mood 
disorders, etc.) (see Appendix G). The SCID provides 
diagnosis(es) of each Axis I category of the DSM-IV (i.e., 
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Mood Disorders, Substance-Related Disorders, Schizophrenia 
and other Psychotic Disorders) . 
For the purposes of this study, only the Psychotic 
Screening and the Substance Use Disorder modules were used. 
The Psychotic Screening Module contains 15 questions with 
regard to unusual experiences that the individual may have 
experienced. The specific questions relate to criterion set 
forth in the DSM-IV. Positive responses to the questions 
yield a diagnosis; negative responses result in not meeting 
threshold criteria and no diagnosis, whereby the examiner 
proceeds to the next module of questions. Specific 
questions include: 
1. Has it ever seemed like people were talking about 
you or did you think it might have been your 
imagination? 
2. What about receiving special messages from the TV, 
radio, or newspaper, or from the way things were 
arranged around you? 
3. What about anyone going out of their way to give 
you a hard time, or trying to hurt you? 
The Substance Use Disorder module contains numerous 
questions that pertain to the use of substances, both licit 
and illicit. The questions correlate to the criteria set 
forth in the DSM-IV for a diagnosis of Substance Use 
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Disorders. Positive responses to the questions yield a 
diagnosis as well as a severity specifier (Mild, Moderate, 
or Severe). Specific questions include: 
1. What are your drinking habits like? 
2. When in your life were you drinking the most? 
3. During that time . 
How often were you drinking? 
What were you drinking? 
4. Have you ever missed work or school because you 
were intoxicated, high, or very hung over? 
5. Did you ever drink in a situation in which it 
might have been dangerous to drink at all? 
Similar questions are presented for illicit substances 
(i.e., stimulants, opioids, etc.). These questions attempt 
to determine if there is abuse, tolerance, or dependence as 
set forth in the DSM-IV. Responses to questions are either 
a yes or no. 
Psychometric Principles. Traditional psychometric 
principles are not applicable to the SCID. The reason for 
this is that the SCID is an exact duplicate of the DSM-IV, 
where verbiage has been added to DSM criteria in order for 
the question to read grammatically correct. Goldfinger et 
al. (1996) reported that the SCID correctly identified 87% 
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of subjects which corroborative data revealed were 
substance abusers. 
It is assumed that the person administering the SCID is 
experienced with psychopathology and clinical knowledge. 
This is required in order that additional queries can be 
posed in order to clarify sub-threshold responses. 
Scoring. The layout of the instrument allows the 
administrator to score the SCID as the particular questions 
are asked. For instance, a page of questions has three 
columns of information. The far left column contains the 
question, the middle columns contains the DSM-IV criteria 
that correlates to that particular question, and the far 
right column contains a Likert-like rating scale (?, 1, 2, 
3). The (?) indicates that the individual provided a 
response that requires further inquiry. The (1) indicates 
that the individual responded with a negative response. The 
(2) indicates that the response was positive, but did not 
meet all of the requirements of the criterion. The score of 
(3) indicates that the response was positive and meets the 
criteria of the question that was posed. 
Once the entire module is completed, the scorer counts 
the number of 3s that were assigned. If a sufficient number 
of 3s were scored, then a diagnosis that corresponds to 
DSM-IV diagnostic criteria will be given. 
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Use. The SCID was used for purposes of excluding anyone 
who was experiencing psychosis or had a history of it 
(Psychotic Screening Module) . The SCID was also used for 
establishing a diagnosis of a Substance-Use Disorder 
(Substance Use Disorder module) . 
Addiction Severity Index - Female (ASI-F) 
The Addiction Severity Index (ASI; SAMHSA, 1997) is the 
most widely used instrument in drug treatment in America 
today (Liese & Najavits, 1997). The ASI-F (Appendix H) is 
an expanded version of the ASI (5th Edition) , and has two 
primary purposes: to provide systematically quantitative 
information to aid in the planning of treatment of the 
individual in drug treatment programs, and to measure 
treatment progress of the individual client and treatment 
outcome of a group of clients in a particular treatment 
program (US Department of Health and Human Services [DHHS], 
1997). 
The ASI-F contains seven sections and a section for 
demographic information. The demographic data that is 
collected includes name, mailing address, date of birth, 
race, language, religion, number of pregnancies, and age 
and location of children. 
The Medical Status section, which is not typically used 
for evaluative purposes, asks questions that pertain to 
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medical conditions that the individual may have 
experienced, such as: chronic medical problems (i.e., 
hepatitis, chalmydia, syphilis), seizures, and the 
importance of receiving medical treatment. The Employment-
Support Status section contains questions such as highest 
education completed, valid driver's license, length of 
employment, employment patterns, and income received from 
various sources. The Drug-Alcohol Use section asks three 
questions in regard to 26 substances. The questions are how 
many days in the past 30 days has the person used that 
particular substance, how many months has the individual 
used the substance in their lifetime, and what was the age 
that they first used the substance. This section also asks 
questions such as which substance is their major problem 
and how long was their last period of abstinence from that 
substance. The Legal Status section asks questions that 
pertain to legal problems that the individual may have 
experienced. For example, are you on probation or parole, 
how many times in your life have you been arrested and 
charged with (shoplifting, vandalism, drug charges, 
forgery, etc.). The Family-Social Relationships section 
pertains to social relationships that the individual has 
had. Specific questions asked include: marital status, if 
they have been homeless in the past 30 days, usual living 
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arrangements, close friends, family history, and if they 
are satisfied with these relationships. The Psychiatric 
Status section contains questions such as, have you had a 
significant period in which you have experienced serious 
depression, serious anxiety or tension, hallucinations, 
trouble understanding, concentrating or remembering, 
thoughts of suicide, and attempted suicide. 
Psychometric Principles. The ASI-F was normed on a 
population of 405 substance abusing females in order to 
develop specific situations and problems that are germane 
to female substance abusers. Reliability of the ASI-F using 
Cronbach Alpha coefficients are reported as: Medical Status 
.53; Alcohol Use .83; Drug Use .83; Legal Status .80; 
Family/Social Relationships .71; and Psychiatric Status 
.80. Interrater reliability was judged using the Guilford 
Chi Square formula and was found to have a very highly 
significant degree of agreement (Chi square = 211.6 
(p< .01)). 
Discriminant validity (the ability of the test to 
accurately differentiate various domains) of the ASI-F has 
also been reported as being superior in its ability to 
discriminate female drug abusers from female subjects who 
are from relatively similar backgrounds and circumstances 
but who are not drug abusers (DHHS, 1997). A sample of 135 
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subjects revealed that with the exception of a correlation 
of r=.41 between the Family/Social Relationships and the 
Psychiatric Status subsections, composite scores of all 
seven sections were small. The authors state that a 
correlation of .41 is high enough to negate the usefulness 
of a composite score between these two subscales whereas 
all other subscales were found to justify separate 
composite scores. Correlations between other subscales 
ranged from a low of -.09 (Alcohol and Legal) to a high 
correlation of .23 (Drug and Family/Social). 
Construct validity was tested via factorial analysis, 
which indicated that the seven domains measured by the ASI-
F were unique and distinct. Varimax rotation yielded 14 
factors that included items that had factor loadings from 
.47 to .96. The authors state that, "the basic concept of 
the ASI, to the effect that each of the seven problem area 
sections was measuring a type of problem that was 
relatively distinct and unique, was supported by several 
results of this factor analysis" (DHHS, 1997, p. 8). 
Predictive validity was evaluated as to whether the ASI-
F could be used to predict treatment outcome. The methods 
used to determine this was a comparison of the percentage 
of reduction in the ASI-F drug problem composite scores 
from pretreatment to post-treatment six months later. The 
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percentages of the ASI-F compared to the ASI were similar 
(47% versus 46%), which further establishes the predictive 
validity of the ASI-F. 
Scoring. Scoring of the ASI-F is based on the summation 
of critical items within each subscale. Composite scores 
for each subscale is based on the following formulas: 
Medical Status (AB/30) 
Employment Status [1-(A4+B4+C120+log D36)] 
Alcohol Status (A210+B210+C210+D28+E56+logF32+logG63) 
Drug Status (A,B,C,D,E,F,G,H,I,K,L,M450+1og N69+0450) 
Family-Social (A20+B20+C,D,E30+E,F,G,H10+I300) 
Psychiatric (A,B,C,D,E,F,G,H,I14+J,K,L,M42+N420) 
The scores can range from 0 to 1, with scores 
approaching 1 indicative of more severe impairment and 
lower scores indicating more adaptive functioning. A 
computerized program, which was made available to the 
Principal Investigator from the Center for Substance Abuse 
Treatment (CSAT), Washington, DC, was used to generate 
composite scores for the ASI-F. 
Use. The ASI-F was developed in order to assess the 
types of problems and situations that are more likely to be 
relevant for females, although the additional items (i.e., 
trading sex for illicit substances) are also relevant for 
male drug abusers (DHHS, 1997). 
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The ASI-F is in the public domain, with no copyright 
restrictions. Therefore, not only is it the most widely 
used instrument for data collection regarding substance 
use, it is also the most readily available. 
Two subscale scores of the ASI-F (Alcohol- and Drug-
Status) were used to determine which treatment condition 
was more efficacious in the reduction of substance use. 
Four subscales of the ASI-F (Employment, Legal Status, 
Family/Social Relationships, and Psychiatric) were used to 
determine if the treatment conditions affected the level of 
psychosocial functioning of the study participants. 
Traditional parametric statistical procedures were used to 
calculate quantitative findings and to evaluate within 
group differences on the data generated by the ASI-F. 
MANOVA procedures were used to determine statistical 
significance for between group differences. 
Profile of Mood States (POMS) 
The Profile of Mood States (POMS; McNair, Lorr, & 
Droppleman, 1961/1981) is a 65-item self-report instrument 
designed to measure six mood or affective states: Tension-
Anxiety; Depression-Dejection; Anger-Hostility; Vigor-
Activity; Fatigue-Inertia; and, Confusion-Bewilderment (see 
Appendix I) . Each item is rated on a 5-point scale (O=not 
at all, 1=a little, 2=moderately, 3=quite a bit, 
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4=extremely). There are two versions of the POMS, an 
Outpatient Form (OP) and a College Form (C) . The Outpatient 
form was used for the current study. Administration time is 
approximately five minutes. 
Psychometric Principles. The Outpatient Form is based on 
norms collected for 650 female and 350 male psychiatric 
outpatients. Ninety-five percent of respondents will yield 
a total score of between 30 and 70. Internal reliability 
(alpha coefficients) ranged from .87 to .95 for the male 
psychiatric patients and alpha coefficients ranged from .84 
to .95 for the female patients. Stability coefficients (rtt) 
ranged from .66 to .74 from intake to pre-therapy, and from 
.43 to .52 from intake to six weeks. These coefficients are 
considered stable for predicting a variable state such as 
one's mood. 
In regard to validity data, the publishers report that 
six studies have been conducted to establish the validity 
of the POMS domains. Of the fifteen items that comprise the 
Depression-Dejection (D) domain, factor loadings (decimals 
omitted) ranged from 34 to 58 in study 1; from 24 to 54 in 
study 2; from 38 to 57 in study 3; from 25 to 64 in study 
4; from 31 to 48 in study 5; and from 25 to 46 in study 6. 
Symptom distress correlates of the POMS with a female 
sample (n=650) found that the depression mood factor 
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correlated with the Tension-Anxiety (T) mood factor (.70), 
the Anger-Hostility (A) factor (.58), the Vigor (V) factor 
(-.42), the Fatigue (F) factor (.69), and with the 
Confusion-Bewilderment (C) factor (.70) (McNair, Lorr, & 
Droppleman, 1961/1981) . Validity coefficients for this same 
sample revealed that the anxiety mood factor correlated 
with the Dejection-Depression factor (.69), the Anger-
Hostility factor (.52), the Vigor factor (-.30), the 
Fatigue factor (.61), and with the Confusion-Bewilderment 
factor (. 68) . 
Concurrent validity of the POMS has also been 
established. Coefficients for the Tension-Anxiety mood 
factor of the POMS correlated with the Manifest Anxiety 
Scale (r=.80); and the Dejection-Depression mood factor of 
the POMS correlated to the Inpatient Multidimensional 
Psychiatric Scale (r=.30) 
It should be noted that in the validity studies, women 
tended to score higher than males on the Tension, 
Depression, Fatigue, and Confusion scales, and older 
patients tended to score somewhat lower on the Anger and 
Confusion scales (Lorr et al., 1961). The authors report 
that POMS scores are little affected by background 
differences. 
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Scoring. To obtain a score for the POMS, individual 
subscale item responses are added together to obtain a 
subscale score. All items are scored in the same direction 
except for Item 2 and Item 54, a higher score in either of 
which indicates a less favorable state. A Total Mood 
Disturbance (TMD) score can be obtained by summing the 
scores on the six mood factors. The TMD score was not used 
in the current study. 
Use. The Depression-Dejection (D) and the Tension-
Anxiety (T) subscale scores of the POMS were used in the 
current study. The Depression-Dejection subscale consists 
of 13 items that indicates feelings of personal 
worthlessness, a sense of emotional isolation, sadness, and 
guilt. The maximum score that can be assessed on the 
Depression-Dejection subscale is 56. 
The Tension-Anxiety subscale consists of 9 items, and 
represents observable somatic states (e.g., Tense, On 
Edge) . The maximum score that can be assessed on the 
Tension-Anxiety subscale is 36. 
Unlike many instruments, the authors (McNair, Lorr, & 
Droppleman, 1961/1981) do not provide data on the 
interpretation of scores, but state that the POMS should be 
used to assess the degree of change in individual scores. 
Scores in the current study were obtained in both the 
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pretest and posttest stages of treatment to determine if 
the treatment conditions produced any affect in the two 
domains of functioning -- depression and anxiety. 
Data Analysis 
Several instruments were used to collect data in this 
study. The SCID and the ASI-F were used to collect 
demographic data (please refer to page 56 for an in-depth 
analysis of demographic variables) . Parametric statistical 
procedures such as means, standard deviations, effect 
sizes, and Multivariate Analysis of Variance (MANOVA) were 
used to analyze the ASI-F and POMS results. 
Effect Size. Effect size for the t test for independent 
means is the difference between the population means 
divided by the standard deviation of the population, 
ES= [ (Ml-M2) / SDpooledl (Aron & Aron, 1997; Kazdin, 1992) . 
Effect size was used to determine whether the difference 
between populations was due to the independent variable and 
if so, to determine the magnitude of that difference. 
Effect size increases with greater differences between mean 
scores and decreases with greater standard deviations in 
the population (Aron & Aron, 1997) . Cohen (1988) 
established levels of effect sizes for small, medium, and 
large differences for both a one-tailed test (a directional 
hypothesis) as well as with a two-tailed test (a non-
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directional hypothesis) . According to Cohen (1988), for a 
sample of 10 individuals in each group, .07 would equate to 
a small effect size, .18 would equate to a medium effect 
size, and .39 would equate to a large effect size. 
Power Analysis. A priori power analysis was conducted 
prior to the initiation of the study in order to address 
the issue of effect size and its relationship to sample 
size. Cohen (1988) suggested that research should have a 
.80 power coefficient; others (Aron & Aron, 1997; Kazdin, 
1986, 1992), however, have stated that expecting a large 
power coefficient makes clinical trials a virtual 
impossibility because of the economics needed to generate a 
sample size large enough to yield a power of 80%. 
Kazdin (1992) suggests that other statistical analyses 
are just as meaningful as power analysis and are more 
reasonable for clinical trials. For instance, statistical 
significance in clinical psychology research can be 
achieved by using parametric statistical procedures (e.g., 
means, standard deviations, effect size) to evaluate 
outcome data. 
Stevens (1992) offers several suggestions to improve 
power analysis: adopt a more lenient alpha level (a= .10), 
employ more stringent sample selection (i.e., increased 
homogeneity between subjects, use of repeated measures 
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designs), and ensure the linkage between the treatment and 
the dependent variable. For the purposes of this study, all 
statistical analyses use an alpha level of .10 unless 
stated otherwise. 
MANOVA Analysis. There is a large debate over whether an 
Analysis of Variance (ANOVA) or Multivariate Analysis of 
Variance (MANOVA) should be used in the analysis of an 
experimental design with multiple dependent variables. An 
ANOVA is the statistical procedure that tests the variation 
among the means of several groups, and answers the question 
of whether the means differ more than expected from 
sampling fluctuation. 
The central issue in determining whether to use the 
ANOVA or the MANOVA is controlling the alpha level. If the 
alpha level is not controlled, the Bonferroni Inequality 
effect becomes an issue. For instance, when an investigator 
is evaluating the results of statistical procedures, they 
set an alpha level (a~ .10, .05, .01, .001), usually at 
.05. The Bonferroni Inequality states that when an 
experimenter has numerous outcome tests, the upper bound on 
overall a will be the sum of the a levels. In the case of 
the current study, the overall Bonferroni would equal .80 
(8 dependent variables X the a of .10). This would increase 
85 
the likelihood of falsely rejecting the null hypothesis to 
a very high and unacceptable level. A MANOVA controls a to 
a level of reasonableness, while still evaluating 
interrelationships among the variables. This is the most 
compelling argument for the use of the MANOVA versus the 
ANOVA. 
The MANOVA is similar to the ANOVA, but the MANOVA can 
analyze multiple independent variables on several dependent 
variables simultaneously, focusing on cases where the 
variables are correlated and share a common conceptual 
meaning (Stevens, 1992) . Thus, the second major rationale 
for using the MANOVA instead of the ANOVA. Stevens (1992) 
concurs with this rationale and posits that the 
multivariate analysis of variance is indicated in the 
present study because this study used several criterion 
measures, which allows for a more comprehensive description 
of the phenomenon being evaluated. 
For the purposes of the current analysis, three MANOVAs 
are indicated. Stevens (1992, 1996) states that separate 
MANOVAs should be run for the dependent variables where the 
literature indicate that main effects should be generated, 
and secondary MANOVAs should be run on the dependent 
variables that are being evaluated on a heuristic nature. 
Thus, one MANOVA would analyze the Drug- and Alcohol-
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Status, another would analyze the Anxiety and Depression 
outcomes, and a third would analyze the psychosocial 
results. 
The first step in conducting a MANOVA analysis is 
generating input data. Brogan and Kutner (1980) state that 
the most reasonable data to be used for the MANOVA analysis 
is the difference score (sometimes referred to as gain 
score) . The difference score is computed by taking the 
posttest score minus the pretest score and computing the 
gain difference score, then the MANOVA is run on the gain 
scores. According to Stevens (1992, 1996), the experimenter 
should run the MANOVA analysis, and the first step in the 
analysis is to evaluate the Wilk,s Lambda, the Roy,s 
largest root, the Hotelling T2 , and the Pillai,s Trace to 
determine if these statistics are significant. 
Wilk,s Lamda is a measure of within-group variability 
and is a multivariate generalization of the univariate sum 
of squares within. Roy,s largest root and Hotelling T 
statistics are generalizations of the univariate F 
statistic. The multivariate two-group test, Hotelling,s ~, 
is analogous to the univariate t test used in the ANOVA 
(Stevens, 1996). Tabachnick and Fidell (1996) state that 
when an effect has only two levels (df = 1, s = 1), the 
statistical value for Wilk,s Lambda, Hotelling,s Trace, and 
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Pillai's Trace are identical. When an effect has more than 
two levels (df > 1), the F statistics are slightly 
different but all three will be either significant or 
nonsignificant, thus it is left to the researcher to decide 
which to use. If the Wilks' Lambda, Roy's largest root, the 
Hotelling's Trace, or the Pillai's Trace are significant, 
then the researcher can proceed to analyzing the MANOVA F 
statistic. If, however, the Wilk's Lambda, Roy's largest 
root, the Hotelling's Trace, or the Pillai's Trace is not 
significant, then the researcher should discontinue the 
MANOVA analysis. Stevens (1992, 1996) states that when 
there are two groups with multiple dependent variables, 
such as in the current study, the Hotelling T2 is the 
preferred multivariate statistic to determine if the 
analysis should proceed to the second level of analysis. 
Thus, the current study used the Hotelling T2 as the 
multivariate statistic. 
The second step in analyzing MANOVA results is to 
determine if the F statistic is significant. If the F 
statistic is significant, then Stevens (1996) states that 
post hoc procedures should be conducted to determine which 
dependent variable(s) contributed to the significance. 
Stevens (1992, 1996) suggests three post hoc procedures to 
determine which dependent variable contributed to the 
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significance: (1) one approach is the Roy-Bose simultaneous 
confidence interval, (2) a second approach is to conduct 
separate univariate t's on each of the dependent variable 
within that particular MANOVA, and (3) the final procedure 
is to conduct separate univariate (ANOVA) tests for the 
dependent variables of that particular MANOVA. The first 
post hoc procedure, the Roy-Bose analysis, reduces the 
power analysis and since the current study has a small 
sample size this procedure would increase the likelihood of 
falsely rejecting the null hypothesis and thus was not 
used. The second post hoc procedure (conducting t tests) 
and the third procedure (conducting separate ANOVAs) 
essentially generate similar results (the t 2 equals the 
ANOVA F statistic). Thus, MANOVA analyses were followed by 
conducting separate t tests for dependent variables where 
the MANOVA F statistic was significant (p divided by the 
number of dependent variables) (Stevens, 19~6). 
Research Question One. In relation to research question 
one (Which treatment condition [CBT or IOP] is more 
efficacious in the treatment of substance abuse in 
females?), the Alcohol- and Drug-Status subscale composite 
scores of the ASI-F were utilized as outcome measures. Each 
of these scores are ratio data, therefore means, standard 
deviations, and effect sizes were used to compare the 
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within group scores. Between group scores were analyzed 
following established MANOVA procedures. 
Research Question Two. In relation to research question 
two (To what extent does CBT and lOP increase overall 
psychosocial functioning of females who abuse substances?), 
composite scores from four subscales of the ASI-F were used 
(i.e., employment/support, legal status, family/social 
relationships, and psychiatric status). Each of these 
scores are ratio data, therefore means, standard 
deviations, and effect sizes were used to compare within 
group scores. MANOVA procedures were used to determine if 
there were any between group statistical significance. 
Research Question Three. In regard to research question 
three (To what extent does CBT and lOP reduce the frequency 
and amount of substance use) , frequency and amount of 
substance use was used for evaluative purposes. The 
frequency and amount of substance use, for the purposes of 
this study, are reported in the amount of substance used 
and the number of days of use. 
Research Questions Four and Five. In regard to research 
question four (To what extent does CBT and lOP reduce 
feelings of depression?) and research question five (To 
what extent does CBT and lOP reduce feelings of anxiety?), 
subscale scores from the Profile of Mood States (POMS) were 
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used. Due to the type of data generated by the Depression-
Dejection and Tension-Anxiety subscales of the Profile of 
Mood States (POMS), means, standard deviations, and effect 
sizes were used to compare the within group scores. MANOVA 
procedures were used to determine if there were any 




This chapter presents a comparative analysis of the data 
for the outcome variables (alcohol and drug use, anxiety, 
depression, and psychosocial functioning) . For the purposes 
of this study, please refer to page 56 for the analysis of 
the demographic data. The Addiction Severity Index, Female 
version (ASI-F) was used to gather data on substance use 
(alcohol and drug use) and general psychosocial 
functioning. The Anxiety and Depression subscales of the 
Profile of Mood States (POMS) were used to gather data on 
these two affective states. 
Addiction Severity Index Composite Scores 
Research question one examined, "Is Cognitive Behavioral 
Therapy (CBT) or Insight-Oriented Psychotherapy (IOP) more 
efficacious in the treatment of substance use/abuse in 
females, as measured by the Alcohol- and Drug-Use subscales 
of the ASI-F?" 
Means and standard deviations were used to analyze 
variability in the data for research question one; effect 
sizes (ES=(M1-M2)/SDpooled) were used to determine statistical 
significance in the variance between sample means; and, a 
MANOVA analysis was conducted to determine if there were 
any statistical significance between-groups. Table 2 
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presents the data for each group for the Alcohol and the 
Drug subscale composite scores of the ASI-F. 
Table 2 



























IOP Within-Group Analysis. Table 2 indicates that for 
the IOP treatment condition, there was an increase in the 
Alcohol Status composite score from pre- to post-test 
assessment. These scores yielded a large negative effect 
size (ES = -.53) from pre-test assessment (M = .29, SD = 
.25) to the post-test assessment (M .42, SD = .01). The 
reason for this negative effect was a result of three 
individuals who relapsed during the course of treatment; 
additional data for these individuals is reported under 
Research Question Three below. 
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Treatment yielded a small effect size (ES = .04) on Drug 
Status from the pre-test assessment (M = .19, SD = .06) to 
the post-test assessment (M = .18, SD = .05) for subjects 
assigned to the IOP treatment condition. 
CBT Within-Group Analysis. Table 2 also indicates that 
subjects in the CBT group reported significant changes in 
both the Alcohol- and the Drug-Status composite scores from 
pre- to post-test assessment. Treatment yielded a large 
effect size (ES .55) on Alcohol Status from pre-test 
assessment (M = .24, SD = .28) to the post-test assessment 
(M = . 07 I SD = .13) . 
The CBT treatment also resulted in a large effect size 
(ES = 1.03) on Drug Status from the pre-test assessment (M 
= .22, SD = .07) to the post-test assessment (M = .13, SD = 
. 07) . 
Figure 1 indicates that the CBT treatment resulted in a 
71% reduction of mean Alcohol-Status composite score from 
the pretest assessment (M = .24) to the posttest assessment 
(M = .07). This is contrasted to a 45% increase in mean 
Alcohol-Status composite score for the IOP treatment 
condition from the pretest assessment (M = .29) to the 
posttest assessment (M = .42). 
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Figure 1. Mean ASI-F Alcohol and Drug-Status composite 
scores at pretest and posttest assessment. 
Figure 1 also represents the effect of treatment on mean 
ASI-F Drug-Status composite scores. While there was 
virtually no change in mean composite scores for the IOP 
treatment condition from pretest assessment (M = .19) to 
the posttest assessment (M = .18), the mean composite score 
for the CBT group was reduced by 32% (pretest M = .19; 
posttest M = .13). 
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Between-Group Analysis. Table 3 presents the results 
from the first step in the multivariate analysis of 
variance for the two dependent variables: Alcohol Status 
and Drug Status as measured by the ASI-F. Hotelling's T2 
indicated that there was a main effect for the dependent 
variables. 
Table 3 
Multivariate Test for Alcohol- and Drug-Status 
Source Value sig. 
Hotelling's Trace 2 1.280 .056* 
* p < .05 
Since the initial step in the MANOVA procedure indicated 
that there was a main effect on the dependent variables, 
the F statistic was analyzed. Table 4 indicates that both 
the Drug Status, F(1, 17):10.236, p .013, and the effect 
for Alcohol Status, F(1, 17):5.566, p: .046, were 
statistically significant at the .10 level. 
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Table 4 













In order to determine which dependent variable was 
contributing to the overall F statistic, separate t tests 
were conducted for each dependent variable. The Alcohol 
Status t test was statistically significant, t(1, 
17)=2.359, p = .046, as was the Drug Status t test, 
t(1,17)=3.199, p = .013. Therefore, both dependent 
variables contributed to the significance of the MANOVA F 
statistic, which indicates that both dependent variables 
were statistically significant. Thus, treatment yielded 
significant outcome on both dependent variables 
Alcohol- and Drug-Status. 
Research Question Two. 
Research question two examined, "To what extent does CBT 
and IOP increase overall psychosocial functioning of 
females who abuse substances as measured by the Employment 
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Status, Legal Status, Family/Social Relationship, and 
Psychological Status subscales of the ASI-F?" 
Means and standard deviations were used to analyze 
variability in the data for research question two, effect 
sizes were used to determine statistical significance in 
the variance between sample means, and a MANOVA analysis 
was conducted to determine if there were any statistical 
significance between-groups. 
Table 5 









































IOP Within-Group Analysis. Table 5 presents the means 
data for pre- and post-test psychosocial composite scores 
of the ASI-F for both treatment conditions. The IOP 
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treatment produced virtually no change from pre-test to 
post-test for Employment Status (ES = .00), Legal Status 
(ES = .01), Family/Social Status (ES = .00), or Psychiatric 
Status (ES = .00). 
The lack of significant effect size indicates that the 
IOP treatment was not effective with increasing 
psychosocial functioning for the subjects assigned to this 
treatment condition. 
CBT Within-Group Analysis. Table 5 also indicates that 
subjects who received the CBT treatment condition yielded a 
small to medium effect size (ES .10) on Employment Status 
from the pre-test assessment (M = .72, SD = .23) to the 
post-test assessment (M = .69, SD = .20). Treatment 
resulted in a small effect size (ES = .05) on Legal Status 
from the pre-test assessment (M .21, SD = .17) to the 
post-test assessment (M = .19, SD = .17). There was a small 
to medium effect size (ES = .12) in Family/Social Status 
from the pre-test assessment (M = .41, SD = .15) to the 
post-test assessment (M = .39, SD = .20). Treatment yielded 
a medium effect size (ES = .17) in Psychiatric Status from 
the pre-test assessment (M = .29, SD = .20) to the post-
test assessment (M = .25, SD .19) . 
Between-Group Analysis. The multivariate analysis of 
variance for Employment status, Legal status, Family/Social 
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status, and Psychiatric status was conducted to determine 
is there were any between group differences. As Table 6 
indicates, Hotelling's T2 was not statistically significant 
for the psychosocial dependent variables. 
Table 6 
Multivariate Tests for Psychosocial Variables 
Source Value sig. 
Hotelling's Trace 4 .329 .451 
* p < .025 
Due to the fact that the analysis of the Hotelling's 
Trace did not yield a statistically significant difference, 
the MANOVA F statistic was not analyzed. The lack of 
statistical significance indicates that neither treatment 
condition produced a main effect for any of the 
psychosocial outcome variables. 
Research Question Three. 
Research question three examined, "To what extent does 
CBT and IOP reduce the frequency and amount of substance 
use as measured by the Alcohol- and Drug-Status subscales 
of the ASI-F?" 
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The data used for this analysis was ratio data therefore 
means and standard deviations were used in the analysis. 
Due to the fact that only three individuals relapsed, 
additional statistical analysis such as ANOVA and MANOVA 
were not used. 
Data from the ASI-F indicated that three individuals 
assigned to the IOP treatment condition reported that they 
relapsed during treatment. The number of days of their use, 
however, was dramatically reduced from the pre-test 
assessment (M = 20, SD = 12.91) to the post-test assessment 
(M = 4, SD = 2.31). Although these three individuals 
relapsed, the amount of their substance use was also 
significantly reduced from a pre-test level (M = 46 oz., SD 
= 31.09) to a post-test level (M = 24 oz., SD = 19.60). No 
subjects assigned to the CBT treatment condition relapsed 
during treatment. 
This finding is contradictory in nature. First, the 
three individuals relapsed during treatment, which suggests 
that treatment produced a negative effect. However, the 
amount of substance use and the number of days of substance 
use were both reduced, which suggests that treatment was 
effective. This finding indicates that treatment was 
clinically significant, even though the individuals 
relapsed during the course of treatment. 
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The Profile of Mood States 
Research question four examined/ "To what extent does 
CBT and IOP reduce feelings of depression in females who 
abuse substances as measured by the Depression-Dejection 
subscale of the POMS?" 
Research question five examined 1 "To what extent does 
CBT and IOP reduce feelings of anxiety in females who abuse 
substances as measured by the Tension-Anxiety subscale of 
the POMS?" 
Means 1 standard deviations/ and effect sizes were used 
to analyze within-group differences for the POMS data. 
MANOVA procedures were used to evaluate the between-group 
differences. Pearson correlations were significant (p < 
.01) from pre-test to post-test for both depression 
(rtt=.81) and anxiety (rtt=.89) subscale scores. 
IOP Within-Group Analysis. Table 7 presents data for 
both treatment conditions on the POMS Anxiety and 
Depression subscales. Subjects in the IOP treatment 
condition reported a reduction in Depression scores from a 
pre-test mean score of 22.89 (SD = 13.40) to a post-test 
mean score of 20.56 (SD = 11.42). This resulted in a medium 
effect size (ES = .20). 
The IOP subjects also reported a reduction in feelings 
of Anxiety from the pre-test (M = 19.33 1 SD = 12.27) to the 
102 
post-test assessment (M = 16.44, SD 
a medium effect size (ES = .27). 
Table 7 
10.70) which produced 




Pretest Post test 
M SD M SD 
22.89 13.40 20.56 11.42 













CBT Within-Group Analysis. Subjects assigned to the CBT 
treatment condition reported a greater reduction in the 
feelings of depression than the IOP subjects; these 
individuals reported a reduction from a pre-test group mean 
score of 14.38 (SD = 5.57) to a post-test group mean score 
of 9.88 (SD = 6.43). This difference resulted in a large 
effect size (ES = .70). 
The CBT subjects also reported a reduction in Anxiety 
scores from a pre-test group mean of 7.75 (SD = 4.63) and a 
post-test group mean of 5.13 (SD = 5.82). This too resulted 
in a large effect size (ES = .45). 
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Mean POMS Anxiety Score Mean POMS Depression Score 
25.00 25.00 .... . . . . . . . . . . .. 
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Figure 2. Mean POMS Anxiety and Depression scores 
at pretest and posttest assessment. 
Figure 2 graphically presents the main effects for mean 
POMS Anxiety and Depression scores by treatment condition. 
The IOP treatment resulted in a 15% reduction of mean 
Anxiety score from the pretest assessment (M = 19.33) to 
the posttest assessment (M = 16.44). This is contrasted to 
the 34% decrease in mean Anxiety score for the CBT 
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treatment condition from the pretest assessment (M = 7.75) 
to the posttest assessment (M = 5.13). 
Figure 2 also represents the effect of treatment on mean 
POMS Depression scores. While the IOP treatment condition 
produced a 10% reduction in scores from pretest assessment 
(M = 22.89) to the posttest assessment (M = 20.56), the 
mean score for the CBT group was reduced by 31% (pretest M 
14.38; posttest M = 9.88). 
Between-Group Analysis. The multivariate tests were 
conducted to determine if there were any main effects for 
Anxiety and Depression. As Table 8 indicates, Hotelling's T 
indicated that there was no main effect for either of the 
two dependent variables. 
Table 8 
Multivariate Test for Anxiety and Depression 
Source value sig. 
Retelling's Trace 2 .107 .491 
* p < .05 
Analysis of the Hotelling's r indicates that neither of 
the dependent variables, anxiety or depression, yielded a 
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statistically significant difference, therefore the MANOVA 
F statistic was not analyzed. The lack of statistical 
significance indicates that neither treatment condition 
produced a main effect for the treatment of anxiety or 
depression. 
Because the CBT treatment condition produced large 
effect sizes, and the fact that a MANOVA may not be 
sensitive enough to detect significance in a small sample 
(Stevens, 1996), subsequent t tests were conducted on the 
dependent variables (Anxiety and Depression) . This analysis 
indicated that there was a statistical significance for 
anxiety, t(1, 17) = 3.43, p = .08, as well as for 
depression, t(1, 17) = 3.09, p = .10. This confirmatory 
statistical analysis indicates that treatment produced 
significant outcome for both a reduction in the feelings of 
depression as well as anxiety. 
Summary 
The objective of the current study was to determine if 
either group was efficacious in the treatment of females 
who use and abuse substances. 
The major findings in this study include: CBT treatment 
was effective in the reduction of alcohol and drug use, 
depression, and anxiety; IOP was not effective in the 
reduction of alcohol use; neither IOP or CBT was effective 
106 
in increasing psychosocial functioning of the current 
sample (employment, legal, family relations, psychiatric); 
CBT was more than ten times more effective than IOP in the 
reduction of alcohol use; CBT was four times more effective 
than IOP in the reduction of drug use; CBT was two times 
more effective than IOP in the reduction of anxiety; and 
CBT was three times more effective than IOP in the 
reduction of depression. Perhaps the most significant 
finding, however, is the fact that a CBT treatment 
developed at a Veterans Affairs Medical Center on male 




Limitations, Discussion, Recommendations, and Implications 
Overview 
Empirically supported treatment for substance abuse has 
predominately focused on male clients (Hatsukami et al., 
1997), and the traditional approach to drug and alcohol 
treatment uses techniques that tend to be confrontational 
which has led clinicians to question their appropriateness 
with female substance abusers (Hatsukami et al., 1997). 
Current research posits that the optimal treatment approach 
for females may be to focus on the process of negative 
emotions (i.e., depression and anxiety) and interpersonal 
relations, both of which are more typical relapse 
indicators for female substance abusers (Stocker, 1998). 
The Cognitive-Behavioral Treatment (Carroll, 1998) in 
this study included: focusing on a functional analysis of 
the substance abuse, individualized training in recognizing 
and coping with cravings, examining the client's cognitive 
processes related to substance abuse, examining high-risk 
situations, encouragement of extra-session skills, and 
practicing of skills within session. 
The Insight-Oriented Psychotherapy (IOP) condition in 
this study draws from Khantzian's Self Medication Model 
(1985, 1986, 1988, 1990), and included: improving deficits 
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in self-care, self-esteem, self-object, and affective 
states. 
The purpose of this study was to determine if Cognitive-
Behavioral Therapy (CBT) or Insight-Oriented Psychotherapy 
(IOP) was more effective in the treatment of female 
substance abuse. Outcome variables included amount and 
frequency of drug use, the level of feelings of anxiety, 
and the level of feelings of depression. Measures that 
evaluated these domains included the Addiction Severity 
Index, Female version (ASI-F) and the Profile of Mood 
States (POMS) . 
This study was designed to (a) evaluate the 
effectiveness of empirically validated treatment protocols 
with female substance abusers, and (b) to identify 
potentially useful treatment techniques with this 
population. 
This chapter will present: (a) limitations of the study, 
(b) a discussion of the findings, (c) conclusions drawn 
from the results, (d) recommendations for practice and 
future research, (e) and implications for practice. 
Limitations 
This study is limited in generalizability because 
outcome measures were based on client self-report data, 
which may be subject to problems with recall and 
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truthfulness of the subject when reporting their substance 
use history. For instance, the study participants were 
previously involved with Child Protective Services and they 
might have wanted to portray themselves in a more favorable 
light during the assessments, which would have lowered the 
pre-test assessment scores. 
Sample and Generalizability 
There are several other threats to the external validity 
of this study: the subjects in this study were from an 
urban inner city on the West Coast, and the subjects were 
primarily women of color with histories of primarily 
cocaine and alcohol abuse. Either of these variables may 
affect the generalizability of the results of the study due 
to demand characteristics. For instance, the pattern of 
drug use of inner city African-Americans on the West Coast 
may be different from that of inner city African-Americans 
on the East Coast. There may also be differences in 
cultural values. For instance, the West Coast may have a 
more liberal view of substance use than the East Coast, or 
visa versa. Either of these conditions, if present, might 
limit the ability to generalize the current findings to 
other females of color or Caucasian females. 
This study employed controls that were designed to 
reduce many of the threats to the internal and external 
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validity of the study. For instance, treatment conditions 
were implemented following standardized implementation 
protocols (i.e., manual driven sessions). Assessment 
instruments that are industry standards and well-validated 
were used, and outcome variables were analyzed through 
statistical procedures other than power, such as effect 
size (Basham, 1986; Kazdin, 1986, 1992). Additionally, 
specific inclusionary and exclusionary parameters were 
designed to reduce the threat to the generalizability of 
the study by generating a homogenous sample. A homogenous 
sample, in theory, would highlight change caused by the 
independent variables rather than from demand 
characteristics of the sample. 
The small sample size may reduce the statistical power 
of the study. Power is the ability of the researcher to 
reject the null hypothesis when it is false (Stevens, 
1992). Power is effected by sample size, alpha level, and 
effect size. A priori power analysis indicates that for a 
two group sample of fifteen subjects in each sample, with 
an alpha level of .10, the power or ability to correctly 
reject the null hypothesis is .63. This equates to a 63% 
probability of correctly rejecting the null. In order for 
the researcher to have a power coefficient of .80 (which 
Cohen, 1998 suggests), with an alpha of .01, each group 
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would require in excess of 100 subjects, which is often not 
practical in clinical research (Kazdin, 1992; Stevens, 
1996) . 
Extraneous Variables. Another possible limitation may be 
extraneous variables. Confounding exists when some 
uncontrolled factor other than the independent variable may 
be responsible for the results. The extraneous variables, 
in this study, could include: simultaneous substance abuse 
treatment from another provider, family dynamics, or social 
variables that interfere with the treatment variable. None 
of the subjects who participated in this study were 
concurrently enrolled in another treatment program. Thus, 
this threat was reduced. 
Therapist Effects. Another limitation to this study is 
the possibility of therapist effects. It is theoretically 
possible that having only one therapist could lead to 
skewed outcome. Having only one therapist who facilitates 
both treatment condition raises the issue that the 
therapist may have been better trained in one theoretical 
orientation, the therapist may have been more aligned with 
one theory and thus more motivated and enthusiastic in its 
application. 
An attempt was made at the outset of the study to 
address this possible limitation. For instance, a concerted 
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effort was made to recruit additional therapists to 
facilitate treatment conditions, but due to the length of 
training required and the commitment to the length of 
treatment additional therapists could not be recruited. 
Crits-Christoph (1991) state that when there are numerous 
therapists, therapist effects should also be controlled 
for. The therapist can effect outcome by virtue of their 
experience, theoretical orientation, motivation, and even 
the number of therapists involved in a study. Thus, having 
only one therapist would counter the effect of having 
multiple therapists. According to Crits-Christoph (1991) if 
there is only one therapist, the therapist will effect each 
treatment condition equally. This argument is analogous to 
the placebo effect in clinical pharmacological studies. 
This threat was addressed in the current study through the 
strict adherence to treatment manuals. Adhering to the 
treatment manuals theoretically should minimize any 
therapist effects. 
It should also be noted that the CBT manual (Carroll, 
1998) was more thoroughly developed than the lOP manual 
(Lubarsky, 1984). CBT is also better suited than a 
psychodynamic paradigm to manualized treatment, this too 
may have affected the outcomes. 
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Methodologies Designed to Reduce Additional Threats 
Many of the Kazdin (1992) suggestions were incorporated 
into the current study. For instance, assessment 
instruments with high reliability and validity were used. 
Each of the outcome measures generated data where 
traditional parametric statistical analyses (e.g., means, 
standard deviations, effect sizes, and MANOVAs) could be 
used to evaluate the data. As far as sample selection is 
concerned, the current study incorporates all of the 
suggestions offered by Stevens (1992, 1996). For instance, 
the sample is highly homogenous with no statistical 
difference on any demographic area (see page 56) . The 
current study also used repeated measures to collect 
outcome data, and there is a strong linkage between 
treatments and the dependent variables. 
Discussion 
Research Question One 
Is Cognitive Behavioral Therapy (CBT) or Insight-
Oriented Psychotherapy (lOP) more efficacious in the 
treatment of substance use/abuse in females as measured by 
the Alcohol- and Drug-Status subscales of the ASI-F? 
The current study found that for both within- and 
between-groups, the CBT treatment condition was more 
efficacious than the lOP treatment condition for both Drug-
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and Alcohol-Status as measured by the ASI-F. For instance, 
the CBT treatment condition resulted in lower drug use and 
alcohol use than the IOP treatment condition. The data also 
reveal that the IOP treatment condition resulted in a 
negative treatment effect for alcohol use. Between-group 
analysis indicated that these findings reached statistical 
significance. 
These findings are consistent with previous research. 
For instance, Hall, Munoz, and Reus (1994) found that 
cognitive behavioral techniques (thought restructuring, 
relaxation training, social skills training, and 
identifying maladaptive thoughts) were significantly more 
effective than a standard treatment in achieving longer 
periods of abstinence. Becket al. (1991) also reported 
similar results where cognitive behavioral interventions 
were effective in the treatment of cocaine addiction. The 
research of Carroll et al. (1995) further supports the 
fundamental premise that substance use or addiction can be 
successfully treated through a cognitive-behavioral 
treatment approach. Woody et al. (1983) also reported that 
cognitive behavioral therapy was more effective than 
supportive expressive therapy in the reduction of substance 
use. 
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Ojehagen et al. (1997), however, found that a multi-
modal behavioral therapy and psychiatric therapy based on a 
psychodynamic paradigm were equally effective in reducing 
alcohol use. 
There are several hypotheses as to why the cognitive-
behavioral treatment condition produced statistically 
significant results for the participants of this study. 
First is the fact that individuals in the early stages of 
recovery need concrete direction in learning the steps 
necessary to break the cycle of addiction. For instance, 
the cognitive-behavioral treatment condition included 
specific sessions on several relapse prevention techniques 
(coping with cravings, developing the motivation to stop, 
and developing skills to help the user decline invitations 
to use substances) (Carroll, 1998). 
Another reason is that before individuals can stop using 
substances, they first must be committed to abstinence 
(Buelow & Buelow, 1998). The CBT subjects may have been 
more committed to abstinence or the concrete material 
covered in the CBT sessions most likely gave these 
individuals the skills necessary for abstinence. 
A third reason is that cognitive-behavioral therapy is 
structured, goal-oriented, and focused on the immediate 
problems that substance abusers face in their recovery 
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process (NIDA, 1998) . Problem-solving approaches are viewed 
as preferred treatment approaches for African-Americans and 
other ethnic groups (Clark, McClanahan, & Sees, 1998). 
Research Question Two 
To what extent does CBT and IOP increase overall 
psychosocial functioning of females who abuse substances as 
measured by four subscale scores of the ASI-F (employment, 
legal status, family/social relationships, and psychiatric? 
The current study found that with regard to these four 
dependent variables (employment, legal, family/social, and 
psychiatric), the IOP condition resulted in negligible 
within-group improvement and the CBT condition showed 
minimal within-group improvements. Between-group analysis 
found that neither group difference was statistically 
significant. 
This finding is not consistent with previous studies. 
For instance, Woody et al. (1983) reported that both 
cognitive behavioral therapy and supportive-expressive 
therapy, based on a psychodynamic paradigm, had more 
improvement in psychological functioning and employment. 
Subjects assigned to the cognitive behavioral treatment, 
however, showed more improvement with legal problems. It 
should be noted, however, that the length of treatment in 
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the Woody et al. study was lengthy, whereas the length of 
treatment in the current study was quite short. 
Khantzian et al. (1990) also reported patterns where 
both cognitive behavioral treatment and supportive 
expressive treatment was effective in improving 
psychological functioning. 
The primary reason that explains the current findings is 
the fact that neither treatment specifically incorporated 
strategies to gain employment, improve legal situations, or 
to improve psychological well being. Each of these domains 
was used to illustrate the negative impact that substance 
abuse can have on one's life, however, each area would 
require in-depth work in order to produce significant 
results. This in-depth work was outside the purview of this 
study, and any improvements in these areas would have been 
an artifact extant to the current study, and not a result 
that the current treatment was entirely responsible for 
producing. 
Research Question Three 
To what extent does CBT and IOP reduce the frequency and 
amount of substance use as measured by the Drug- and 
Alcohol-Use subscales of the ASI-F? 
The current study found that (a) subjects assigned to 
the CBT treatment condition reported a statistically 
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significant reduction in both drug and alcohol use, and (b) 
there was a negative effect in alcohol usage for subjects 
assigned to the IOP treatment condition. Three individuals 
assigned to the IOP treatment condition relapsed during the 
course of treatment. 
The primary reason that the CBT treatment produced 
significant reductions in both alcohol and drug use is the 
fact that this treatment condition was specifically 
designed for the treatment of substance abuse. Sessions 
were designed to help the individual participant develop 
skills necessary for abstinence. Thus, the CBT treatment 
regimen attempted to develop functional coping skills in 
the participants which they could draw upon rather than 
turning to substances as a coping mechanism. 
There are numerous reasons as to why the three 
individuals assigned to the IOP condition relapsed during 
treatment. One is that relapse is a part of treatment and 
is traditionally viewed as a symptom of recovery from 
substance abuse and not a failed treatment (Buelow & 
Buelow, 1998). Treatment may have uncovered psychological 
pain that the participants were unable to deal with, which 
resulted in their continued maladaptive coping mechanism --
the use of substances. 
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Another view of the relapse of these individuals is that 
the lOP treatment was at least partially effective. 
Treatment based on an insight oriented treatment paradigm 
is designed to discuss and uncover material that is often 
painful (Khantzian, 1985, 1988). Viewed from this 
perspective, the lOP treatment condition was partially 
successful, with the individuals needing further treatment 
in order to develop more adaptive coping mechanisms. 
Previous research has indicated that longer treatment 
results in better outcome or prognosis (CSAT, 1997). Thus, 
the current treatment may have been too time-limited in 
order to develop positive outcome. 
Research Question Four and Five 
To what extent does CBT and lOP reduce feelings of 
depression in females who abuse substances as measured by 
the Depression-Dejection subscale of the POMS? 
To what extent does CBT and lOP reduce feelings of 
anxiety in females who abuse substances as measured by the 
Tension-Anxiety subscale of the POMS? 
Within-group analysis indicated that both treatment 
conditions yielded positive results in the reduction of 
anxiety as well as depression. The lOP treatment condition 
produced a small effect size difference for anxiety and a 
medium effect size change for depression. The CBT treatment 
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condition, however, produced large effect size differences 
in the reduction of both anxiety and depression. Between-
group analyses indicated that the CBT group difference was 
statistically significant. 
These statistical findings corroborate previous and 
extensive research on the treatment of depression (Beck et 
al., 1991; Hall, Munoz, & Reus, 1994) and anxiety (Hollon & 
Beck, 1994; Wolpe, 1990), which indicates that these 
disorders can be successfully treated with psychotherapy. 
Initial analysis indicated that the CBT treatment 
condition produced large effect sizes, yet the between-
group MANOVA difference was not statistically significant. 
If only the effect size was used to analyze the results, 
then one would conclude that the CBT treatment condition 
yielded significant results. Stevens (1996) states that a 
MANOVA analysis may not be sensitive enough to detect 
significance in a small sample. Due to conflicting 
statistical results, separate t tests for these two 
independent variables were conducted (Stevens, 1996). This 
analysis resulted in statistical significance and 
corroborated the large effect size differences. 
The primary reason that the CBT treatment condition 
produced significant results in the treatment of anxiety is 
that individuals who abuse substances tend to be anxious 
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over not being able to properly handle situations. 
Substance abusers often form the opinion that when they are 
under the influence of a substance that they can handle a 
problematic situation better than if they are clean. This 
is in fact a distorted perception, yet a firmly held one. 
The CBT treatment condition covered various high-risk 
situations with specific sessions devoted to coping with 
these situations. This is designed to give the subjects the 
confidence that they might be able to handle a problematic 
situation without turning to substances. 
Similar to the distortions associated around false 
esteem is the fact that many individuals who abuse 
substances feel guilty because of the negative impact that 
substances have had on their lives (i.e., the removal of 
children, loss of employment) . This quilt often generates 
feelings of shame and embarrassment. The CBT treatment 
condition included in-session discussions of the negative 
consequences of their substance use. Thus, the CBT 
treatment approach provided specific awareness, skills, and 
a change of perception. Whereas, the lOP was more 
relational based, and produced minimal effects. 
Conclusions 
Epidemiologic research has established the fact that 
anxiety and depression are potentiating factors that often 
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lead to substance use and abuse by females (Reiger et al., 
1990). Etiological research has also established that 
substance use and abuse in females progresses faster and is 
more destructive than in males who abuse substances. With 
these facts in mind, contemporary research has consistently 
shown that treatment can produce significant outcomes with 
substance abuse (Becket al., 1991; Buelow & Buelow, 1998; 
Carroll, 1998; Clark, McClanahan, Smith, & Landry, in 
press; Hall, Munoz, & Reus, 1994; Haller, 1991; Khantzian, 
1985, 1986, 1988; Luborsky, 1984; Moras, 1998a; O'Brien et 
al., 1995; Onken et al., 1997; Woody et al., 1983), anxiety 
(Beck, 1979; Ellis & Yeager, 1989; Hollon & Beck, 1994;) 
and depression (Beck, 1979; Hall, Munoz, & Rues, 1994; 
Meichenbaum, 1977; McNair, Lorr, & Droppelman, 1981; 
Weissman et al., 1977; Wolpe, 1990). 
It should be noted that the conclusions drawn from the 
current findings should be taken with caution due to the 
aforementioned limitations of this study. For the purposes 
of this section, conclusions are presented by treatment 
condition. 
Insight-Oriented Psychotherapy 
The current findings suggest that IOP treatment is not 
the treatment of choice for females with a history of 
substance use and abuse who are in the early stages of 
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recovery. Others have suggested that treatment based on a 
psychodynamic paradigm should not be used with individuals 
who are in the early stages of recovery because these 
treatments are often anxiety provoking and could lead to 
further substance use (Levenson, 1995) . The current 
findings corroborate this viewpoint. Both the current 
findings, as well as previous research, suggest that 
substance abuse treatment based on psychodynamic paradigms 
might be used with individuals who are committed to 
abstinence and who have demonstrated a history of being 
abstinent. 
Since the IOP treatment condition did not specifically 
cover psychosocial domains, it is difficult to reach any 
definitive conclusions from the current findings. Previous 
research, however, has established that IOP can be more 
efficacious than CBT in the treatment of certain 
psychosocial functioning domains, such as psychological 
functioning and employment (Woody et al., 1983). 
It is theoretically logical that a relational therapy, 
such as the IOP treatment condition, should be more long-
term. Thus, the eight-session limit may have negatively 
affected the outcomes of the IOP treatment condition. 
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Cognitive-Behavioral Therapy 
The fact that the CBT treatment condition resulted in 
statistically significant outcomes leads one to conclude 
that the subjects in this study responded well to treatment 
based on a cognitive-behavioral paradigm. This contradicts 
the traditional clinical bias that females respond best to 
process oriented treatment. 
Previous research of substance abuse has been conducted 
primarily in Veteran Affairs Medical Center settings with 
male clients, and the findings of this study indicate that 
a treatment approach designed for male veterans can be 
transported to: (1) a female population, and (2) to an 
outpatient community mental health setting. The findings 
indicate that substance abuse is a cross-cultural variable 
that often subsumes cultural differences, and this view is 
shared by other researchers (Clark & McClanahan, 1998; 
Clark, McClanahan, & Sees, 1998). 
The CBT treatment condition also produced significant 
differences in the reduction of both anxiety and depression 
for the study sample. While this corroborates previous 
research, this study is the first to empirically evaluate 
outcomes with a female sample. The findings corroborate the 
fact that a CBT treatment paradigm can be used successfully 
with a female sample. 
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Recommendations 
The results of this study suggest that clinicians and 
researchers should follow several tenets when conducting 
research with females who abuse substances. 
Recommendations for Clinicians 
1. Substance abuse treatment for individuals in the 
early stages of recovery should be based on a cognitive-
behavioral paradigm. Individuals in early stages of 
recovery require concrete direction in identifying their 
particular patterns and associating those patterns with the 
negative consequences of their substance use. 
2. Substance abuse treatment based on a psychodynamic 
paradigm might be useful for individuals who are in the 
latter stages of recovery and who have a history of 
abstinence. 
3. In order that an outcome variable can be evaluated 
properly, each variable should be incorporated into the 
treatment paradigm. For instance, if an experimenter is 
evaluating the treatment outcome effect on employment, then 
the treatment should include employment strategies, such as 
resume building, into the treatment regimen. 
4. Clinicians should conduct thorough assessments using 
empirically-validated instruments. One of the instruments 
used in this study, the SCID, is generally viewed as 
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cumbersome and requires fairly extensive training in order 
to develop a level of competency that is fundamental to its 
administration. In a clinical setting, however, this 
instrument can be shortened and only critical items 
included in an intake interview. This would increase the 
clinical utility of the instrument while gathering 
pertinent data. The general criticism to creating a 
shortened instrument is the fact that the instrument's 
validity would be invalid. Item analysis can re-establish 
validity coefficients quite easily, thereby addressing this 
criticism, while making the instrument more user friendly. 
5. Clinicians should establish realistic goals of 
treatment and adapt the treatment regimen accordingly. By 
incorporating each individual's history into the treatment 
regimen, clients can make the linkage from substance use to 
other life problems, such as involvement with Child 
Protective Services. Clients can often gain insight into 
their own problems vicariously through others sharing their 
"stories". 
6. A final point is the growing position that abstinence 
is not an all or nothing proposition. Reduced substance use 
is in itself a great accomplishment and should not be 
viewed as failure. Instead, reduced substance consumption 
should be rewarded. 
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Recommendations for Further Research 
This study focused on the evaluation of which treatment 
approach was the most efficacious in the .treatment of 
female substance abuse and ancillary issues, such as 
anxiety and depression. 
These findings suggest several recommendations for 
future research, such as: 
1. The ideal comparative study would follow a Solomon 
Four Group design where two therapists who would provide 
each of the treatment conditions. Therapist effects could 
then be measured and controlled for by treatment cell. 
2. Subsequent research should evaluate the aspects of 
the CBT treatment approach that resulted in a reduction in 
alcohol use, drug use, depression, and anxiety (i.e., in-
session discussions, didactic approach, problem solving 
exorcises) . 
3. Research should be conducted using an IOP treatment 
condition with a sample of individuals who are in the 
latter stages of recovery to determine if this treatment 
approach is effective. 
4. Research should be conducted using the CBT treatment 
manual (Carroll, 1998) for females with a history of 
substance abuse and who are in the latter stages of 
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recovery to determine if this treatment approach is 
effective for females. 
5. Research should be conducted that compares this CBT 
manualized treatment with IOP treatment with a sample of 
individuals in the latter stages of recovery to determine 
which, if either, treatment is more effective in the 
treatment of substance abuse for females. 
6. Researchers should evaluate the individuals' 
motivation for change and determine the appropriateness for 
inclusion in the research. For instance, an individual in 
the early stages of recovery but who is not committed to 
abstinence should be excluded from treatment. The reason 
for this exclusion is that the individual would not benefit 
from treatment and may even have a negative affect on other 
participants. 
7. Research should be conducted to determine the leading 
cause(s) of relapse, and these causes should be 
incorporated into all treatment regimens, regardless of 
theoretical paradigm. 
Implications for Practice 
The ultimate objective of this study was to determine if 
a traditional approach to treating male substance abuse 
(Cognitive Behavioral Therapy) is a more efficacious 
treatment than a process oriented approach (Insight-
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Oriented Psychotherapy) . Previous results indicate that 
components of each treatment approach may be efficacious 
for certain subtypes of substance abuse or mood factors. As 
Najavits, Weiss, and Shaw (1997) state, finding the best 
type of treatment for the substance-abusing female is 
tantamount. 
To this end, the current findings suggest that a 
treatment program based on the tenets of cognitive-
behavioral therapy is the treatment of choice for females 
in the early stages of recovery. Additional research is 
needed in order to conclude whether a treatment program 
based on a psychodynamic paradigm is efficacious in the 
treatment of substance abuse for individuals in the early 
stages of recovery. Additional research is also needed in 
order to determine which, if either, treatment (CBT or IOP) 
is efficacious in the treatment of substance abuse for 
individuals in the latter stages of recovery. 
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Appendix A 
Research Design Schematic 
Study Design: 
Pretest-Posttest Comparative Experimental Design. 
"R(cognitive Behavioral Therapy) 01 X 02 
"R(Insight Oriented Psychotherapy) 01 X 02 
Variables: 
Independent V ariable1: 
Independent Variable2 : 
Dependent V ariable1: 
Dependent V ariable2 : 
Dependent Variable3: 
Dependent V ariable4 : 






Cognitive Behavioral Treatment (CBT) 
Insight Oriented Psychotherapy (lOP) 
Drug- and Alcohol-Status 
Psychosocial Functioning 




Structured Clinical Interview using the DSM 
ASI-F, Drug- and Alcohol-Status subscales 
ASI-F, Composite Scores 
ASI-F, Drug- and Alcohol Use subscales 
POMS, Depression subscale 
POMS, Anxiety subscale 
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Appendix B 
Research Participant Recruitment 
Do life's pressures cause you to drink or use drugs? 
Are you concerned that your drinking is out of control? 
Are you using more drugs than you think you should be? 
Do friends comment about your drinking or drug use? 
Have you been neglecting your obligations? 
Ifyou are a female, between the ages of 17 and 44, and would like to receive counseling 
regarding your alcohol or drug use, please call Terry at (415) 422-6037. After an initial intake 
session regarding your drinking or drug use, you will receive eight group counseling sessions 
with others who have concerns similar to your own. Counseling is free and confidential. You 
will be paid for your time after each session. Your name will not be included on any records. 
Please call Terry at (415) 422-6037, leave a message that indicates the best time to reach you. 
Your call will be promptly returned. 
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Appendix C 
Telephone Screening Script 
Introduction. Thank you for taking an interest in the study. I 
would like to give you a brief description of the project. 
Afterward, if you're still interested I'll ask you some 
questions to see if you meet the basic requirements of the 
study. 
Studv Overview. This research study is investigating which 
treatment is more effective in the treatment of substance abuse 
in females. Everyone who participates in the study will receive 
one group counseling session per week for a period of eight 
weeks. Half of the people participating in the study will 
receive Cognitive-Behavioral (CBT) counseling and the other half 
will receive Insight Oriented Psychotherapy (IOP) . 
Prior to being accepted into the study, you will be asked to 
complete a thorough evaluation that will involve one two-hour 
appointment. After which, if you are still eligible and you 
decide to participate, you will be given a schedule for your 
counseling sessions. After each appointment you will be 
reimbursed for your time. 
Questions & Answers. 
Q. Do you have any questions? 
Q. Are you interested in participating in the program? 
If yes, proceed to the Telephone Pre-Screening 
Inclusionary/Exclusionary Form. 
If no, thank the subject for their inquiry, and inquire if 
they would like a referral to a community treatment facility. 
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Appendix D 
Telephone Pre-Screening Inclusionary/Exclusionary For.m 
Demographic: 
Caller's name: 
Phone number: (home) 
Date of Birth: 





Age: Ethnicity: Marital Status: Gender: 
Current Drug Use Patterns: 
Do you currently use any street drugs? ____ Yes ____ No 
What is your drug of choice? 
How many days/weeks have you used in the past month? 
How much did you use in the past month? 
What was the dollar value of the drug you used (per day for the 
last 4 weeks)? 
Medical: 




___ Heart Attack 
___ Heart Disease or Angina 
___ Irregular Heart Rhythm 
___ High Blood Pressure 
___ Kidney Disease 
___ Liver Disease 
___ Bulimia 
Do you have any other significant medical problems? 
Are you currently taking any prescribed medications? 
Have you ever been told that you have a manic-depressive 
disorder? (Y/N) 
Have you ever heard voices or seen things that you knew 
were not there? (Y/N) 
If yes, was it due to your drug use? (Y/N) 




Consent to Participate in A Research Project 
Title of Study: 
Investigator: 
Purpose: 
A Comparative Evaluation of Cognitive-
Behavioral Therapy (CBT) and Insight Oriented 
Psychotherapy (IOP) in the Treatment of 
Substance Abusing Females. 
Terry Michael McClanahan, M.A. 
Doctoral Candidate 
Dept of Counseling Psychology 
University of San Francisco 
(415) 422-6037 
This study is investigating the effectiveness of two treatments to 
reduce the symptoms associated with substance abuse in females. 
Procedures: 
If you decide to participate in the study, an initial two-four 
hour appointment will be scheduled. During this appointment you 
will be asked to complete various questions concerning your drug 
use history, and occurrences in your life. Following this initial 
appointment, if you decide to participate in the study, you will 
be scheduled for your counseling sessions. At the end of your 
treatment, a final 1-3 hour appointment will also be necessary. 
During this final appointment you will also be asked to complete 
various questions concerning your drug use. There are two groups 
in this research project, and you have an equal chance of being 
assigned to either treatment. Treatment lasts eight sessions. 
Risks: 
There are no known risks aside from the time involved to 
participate, which is a total of approximately 15 hours for the 
entire study, and includes the 2-4 hours for the initial 
interview, the 1 hour per counseling session, and the 1-3 hours 
for the post-therapy appointment. While there are no known risks 
associated with either treatment, you will be asked to discuss 
some things in depth that have happened to you. This may cause 
discomfort to you, but each therapy is designed for you to raise 
this discomfort with your therapist. 
Benefits: 
This study may be beneficial to you. Therapy has been proven to be 
effective at reducing suffering in people with severe emotional 
distress. 
Confidentiality: 
All information concerning you will be held in confidence. A file 
is necessary for each person that participates in the study, 
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however, you will be assigned a number, and that number will be 
how your file is maintained. In addition, you will be instructed 
to use only your particular number on any questionnaire that you 
complete during the study. 
By agreeing to participate in this study, you agree that the 
Principal Investigator is allowed to use the findings of this 
study in professional literature that includes professional 
presentations, journal articles, books, etc. In the event that the 
investigator uses the information derived from this study, the 
information will contain only your subject number. 
Names and addresses of both yourself and your contacts will be 
maintained separately from your treatment chart, in a locked file 
to which only the principle investigator has access. 
Costs and Compensation: 
The treatment is provided at no cost to the study participants. 
Study participants may be compensated for participating in the 
study at the following rates: completion of the initial assessment 
interview ($10), each weekly therapy appointment ($5), final post-
therapy appointment ($10), and a bonus for completing all 
requirements ($10) . This equals to a total of $70 that is possible 
for completing all requirements. 
Right to Refuse or Withdraw from Treatment: 
Participation in this study is voluntary. At any point in time 
during the treatment, you have the right to refuse to participate 
and may withdraw from the treatment study. 
A pager number of Terry Michael McClanahan (Principal 
Investigator) will be given to you for emergency use (e.g., 
relapse, medical emergency) if you decide to participate in the 
study. Your signature below indicates that you have read and 
understand the information contained in this document, that you 
have agreed to participate in the study, that you understand that 
your participation is voluntary, and that you have the right to 
withdraw from the study at any time, should you decide to do so. 
Signature of Research Participant Date 
Signature of Principal Investigator Date 
Informed Consent Page 2 
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Appendix F 
Research Study Participant Reimbursement Schedule 
Research Participant Name ________________________________ __ 
Please initial beside the appropriate line that you have 
received the amount of the reimbursement for participating in 
this research project: 
Intake Assessment ($10.00) (initials) 
Counseling session #1 ($5.00) (initials) 
Counseling session #2 ($5.00) (initials) 
Counseling session #3 ($5.00) (initials) 
Counseling session #4 ($5.00) (initials) 
Counseling session #5 ($5.00) (initials) 
Counseling session #6 ($5.00) (initials) 
Counseling session #7 ($5.00) (initials) 
Counseling session #8 ($5.00) (initials) 
End-of-Treatment Assessment ($10.00) (initials) 
Bonus for all requirements ($10.00) (initials) 
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Appendix G 
Structured Clinical Interview using the DSM (SCID) 
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..,CID-I/NP or P W/PSY SCREEN (for DSM-IV) Psychotic Symptoms (FEB 1996 FINAL). 
B/C PSYCHOTIC SCREENING MODULE (FOR SCID-I/NP OR p W/PSYCHOTIC SCREEN) 
THIS. MODULE IS FOR CODING PSYCHOTIC AND ASSOCIATED SXS THAT HAVE 
BEEN PRESENT AT ANY POINT IN THE PERSON'S LIFETIME. IT CAN BE USED FOR 
CLINICAL AND RESEARCH SETTINGS WHERE THOSE WITH A HISTORY OF PSYCHOTIC SXS 
THAT ARE NOT DUE TO SUBSTANCE USE OR A GENERAL MEDICAL CONDITION OR THAT 
OCCUR OUTSIDE THE CONTEXT OF A MOOD DISORDER ARE TO BE EXCLUDED. 
FOR EACH PSYCHOTIC SYMPTOM CODED "3," DESCRIBE THE ACTUAL CONTENT AND 
INDICATE THE PERIOD OF TIME DURING WHICH THE SYMPTOM WAS PRESENT. 
FOR ANY PSYCHOTIC AND ASSOCIATED SYMPTOMS CODED "3," DETERMINE 
WHETHER THE SYMPTOM IS DEFINITELY "PRIMARY" OR WHETHER THERE IS A 
POSSIBLE OR DEFINITE ETIOLOGIC SUBSTANCE (INCLUDING MEDICATIONS) OR 
GENERAL MEDICAL CONDITION. THE FOLLOWING QUESTIONS MAY BE USEFUL IF 
THE OVERVIEW HAS NOT ALREADY PROVIDED THE INFORMATION: 
Just before (PSYCHOTIC SXS) began, were you using drugs? ... on any 
medications? ... did you drink much more than usual or stop drink-
ing after you had been drinking a lot for a while? ... were you 
physically ill? 
IF YES TO ANY: Has there been a time when you had (PSYCHOTIC SXS) 
and were not (USING DRUGS/TAKING MEDICATION/CHANGING YOUR DRINK-
ING HABITS/ILL)? 
Now I am going to ask you about 
unusual experiences that people 
sometimes have. 
DELUSIONS 
False personal beliefs based on incorrect 
inference about external reality and firmly 
sustained in spite of what almost everyone 
else believes and in spite of what consti-
tutes incontrovertible and obvious proof or 
evidence to the contrary. The belief is not 
one ordinarily accepted by other members of the 
person's culture or subculture. Code overvalued 
ideas (unreasonable and sustained beliefs 
B/C. 1 
that are maintained with less than delusional I 
Has it ever seemed like people 
were talklng about you or taking 
special notice of you? 
IF YES: Were you convinced 
they were talking about you or 
did you think it might have 
been your imagination? 
What about receiving special 
messages from the TV, radio, or 
newspaper, or from the way things 
were arranged around you? 
intensity) as "2." I 
I 
Delusion of reference, i.e., ? 1 2 3 I BC. 
events, objects, or other I I 
people in the individual's I I 
immediate environment have a 1 3 I I BC. 
particular or unusual signifi- I I 
cance. POSS/DEF PRI-1 I 
SUBST /GMC MARY I I 
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What about anyone going out of 
their way to give you a hard 
time, or trying to hurt you? 
Did you ever feel that you 
were especially important in 
some way, or that you had special 
powers to do things that other 
people couldn't do? 
Did you ever feel that something 
was very wrong with you physi-
cally even though your doctor 
said nothing was wrong ... like 
you had cancer or some other 
terrible disease? 
Persecutory delusion, i.e., 
the individual {or his or her 
group) is being attacked, 
harassed, cheated, persecuted, 
or conspired against. 
DESCRIBE: 
Grandiose delusion, i.e., 
content involves exaggerated 
power, knowledge or importance, 
or a special relationship to a 
deity or famous person. 
DESCRIBE: 
Somatic delusion, i.e., 
content involves change or 
disturbance in body appearance 
or functioning. 
DESCRIBE: 
Have you ever been convinced that 
something was very wrong with the way 
a part or parts of your body looked? 
{Did you ever feel that something 
strange was happening to parts of 
your body?) 
{Did you ever have any unusual 
religious experiences?) 
{Did you ever feel that you had 
committed a crime or done some-
thing terrible for which you 
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SCIO-I/NP or P W/PSY SCREEN (for DSM-IV) Psychotic Symptoms (FEB 1996 FINAL) B/C. 3 
Did you ever hear things 
that other people couldn't 
hear, such as noises, or the 
voices of people whispering 
or talking? (Were you awake 
at the time?) 
IF YES: What did you hear? 
How often did you hear it? 
IF VOICES: Did they comment 
on what you were doing or 
thinking? 
How many voices did you 
hear? Were they talking 
to each other? 
Did you ever have visions or 
see things that other people 
couldn't see? (Were you 
awake at the time?) 
NOTE: DISTINGUISH FROM AN ILLU-
SION, I.E., A MISPERCEPTION OF 
A REAL EXTERNAL STIMULUS. 
HALLUCINATIONS (PSYCHOTIC) 
A sensory perception that has 
the compelling sense of reality 
of a true perception but occurs 
without external stimulation of 
the relevant sensory organ. 
(CODE "2" FOR HALLUCINATIONS 
THAT ARE SO TRANSIENT AS TO 
BE WITHOUT DIAGNOSTIC SIGNI-
FICANCE) 
Auditory hallucinations 
when fully awake, heard 
either inside or outside 
of head 
DESCRIBE: 
A voice keeping up a 
running commentary 
on the individual's 
behavior or thoughts 
as they occur 
Two or more voices 
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SCID-I/NP or P W/PSY SCREEN (for DSM-IV) Psychotic Symptoms (FEB 1996 FINAL) B/C. 4 
What about strange sensations 
in your body or on your skin? 
(What about smelling or tasting 
things that other people couldn't 
smell or taste?) 
IF A MAJOR DEPRESSIVE OR MANIC 
EPISODE HAS EVER BEEN PRESENT: 
Has there ever been a time when 
you had (PSYCHOTIC SXS) and you 
were not (DEPRESSED/MANIC)? 
Tactile hallucinations, e.g., ? 1 2 3 I BC. 
electricity I I 
II 
DESCRIBE: 1 3 I I BC. 
II 
POSS/DEF PRI-1 I 
SUBST/GMC MARY! I 
-------'' I 
I 
Other hallucinations, e.g., ? 1 2 3 I BC. 
gustatory, olfactory I I 
II 
Check if: 1 3 II BC. 
gustatory I I BC. 
--olfactory POSS/DEF PRI-J I BC. 
SUBST/GMC MARY! I 





ANY ITEM CODED "3" IN "PRIMARY" ? 1 3 I BC. 
SECTION I I I 
/GO TO -I lA PRI=-1 I 
I NEXT I I MARY I I 
!MODULE I I PSYCHO-I I 
I JITIC SX II 
I HAS I I 
!BEEN I I 
I PRESENT I I 
I 
Psychotic symptoms occur at ? 1 3 I BC. 
times other than during mood I 
syndromes I I I 
I I I 
NOTE: CODE "3" IF NO MOOD 1-::::P-:::S-;-;Y-;:::;C-;-;H-;:;0-;:;;T-::;I-;:::;C I IPSY- -II 
SYNDROMES OR PSYCHOTIC SXS !MOOD DIS- I ICHOTIC I I 
W/0 MOOD EPISODES. CODE !ORDER. IF I JDISOR- I I 
"1" ONLY IF PSYCHOTIC SYMP- !ALLOWED BYI IDER I I 
TOMS OCCUR EXCLUSIVELY OUR- !STUDY, GO I !LIKELY I I 
ING UNEQUIVOCAL MOOD SYN- ITO NEXT I I I 
DROMES . I MODULE. I I I 
----------------------------------------------------------------------1 I 
I 
EXPLORE DETAILS AND DESCRIBE DIAGNOSTIC SIGNIFICANCE: 
?=inadequate information l=absent or false 2=subthreshold 3=threshold or true 
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~- SUBSTANCE USE DISORDERS 
ALCOHOL USE DISORDERS (LIFETIME) 
IF SCREENING QUESTION lll ANSWERED "NO," CHECK HERE 
*NON-ALCOHOL SUBSTANCE USE DISORDERS,* E. 10 
IF SCREENER NOT USED OR IF QUESTION #1 IS 
ANSWERED "YES," CONTINUE: 
What are your drinking habits 
like? (How much do you drink?) 
(Has there ever been a time in your 
life when you had five or more drinks 
on one occasion?) 
AND SKIP TO 
When in your life were you 
drinking the most? (How long 
did that period last?) 
RECORD DATE OF HEAVIEST 
USE AND DESCRIBE PATTERN: 
During that time ... 
how often were you drinking? 
what were you drinking? how much? 
During that time ... 
did your drinking cause problems 
for you? 
did anyone object to your drinking? 
IF ALCOHOL DEPENDENCE SEEMS LIKELY, 
CHECK HERE AND SKIP TO *ALCOHOL 
DEPENDENCE,-*--£. 4. 
IF ANY INCIDENTS OF EXCESSIVE DRINKING OR 
ANY EVIDENCE OF ALCOHOL-RELATED PROBLEMS, CONTINUE WITH 
*ALCOHOL ABUSE,* ON NEXT PAGE. 
IF NEVER HAD ANY INCIDENTS OF EXCESSIVE DRINKING AND 
THERE IS NO EVIDENCE OF ANY ALCOHOL-RELATED PROBLEMS, 
SKIP TO *NON-ALCOHOL SUBSTNCE USE DISORDERS,* E. 10 
?=inadequate information !=absent or false 2=subthreshold 
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!SCREEN Q#l I 
I YES II NO I 
I II I -,-
1 IF NO: GO TO 
!*NON-ALCOHOL I 
!USE DISORDERS*! 
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SCID-I Version 2.0 (for DSM-IV) Alcohol Abuse (FEB 1996 FINAL) E. 2 
*LIFETIME ALCOHOL ABUSE* 
.et me ask you a few more 
questions about your drinking 
habits. 
ALCOHOL ABUSE CRITERIA 
A. A maladaptive pattern of 
substance use leading to clinically 
significant impairment or distress, 
as manifested by one (or more) of 
the following occurring within a 
twelve month period: 
Have you ever missed work or 
school because you were intoxi-
cated, high, or very hung over? 
(How often? What about doing 
(1) recurrent alcohol use ? 
a bad job at work or failing 
courses at school because of your 
drinking?) 
IF NO: What about not keeping 
your house clean or not ~aking 
proper care of your children 
because of your drinking? 
(How often?) 
resulting in a failure to 
fulfill major role obligations 
at work, school, or home 
(e.g., repeated absences or poor 
work performance related to 
alcohol use; alcohol-related 
absences, suspensions, or 
expulsions from school; neglect 
of children or household) 
IF YES TO EITHER OF ABOVE: How 
often? (Over what period of time?) 
Did you ever drink in a situa-
tion in which it might have 
been dangerous to drink at all? 
(Did you ever drive while you 
were really too drunk to drive?) 
IF YES AND UNKNOWN: How often? 
(Over what period of time?) 
Has your drinking gotten you into 
trouble with the law? 
IF YES AND UNKNOWN: How often? 
(Over what period of time?) 
IF NOT ALREADY KNOWN: Has your 
drinking caused problems with 
other people, such as with 
family members, friends, or peo-
ple at work? (Have you ever got-
ten into physical fights or had 
bad arguments about your 
drinking?) 
IF YES: Did you keep on 
drinking anyway? (Over what 
period of time?) 
(2) recurrent alcohol use in 
situations in which it is 
physically hazardous (e.g., 
driving an automobile or 
operating a machine when 
impaired by alcohol use) 
(3) recurrent alcohol-related 
legal problems (e.g., arrests 
for alcohol-related disorderly 
conduct) 
(4) continued alcohol use 
despite having persistent or 
recurrent social or inter-
personal problems caused or 
exacerbated by the effects of 
alcohol (e.g., arguments with 
spouse about consequences 
of intoxication, physical 
fights) 




























1 2 3 EC. 
1 2 3 ED. 
1 2 3 EE. 
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SCID-I Version 2.0 (for DSM-IV) 
I 
Alcohol Abuse 
AT LEAST ONE "A" ITEM 
CODED "3" 
IF NO POSSIBILITY OF PHYSIOLOGICAL DEPENDENCE 
USE, GO TO *NON-ALCOHOL USE DISORDERS,* E. 10 
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ALCOHOL DEPENDENCE 
I'd now like to ask you some 
more questions about your 
drinking habits. 
Have you often found that when you 
started drinking you ended up 
drinking much more than you · 
were planning to? 
IF NO: What about drinking 
for a much longer period of 
time than you were planning 
to? 
Have you tried to cut down or stop 
drinking alcohol? 
IF YES: Did you ever 
actually stop drinking alto-
gether? 
(How many times did you try 
to cut down or stop altogether?) 
IF NO: Did you want to stop 
or cut down? (Is this something 
you kept worLying about?) 
Have you spent a lot of time 
drinking, being high, or hung 
over? 
Have you had times when you would 
drink so often that you started to 
drink instead of working or spend-
ing time at hobbies or with your 
family or friends? 
Alcohol Abuse (FEB 1.996 FINAL) E. 4 
ALCOHOL DEPENDENCE CRITERIA 
A maladaptive pattern of 
alcohol use, leading to 
clinically significant 
impairment or distress, as 
manifested by three (or more) 
of the following occurring 
at any time in the same 
twelve month period: 
NOTE: CRITERIA FOR ALCOHOL 
DEPENDENCE ARE NOT IN OSM-IV 
ORDER 
(3) alcohol is often taken ? 
in larger amounts OR 
over a longer period than 
was intended 
(4) there is a persistent ? 
desire OR unsuccessful 
efforts to cut down or con-
trol substance use 
(5) a great deal of time is ? 
spent in activities necess-
ary to obtain alcohol, use 
alcohol, or recover from its 
effects 
(6) important social, occu- ? 
pational, or recreational 
activities given up or reduced 
because of alcohol use 
I 
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IF NOT ALREADY KNOWN: Has your 
drinking ever caused any psycho-
.ogical problems like making you 
depressed or anxious, making it 
difficult to sleep, or causing 
"blackouts?" 
IF NOT ALREADY KNOWN: Has your 
drinking ever caused significant 
physical problems or made a 
physical problem worse? 
IF YES TO EITHER OF ABOVE: Did 
you keep on drinking anyway? 
Have you found that you needed to 
drink a lot more in order to get 
the feeling you wanted than you 
did when you first started drinking? 
IF YES: How much more? 
IF NO: What about finding that 
when you drank the same amount, it 
had much less effect than before? 
Have you ever had any withdrawal 
symptoms when you cut down or 
stopped drinking like ... 
... sweating or racing heart? 
... hand shakes? 
... trouble sleeping? 
... feeling nauseated or vomiting? 
... feeling agitated? 
... or feeling anxious? 
(How about having a seizure or 
seeing, feeling, or hearing things 
that weren't really there?) 
IF NO: Have you ever started the day 
with a drink, or did you often drink 
to keep yourself from getting the 
shakes or becoming sick? 
(7) alcohol use is continued ? 
despite knowledge of having 
a persistent or recurrent 
physical or psychological 
problem that is likely to 
have been caused or exacer-
bated by alcohol (e.g., con-
tinued drinking despite recog-
nition that an ulcer was made 
worse by alcohol consumption) 
(1) tolerance, as defined by ? 
either of the following: 
(a) a need for markedly in-
creased amounts of alcohol 
to achieve intoxication or 
desired effect 
(b) markedly diminished 
effect with continued use 
of the same amount of 
alcohol 
(2) withdrawal, as manifested ? 
by either (a) or (b): 
(a) at least TWO of the 
following: 
autonomic hyperactivity 
(e.g., sweating or pulse 
rate greater than 100) 
increased hand tremor 
insomnia 
nausea or vomiting 
psychomotor agitation 
anxiety 




transient visual, tactile, or 
auditory hallucinations or 
illusions 
(b) alcohol (or a substance from 
the sedative/hypnotic/anxiolytic 
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IF UNKNOWN: When did (SXS CODED "3" AT LEAST THREE "A" ITEMS 1 3 I EO. 
ABOVE) occur? (Did they all happen CODED "3" AND ITEMS OCCURRED I 




I I ALCOHOL I I 
I I DEPENDENCE I I 
I I I 
I I 
I Indicate if: I EP. 
I 1 - With Physiological Dependence I 
I (current evidence of tolerance or I 
I withdrawal) I 
I 2 - Without Physiological Dependence I 
I (no current evidence of tolerance I 
I or withdrawal) I 
I I 
I I I 
I I GO TO DEPENDENCE CHRONOLOGY, E. 7 I I 
I I 
IF ALCOHOL ABUSE QUESTIONS (PAGES E.1-E.3) HAVE NOT YET I 
BEEN ASKED, GO TO PAGE E.1. AND CHECK FOR ABUSE. I 
I 
IF ABUSE QUESTIONS HAVE BEEN ASKED AND ABUSE IS PRESENT, CODE "3" 1 3 I EQ. 
OTHERWISE, IF QUESTIONS HAVE BEEN ASKED AND ABUSE IS NOT PRESENT, I 
GO TO *NON-ALCOHOL USE DISORDERS,* E.10. I I 
I GO TO *NON- I I ALCOHOL I I 
I ALCOHOL USE I I ABUSE I I 
!DISORDER,*- I I I 
JE. 10 I I I 
--------------------------------------------------------------------------1 I I 
How old were you when you first Age at onset of Alcohol I ER. 
had (ABUSE SXS CODED "3")? Abuse (CODE 99 IF UNKNOWN) I 
I 
IF UNCLEAR: During the past Criteria for Alcohol Abuse ? 1 3 I ES. 
month, have you had anything met at any time in past I 
at all to drink? month I I ! 
I PAST I I CURRENT I I 
IF YES: Tell me more about it. I ABUSE I I ABUSE I I 
(Has your drinking caused you ---1 I I 
any problems?) I GO TO *NON- I I 
I ALCOHOL USE I I 
I DISORDER,* I I 
IE. 10 II 
?=inadequate information l=absent or false 2=subthreshold 3=threshold or true 
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*CHRONOLOGY FOR DEPENDENCE* 
~ow old were you when you first 
had (LIST OF ALCOHOL DEPENDENCE 
OR ABUSE SXS CODED "3")? 
IF UNCLEAR: During the past 
month, have you had anything 
at all to drink? 
IF YES: Tell me more about it. 
(Has your drinking caused you 
any problems?) 
Alcohol Dependence (FEB 1996 FINAL) 
Age at onset of Alcohol 
Dependence or Abuse (CODE 
99 IF UNKNOWN) 
Full criteria for Alcohol 
Dependence met at any time 
in past month (or never had 
a month without symptoms of 
Dependence or Abuse since 









I *REMISSION I 
I SPECIFIERS* I 




















-----------------------------------------------------------------------------1 I I I 
*SEVERITY SPECIFIERS FOR DEPENDENCE* I 
NOTE SEVERITY OF DEPENDENCE FOR WORST WEEK OF PAST MONTH 
(Additional questions about the effect of alcohol on social 
and occupational functioning may be necessary.) 
1 Mild: Few, if any, symptoms in excess of those required 
to make the diagnosis, and the symptoms result in 
no more than mild impairment in occupational function-
ing or in usual social activities or relationships 
with others (or criteria met for Dependence in the 
past and some current problems). 
2 Moderate: Symptoms or functional impairment between "mild" and 
"severe." 
3 Severe: Many symptoms in excess of those required to make the 
diagnosis, and the symptoms markedly interfere with 
occupational functioning or with usual social activities 
or relationships with others. 
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*REMISSION SPECIFIERS FOR DEPENDENCE* 
THE FOLLOWING REMISSION SPECIFIERS CAN BE APPLIED ONLY AFTER NO CRITERIA 
FOR DEPENDENCE OR ABUSE HAVE BEEN MET FOR AT LEAST ONE MONTH IN THE PAST. 
Note: These specifiers do not apply if the individual is On 
Agonist Therapy or In a Controlled Environment (next page). 
Number of months prior to interview when last 
had some problems with Alcohol 
l Early Full Remission: For at least one month, but less than 
twelve months, no criteria for Dependence or Abuse have been met. 
2 Early Partial Remission: ·For at least one month, but less than 
twelve months, one or more criteria for Dependence or Abuse have 
been met (but the full criteria for Dependence have not been met). 
3 Sustained Full Remission: None of the criteria for Dependence 
or Abuse have been met at any time during a period of twelve 
months or longer. 
4 Sustained Partial Remission: Full criteria for Dependence have 
not been met for a period of twelve months or longer; however, 
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Check 
Check 
if On Agonist Therapy: The individual is on a prescribed 
agonist medication (e.g., valium) and no criteria for 
Dependence or Abuse have been met for that class of medi-
cation for at least the past month (except tolerance to, 
or withdrawal from, the agonist). This category also 
applies to those being treated for Dependence using 
a partial agonist or a mixed agonist/antagonist. 
if In A Controlled Environment: The individual is in an 
environment where access to alcohol and controlled 
substances is restricted and no criteria for Dependence 
or Abuse have been met for at least the past month. 
Examples are closely-supervised and substance-free jails, 
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*NON-ALCOHOL SUBSTANCE USE DISORDERS* (LIFETIME DEPENDENCE AND ABUSE) 
~F SCREENING QUESTIONS i2 AND i3 ARE BOTH ANSWERED "NO," CHECK HERE 
AND SKIP TO THE NEXT MODULE. 
!SCREEN Qi 21 
I YES II NO I 
I II I _____ -,-
IF SCREENER NOT USED OR IF QUESTION i2 OR QUESTION i3 WAS 
ANSWERED "YES," CONTINUE: 
1 SCREEN Qi 3 I I 
I YES II NO I I 
Now I am going to ask you about 
your use of drugs or medicines. 
I II I I 
I I 
I __ I ,F--,-.,N"'"O___,-T-0-BOTH:-
SHOW DRUG LIST TO SUBJECT. 
Have you ever taken any of 
these to get high, to sleep 
better, to lose weight, or to 
change your mood? 
IGO TO NEXT 
I MODULE 
REFERRING TO LIST ON NEXT PAGE, DETERMINE LEVEL OF DRUG USE USING GUIDELINES BELOW 
GUIDELINES FOR RATING LEVEL 
OF DRUG USE: 
FOR EACH DRUG GROUP EVER USED: 
-> IF STREET DRUG: When were you 
I using (DRUG) the most? 
I 
I (Has there ever been a time 
I when you used it at least 
I ten times in a one-month 
I period of time?) 
I 
-> IF PRESCRIBED: Did you ever 
get hooked (become dependent) 
on (PRESCRIBED DRUG) or take 
much more of it than was 
prescribed? 
Either (1) or (2): 
(1) has ever taken street drug 
more than 10 times in a one-month 
period 
(2) reports becoming dependent 
on a prescribed drug OR using 
much more of it than was pre-
scribed 
-> IF DRUG GROUP NEVER USED OR USED ONLY ONCE, OR IF PRESCRIBED DRUG USED 
I AS DIRECTED, CIRCLE "1" FOR DRUG GROUP ON E.ll 
I 
-> IF DRUG GROUP USED AT LEAST TWICE, BUT LESS THAN LEVEL INDICATED ON 
( 1), CODE "2" FOR DRUG GROUP ON E .11 
-> IF DRUG GROUP USED AT LEVEL INDICATED IN ITEM(1} OR IF POSSIBLY 
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CIRCLE THE NAME OF EACH DRUG EVER 
JSED (OR WRITE IN NAME IF "OTHER") 
Sedatives-hypnotics-anxiolytics: 
Quaalude, Seconal, Valium, Xanax, 
Librium, barbiturates, Miltown, 
Ativan, Dalmane, Halcion, Resto-
ril, or other: 
Cannabis: mar1JUana, hashish, THC, 
or other: 
Stimulants: amphetamine, "speed", 
crystal meth, dexadrine, Ritalin, 
"ice", or other: 
Opioids: heroin, morphine, opium, 
Methadone, Darvon, codeine, Perco-
dan, Demerol, Dilaudid, unspeci-
fied or other: 
Cocaine: intranasal, IV, freebase, 
crack, "speedball," unspecified 
or other: 
Hallucinogens/PCP: LSD, mescaline, 
peyote, psilocybin, STP, mush-
rooms, PCP ("angel dust"), Extasy, 
MDMA, or other: 
Other: steroids, "glue," paint, in-
halants, nitrous oxide ("laughing 
gas"), amyl or butyl nitrate ("pop-
pers"), nonprescription sleep or 
diet pills, unknown, or other: 
RECORD PERIOD OF HEAVIEST USE 
(AGE OR DATE, AND DURATION) 
AND DESCRIBE PATTERN OF USE 
ANY DRUG GROUPS CODED "2" 
OR "3" 
INDICATE LEVEL 
OF USE (USE 
GUIDELINES, 
E. 10) 
? 1 2 3 
? 1 2 3 
? 1 2 3 
? 1 2 3 
? 1 2 3 
? 1 2 3 




I NEXT I 
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IF AT LEAST THREE DRUG GROUPS USED 
AND PERIOD OF INDISCRIMINANT USE 
"EEMS LIKELY, ASK THE FOLLOWING: 
You've told me that you've used 
(DRUG/ALCOHOL). Was there a 
period where you were using a lot 
of different drugs at the same 
time and that it did not matter 
what you were taking as long as 
you could get high? 
Non-Alcohol Use Disorders (FEB 1996 FINAL) 
Behavior during the same 12-month 1 
period in which the person was re-
peatedly using at least three groups 
of substance (not including caffeine 
and nicotine), but no single substance 
predominated. Further, during this 
period, the Dependence criteria were 
(likely) met for substances as a group 
but not for any specific substance. 
NOTE: IN CASES THAT INCLUDE PERIODS OF 
INDISCRIMINATE USE AND OTHER PERIODS 
OF USE OF SPECIFIC DRUGS, POLY DRUG 
SHOULD BE CODED IN ADDITION TO SPECIFIC 
DRUG COLUMNS. 
IF NO DRUG CLASSES WERE CODED "3" ON PREVIOUS PAGE (I.E., "2"S ONLY), 
GO TO *SUBSTANCE ABUSE*, E. 22 
E. 12 
I 















FOR DRUG CLASSES CODED "3" CIRCLE THE APPROPRIATE COLUMNS ON PAGES E. 12 TO E. 18 
Now I'm going to ask you some specific questions 
about your use of (DRUGS CODED "3"). 
ASK EACH OF THE FOLLOWING QUESTIONS FOR 
EACH DRUG CODED "3": For (DRUG) ... 
Have you often found that when you 
started using (DRUG) you ended up 
1sing much more of it than you 
were planning to? 
IF NO: What about using it 
over a much longer period of 
time than you were planning to? 
NOTE: CRITERIA FOR DEPENDENCE 
ARE IN A DIFFERENT ORDER THAN 
IN DSM-IV. 
(3) The substance is often 
taken in larger amounts OR 
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STIMU OPI coc HALL/ 
LANTS OID AINE PCP POLY OTHER 
3 3 3 3 3 3 
2 2 2 2 2 2 
1 1 1 1 1 1 
? ? ? ? ? ? 
ELL. EMM. ENN. EOO. EPP. EQQ. 
2=subthreshold 3=threshold or true 
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Dependence (FEB l996 FINAL) E. l3 
Have you tried to cut down or stop 
using (DRUG)? 
IF YES: Have you ever actually 
stopped using (DRUG) altogether? 
(How many times did you try to 
cut down or stop altogether? 
IF UNCLEAR: Did you want to stop 
or cut down? 
IF YES: Is this something 
you kept worrying about? 
(4) There is a persistent 
desire OR unsuccessful efforts 
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STIMU OPI coc HALL/ 
LANTS OID AINE PCP POLY OTHER 
3 3 3 3 3 3 
2 2 2 2 2 2 
l l 1 1 1 1 
? ? ? ? ? ? 
ETT. EUU. EVV. EWW. EXX. EYY. 
2=subthreshold 3=threshold or true 
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Have you spent a lot of time 
using (DRUG) or doing whatever 
fOU had to do to get it? Did it 
take you a long time to get back 
to normal? (How much time? As long 
as several hours?) 
(5) A great deal of time is 
spent in activities necessary 
to obtain the substance, use 
























PCP POLY OTHER 
3 3 3 
2 2 2 
l 1 1 
EZZ. EAAA. EBBS. ECCC. EDDD. EEEE. EFFF. EGGG. 
Have you had times when you would use 
(DRUG) so often that you used (DRUG) instead 
of working or spending time on hobbies 
or with your family or friends? 
(6) Important social, occu-
pational, or recreational 
activities given up or 





































? ? ? ? ? ? ? ? 
EHHH. EIII. EJJJ. EKKK. ELLL. EMMM. ENNN. EOOO. 
?=inadequate information l=absent or false 2=subthreshold 3=threshold or true 
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IF NOT ALREADY KNOWN: Has (DRUG) 
caused psychological problems, like 
laking you depressed? 
IF NOT ALREADY KNOWN: Has (DRUG) 
ever caused physical problems or 
made a physical problem worse? 
IF YES TO EITHER OF ABOVE: Did 
you keep on using (DRUG) anyway? 
(7) The substance use is contin-
ued despite knowledge of having 
had a persistent or recurrent 
physical or psychological 
problem that is likely to have 
been caused or exacerbated by 
by the substance (e.g., 
recurrent cocaine use despite 
recognition of cocaine-related 
depression) 
Have you found that you needed to 
use a lot more (DRUG) in order 
:o get high than you did when 
you first started using it? 
IF YES: How much more? 
IF NO: What about finding that 
when you used the same amount, 
it had much less effect than 
before? 
(1) Tolerance, as defined by 
either of the following: 
(a) a need for markedly in-
creased amounts of the sub-
stance to achieve intox-















(b) markedly diminished effect 
with continued use of the ? 

















?=inadequate information !=absent or false 
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STIMU OPI coc HALL/ 
LANTS OID AINE PCP POLY OTHER 
3 3 3 3 3 3 
2 2 2 2 2 2 
1 1 1 1 1 1 
? ? ? ? ? ? 
ERRR. ESSS. ETTT. EUUU. EVVV. EWWW. 
STIMU OPI coc HALL/ 
LANTS OID AINE PCP POLY OTHER 
3 3 3 3 3 3 
2 2 2 2 2 2 
1 1 1 1 1 1 
? ? ? ? ? ? 
EZZZ. EAAAA. EBBBB. ECCCC. EDDDD. 
2=subthreshold 3~threshold or true 
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THE FOLLOWING ITEM MAY NOT APPLY TO 
:ANNABIS AND HALLUCINOGENS/PCP 
Have you ever had withdrawal symptoms, 
that is, felt sick when you cut down 
or stopped using (DRUG)? 
IF YES: What symptoms did 
you have? REFER TO LIST OF 
WITHDRAWAL SYMPTOMS ON E. 17 
IF HAD WITHDRAWAL SXS: After not 
using (DRUG) for a few hours or 
more, have you often used it to keep 
yourself from getting sick with 
(WITHDRAWAL SXS)? 
What about using (DRUG IN SAME 
GROUP) when you were feeling 
sick with (WITHDRAWAL SXS) so 
that you would feel better? 
(2) Withdrawal, as manifested 
by either of the following: 
(a) the characteristic 
withdrawal syndrome for the 
substance 
(b) the same (or a closely 
related) substance is taken 


















?=inadequate information l=absent or false 
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STIMU OPI coc HALL/ 
LANTS OID AINE PCP POLY OTHER 
3 3 3 3 3 3 
2 2 2 2 2 2 
1 1 1 1 1 1 
? ? ? ? ? ? 
EHHHH. EIIII. EJJJJ. EKKKK. ELLLL. 
2=subthreshold 3=threshold or true 
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LIST OF WITHDRAWAL SYMPTOMS (FROM DSM-IV CRITERIA) 
Listed below are the characteristic withdrawal symptoms for those classes of 
psychoactive substances for which a withdrawal syndrome has been identified. 
(NOTE: A specific withdrawal syndrome has not been identified for CANNABIS 
AND HALLUCINOGENS/PCP). Withdrawal symptoms may occur following the cessation 
of prolonged moderate or heavy use of a psychoactive substance or a reduction 
in the amount used. 
SEDATIVES, HYPNOTICS, AND ANXIOLYTICS: 
Two (or more) of the following, developing within several hours to a few days 
after cessation (or reduction) of sedative, hypnotic, or anxiolytic use, which 
has been heavy and prolonged: 
(1) autonomic hyperactivity (e.g., sweating or pulse rate greater than 100) 
(2) increased hand tremor 
(3) insomnia 
(4) nausea or vomiting 
(5) transient visual, tactile, or auditory hallucinations or illusions 
(6) psychomotor agitation 
(7) anxiety 
(8) grand mal seizures 
STIMULANTS/COCAINE 
Dysphoric mood AND two (or more) of the following physiological changes, 
developing within a few hours to several days after cessation (or reduction of 
substance use which has been heavy and prolonged) : 
1) fatigue 
(2) vivid, unpleasant dreams 
(3) insomnia or hypersomnia 
(4) increased appetite 
(5) psychomotor retardation or agitation 
OPIOIDS: 
E. 17 
Three (or more) of the following, developing within minutes to several days after 
cessation (or reduction) of opioid use which has been heavy and prolonged (several weeks 
or longer) or after administration of an opioid antagonist (after a period of opioid use): 
(1) dysphoric mood 
( 2) na"usea or vomiting 
(3) muscle aches 
(4) lacrimation or rhinorrhea 




( 9) insomnia 
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IF UNKNOWN: When did (SXS CODED 
"3" ABOVE) occur? (Did they all 
tappen around the same time?) 
SUBSTANCE DEPENDENCE At least 3 
items are code "3" AND items 




With Physiological Dependence 
(current evidence of tolerance or 
withdrawal) 
Without Physiological Dependence 

























FOR EACH CLASS CODED "3", GO TO *CHRONOLOGY*, E. 19 
Fewer than 3 items coded "3" 
I 
GO TO *LIFETIME SUBSTANCE ABUSE*, E. 23 
AND ASK THE FOUR ABUSE ITEMS FOR EACH 
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*CHRONOLOGY* 
·F UNCLEAR: During the past month, 
.1ave you used (DRUG) at all? 
IF YES: Has your (DRUG) use 
caused you any problems? 
(How about being high when you were 
at school or work, or taking care of 
children? How about missing some-
thing important because of being high 
or hung over? How about using (DRUG) 
while you were driving? How about 
getting into trouble with the law 
because of your use of (DRUG)?) 
NOTE: YOU MAY NEED TO REFER TO SED.-
ABUSE CRITERIA, PAGE E. 23. HYPN.-
ANX. 
Full criteria for Dependence met 
at any time in past month (or 3 
never had a month without symp-
toms of Dependence or Abuse XX 
since onset of Dependence) 
I 
FOR EACH CLASS CODED "3" INDICATE 
SEVERITY SPECIFIERS ON FOLLOWING PAGE 
No symptoms of Dependence or 
Abuse in past month or meets 
partial criteria after one 
month without symptoms 
I 
FOR EACH CLASS CODED "1" INDICATE 










STIMU OPI coc- HALL-
LANTS OID AINE PCP 
3 3 3 3 
XX XX XX XX 
1 1 1 1 
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FOR EACH DRUG CLASS WITH CURRENT DEPENDENCE, CODE SEVERITY: 
SED.-
JSE SCALE BELOW TO RATE SEVERITY HYPN.- CANN STIMU OPI coc- HALL-
OF DEPENDENCE FOR WORST WEEK OF ANX. ABIS LANTS OID AINE PCP 
PAST MONTH (Additional questions 
about the effect of the substance 1 1 1 1 1 
on social and occupational 
functioning may be necessary) 2 2 2 2 2 
1 Mild: 
3 3 3 3 
Few, if any, symptoms in excess of those required 
to make the diagnosis, and the symptoms result in 
3 
no more than mild impairment in occupational function-
ing or in usual social activities or relationships 
with others. 
2 Moderate: Symptoms or functional impairment between "mild" and 
"severe." 
3 Severe: Many symptoms in excess of those required to make the 
diagnosis, and the symptoms markedly interfere with 
occupational functioning or with usual social activities 
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*REMISSION SPECIFIERS* 
THE FOLLOWING REMISSION SPECIFIERS CAN BE APPLIED ONLY AFTER NO CRITERIA 
FOR DEPENDENCE OR ABUSE HAVE BEEN MET FOR AT LEAST ONE MONTH IN THE PAST. 
Note: these specifiers do not apply if the individual is 
On Agonist Therapy or In a Controlled Environment. 
(See page E 9 for definitions of these specifiers). 
1 Early Full Remission: For at least one month, but for less than 
twelve months, no criteria for Dependence or Abuse have been met. 
2 Early Partial Remission: For at least one month, but less than 
twelve months, one or more criteria for Dependence or Abuse have 
been met (but the full criteria for Dependence have not been met). 
3 Sustained Full Remission: None of the criteria for Dependence 
or Abuse have been met at any time during a period of twelve 
months or longer. 
4 Sustained Partial Remission: Full criteria for Dependence have 
not been met for a period of twelve months or longer; however, 
one or more criteria for Dependence or Abuse have been met 










AINE PCP POLY 
Early Full Remission 1 1 1 1 1 1 1 
Early Partial Remission 2 2 2 2 2 2 2 
Sustained Full Remission 3 3 3 3 3 3 3 
Sustained Partial Remission 4 4 4 4 4 4 4 
Check if On Agonist Therapy 
Check if In a Controlled Environment 
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*LIFETIME SUBSTANCE ABUSE* 
->FOR EACH DRUG CLASS CODED "2" (I.E., DRUGS USED 
AT A LEVEL OF <10 TIMES IN ANY ONE MONTH), START 
THIS SECTION WITH THE FOLLOWING INTRODUCTION: 
Now I'm going to ask you some specific 
questions your use of (DRUGS CODED "2"). 
-> FOR EACH DRUG CLASS CODED "3" ON PAGE E. 18 
THAT DID NOT MEET CRITERIA FOR DEPENDENCE. 
Now I'd like to ask you a few 
more questions about your use 
of (DRUGS CODED "3" THAT DID 
NOT MEET CRITERIA FOR DEPENDENCE). 
Have you ever missed work or school 
because you were intoxicated, high, 
or very hung over? (How often? What 
about doing a bad job at work or failing 
courses at school because of your [DRUG] 
use?) 
IF NO: What about not keeping your 
house clean or not taking proper 
care of your children because of 
your (DRUG) use? 
IF YES TO EITHER OF ABOVE: How often? 
(Over what period of time?) 
(1) Recurrent substance use SED/ 
SUBSTANCE ABUSE CRITERIA 
A. A maladaptive pattern of 
substance use leading to 
clinically significant impair-
ment or distress, as mani-
fested by one (or more) of the 
following occurring within a 
twelve month period: 
resulting in a failure to ful- HYPN/ CANN STIMU OPI coc HALL/ 
fill major role obligations at ANX ABIS LANTS OID AINE PCP 
work, school, or horne (e.g., 
repeated absences or poor 3 3 3 3 3 3 
work performance related to 
substance use; substance- 2 2 2 2 2 2 
related absences, suspensions, 
or expulsions from school; 1 1 1 1 1 1 
neglect of children or house-








SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Abuse 
Have you ever used (DRUG) in a situation 
in which it might have been dangerous 
to be using (DRUG) at all? 
(Have you ever driven while you were 
really too high to drive?) 
IF YES AND UNKNOWN: How often? 
(Over what period of time?) 
(2) Recurrent substance use 
in situations in which it is 
physically hazardous (e.g., 
driving an automobile or 
operating a machine when 








Has your use of (DRUG) ever gotten you 
into trouble with the law? 
IF YES AND UNKNOWN: How often? 




(3) Recurrent substance- 3 
related legal problems (e.g., 

















(FEB 1996 FINAL) E. 23 
OPI coc HALL/ 
OID AINE PCP POLY OTHER 
3 3 3 3 3 
2 2 2 2 2 
1 1 1 1 1 
XX XX XX XX XX 
OPI coc HALL/ 
OID AINE PCP POLY OTHER 
3 3 3 3 3 
2 2 2 2 2 
1 1 1 1 1 
XX XX XX XX XX 
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IF NOT ALREADY KNOWN: Has your 
use of (DRUG) caused problems with 
'ther people, such as with 
family members, friends, or 
people at work? (Did you ever 
get into physical fights or 
bad arguments about your 
drug use?) 
IF YES: Did you keep on using 
(DRUG) anyway? (Over what period 
of time?) 
(4) Continued substance use SED/ 
despite having persistent or HYPN/ CANN STIMU OPI coc HALL/ 
recurrent social or inter- ANX ABIS LANTS OID AINE PCP POLY OTHER 
personal problems caused or 
exacerbated by the effects 3 3 3 3 3 3 3 3 
of the substance (e.g., 
arguments with spouse about 2 2 2 2 2 2 2 2 
consequences of intoxication, 
physical fights) 1 1 1 1 1 1 1 1 
XX XX XX XX XX XX XX XX 
SED/ 
HY.PN/ CJWN STIMU OPI coc HALL/ 
"AN X ABIS LANTS OID AINE PCP POLY OTHER 
SUBSTANCE ABUSE (LIFETIME): 3 3 3 3 3 3 3 3 
At least one "A" item 
is coded "3" 
1 1 1 1 1 1 1 1 
XX XX XX XX XX XX XX XX 
FOR DRUG CLASSES WITH LIFETIME SED/ 
ABUSE (I.E., CODED "3" ON PRIOR HYPN/ CANN STIMU OPI coc HALL/ 
ITEM): ANX ABIS LANTS oro AINE PCP POLY OTHER 
Has some symptoms of Substance 3 3 3 3 3 3 3 3 
Abuse in past month 
IF UNCLEAR: When was the last 1 1 1 1 1 1 1 1 
time you had problems with 
(SUBSTANCE)? XX XX XX XX XX XX XX XX 
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Appendix H 
Addiction Severity Index - Female (ASI-F) 
180 
Supplementa~ Administration Manual 
for the 
Expanded Female Version of the 
Addiction Severity Index (AS/) Instrument, 
The AS/- F 
U.S. Department of Health and Human Services 
Substance Abuse and Mental Health Services Administration 
Center for Substance Abuse Treatment 
Rockwall II Building 
5600 Fishers Lane 
Rockville, Maryland 20857 
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Leave no blanks. Where appropriate code items: 
X=question not answered 
N=question not applicable 
Use only one character per item. 
AS I-F 
Item numbers circled are to be asked at follow-up. Items with 
an asterisk are cumulative and should be rephrased at follow-
up (See Manual). 
Space is provided after sections for additional pertinent 
comments. 
SEVERITY RATINGS 
The severity ratings are interviewer estimates of the patient's 
need for additional treatment in each area. The scales range 
from 0 (no treatment necessary) to 9 (treatment needed to 
intervene in life-threatening situation). Each rating is based 
upon the patient's history of problem symptoms. present 
condition and subjective assessment of her treatment needs in 
a given area. For a detailed description of severity ratings' 
derivation procedures and conventions, see manual. 
IDENTIFICATION INFORMATION 
LAST 4 DIGITS OF SOCIAL SECURITY NUMBER: 
INTERVIEWER CODE NUMBER: ___ _ 
DATE OF ADMISSION: ______ DATE OF INTERVIEW: _____ _ 
TIME BEGUN: ____ : ____ !=A.M. 2=P.M. (circle one) 
GENDER !=Male 2=Female 
CLASS: __ !=Intake 2=Follow-up CONTACT CODE: __ !=In Person 2=Phone 













M E A D L F p 
E M L R E A s 
D p c u G M y 
I I 0 G A I c 
c s H L s H 
A u 0 0 
L p L c 
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PATIENTS RATING SCALE 





INTERVIEWER SEVERITY RATING 
0-1 No real problem 
2-3 Slight problem 
4-5 Moderate problem 
6-7 Considerable problem 
8-9 Extreme problem 






l. How long have you lived at this address? 
Years Months 
2. Is this residence owned by you or your family?__ O=No l=Yes 
3. Whatisyourdateofbirth? __ __ ! ____ ! __ _ _ 
4. In what country were you born? ___________ code: ___ _ 
4a If other than U.S., how many years have you lived in U.S.? ___ _ 
S. In what country was your mother born? ________ code: ___ _ 
6. In what country was your father born? ________ code: ___ _ 
7. What race do you consider yourself to be? _____ _ 
1 :White (not of Hispanic origin) 
2:Black (born in U.S.) 
J=Black (other) 
4"' Native American 
S: Alaskan Native 
6: Asian of Pacific Islander 
7= Hispanic - Mexican 
8= Hispanic - Dominican 
9= Hispanic - Puerto Rican 
10= Hispanic- Cuban 
11 = Other Hispanic 
12= Other------------



































12. Have you been in any kind of a controlled residential setting like a hospital or a jail (but not a shelter) in the 
past 30 days? O=No l=Yes 
If YES, cheek all that apply: 
For each setting, indicate number of days 
a Jail 
b. Alcohol or drug treatment 
c. Medical treatment 











14 .. What is the occupation of the head of household? 
1 =Higher Executives; Large Proprietors; Major Professionals 
2=Business Managers; Medium Proprietors: Lesser Professionals 
3=Administrative Personnel; Small Proprietors; Minor Professionals 
4=Clerical!Sales Workers; Technicians 
5:eSkilled Manual Employees 




IO=None; No Work History 
15. How many times have you been pregnant? _____ _ 




17. How old were you when the fU"St baby was born? ___ _ 
18a.Starting with the youngest child, what is the sex and birthdate of each of your children? 
NOTE SEX IN COLUMN A; ENTER BIRTIIDA TES (COLT TMN B) IN CHART BELOW. 
FOR EACH CHILD ASK: 
l8b. Where is living now? ENTER CODE IN COLUMN C Of CHART; 
ASK FOR ADDITIONAL INFORMATION FOR CODES 5, 6, 7. 
O=With patient 







.. _____ _ 
2-------
3. _____ _ 
4. _____ _ 
5. _____ _ 
6 ______ _ 
7 ______ _ 
s ______ _ 
9. _____ _ 
10. _____ _ 
4=Adopted 
S=Institution 
6=Died (When)------7=0ther ______________ __ 
(B) (C) 

















I. How many times in your life have you been hospitalized for medical 
problems? (INCLUDE ODs, DTs; EXCLUDE DETOX, PREGNANCY) ____ _ 
2. How long ago was your last hospitalization for a physical problem 
(NOT PREGNANCY)? __ __ _ __ _ 
Years Months 
3. Do you have any chronic medical problems which continue to interfere with 
yourlife? ___ O=No l=Yes ________ _ 
Specify 
4. Have you ever had any of the following health problems? USE STREET TERMS 






Pelvic Inflammatory Disease 
HIV+ 
AIDS 
5. Have you ever had a fit or a seizure? ___ O=No 1 =Yes 
6. Are you taking any prescribed medication on a regular basis for a physical 
problem? ___ O=No l=Yes 
7. Do you receive a pension for a physical disability? (EXCLUDE PSYClllA TRIC 
DISABILITY) __ O=No l=Yes _________ _ 
Specify 
8. How many days have you experienced medical problems in the past 30? 
(NOT PREGNANCY RELATED) ___ _ 
FOR QUESTIONS 9 & I 0 PLEASE ASK PATIENT TO USE TIIE PATIENTS RATING SCALE 
9. How troubled or bothered have you been by these medical problems in the 
past 30 days? __ _ 




INTERVIEWER SEVERITY RATING 
11. How would you rate the patient's need for medical treatment? 
CONFIDENCE RATINGS 
Is the above information significantly distorted by: 
12. Patient's misrepresentation? ___ O=No l=Yes 
13. Patient's inability to understand? ___ O=No 1=Yes 
COMMENTS 
EMPLOYMENT/SUPPORT STATUS 
1. Educationcomp1eted (GED=l2 years) ___ _ 
Years Months 
2. Training or technical education completed 
Months 
3. Do you have a profession, trade or skill? 
O=No 
l=Yes __________________ _ 
Specify 
4. Do you have a valid driver's license? ___ O=No 1 =Yes 
S. Do you have an automobile available for use? O=No l=Yes 
(ANSWER NO IF NO VALID DRIVER'S LICENSE) 
6. How long was your longest full-time job? 
Years Months 
7. Usual (orlast) occupation. 
(Specify in detail) 
S. Does someone contribute to your support in any way? O=No l=Yes 
(Sa AND Sb APPLY ONLY IF ITEMS IS YES) 
Sa Who is that person? (RELATIONSHIP) __ 
1 =Spouse/partner 4=Grandparent 
2=Parent/foster parent S=Other relative 
3=Brother/sister 6=Unrelated other 
Sb. Does this constitute the majority of your support? ___ O=No I=Yes 
9. Usual employment pattern. past 3 years. __ _ 
188 
I =full time ( 40 hrslweek) 
2=part time (regular hours) 





8=in controlled environment 
10. How many days were you paid for working in the past 30? _____ _ 
(INCLUDE "UNDER 1HE TABLE" WORK) 
How much money did you receive from the following sources in the past 30 days? 
11. Employment (net income) 
12. Unemployment compensation 
13. Welfare (DPA) (AFDC) 
14. WlC 
15. Food stamps 
16. Pension, benefits or social security 
17. Mate, family or friends 
(Money for personal expenses) 
18. Illegal activities 
19. How many people depend on you for the majority of their food, shelter, 
etc.? 
20. How many days have you experienced employment problems in the past 30? 
FOR QUESTIONS 21 & 22 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE 
21. How troubled or bothered have you been by these employment problems in the past 30 days? 
22. How important to you NOW is counseling for these employment problems? 
INTERVIEWER SEVERITY RATING 
23. How would you rate the patient's need for employment or support 
counseling? __ _ 
CONFIDENCE RATINGS 
Is the above information significantly distorted by: 
24. Patient's misrepresentation? ___ O=No l=Yes 






1. Alcohol, any use 
2. Alcohol, to intoxication 
3. Heroin, total 
4. Heroin, snorting 
S. Heroin, shooting 
6. Methadone, illegal 
7. Other opiates/analgesics 
(Percodan, Dialudid, opium,etc.) 
8. Barbiturates, all routes 
(Seconal "reds", etc.) 
9. Barbiturates, oral 
~0. Barbiturates, shooting 
11. Other sedatives!hypnoticsltranq. _____ _ 
(Valium, Librium, Xanax, etc.) 
12. Cocaine, total 
13.Cocaine,snorting 
14. Cocaine, shooting 
1S.Cocaine,~basing 
16. Crack Cocaine 
17. All "speed" 
18. Amphetamine, oral 
(Dexedrine, "Bennies, 
Black Beauties, etc) 
SPECIFY 






AGE OF 1ST USE 
DRUG/ALCOHOL USE 
PAST 30 DAYS LIFETIME USE 
MONTHS 
20. Methamphetamine snorting 
(Methedrine, "crystal meth") 
21. Methamphetamine shooting 
22. "Ice" smoking 
23. Marijuana, hashish 






25. lnhalants,(glue gas, 
solvents, etc) 
Specify ---------
26. More than one 
substance per day 
(including alcohol) 
J.D._ 
AGE OF 1ST USE 
Note: Heroin, snorting and Heroin, shooting may add up to more than Heroin, total because both forms of administration may 
be used on some or all of the same days or months of use. Detailed questioning may be necessary to determine these 
differences. This also holds true for Barbiturates, all routes, Cocaine, total and All "speed". 
COMMENTS 
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19. Which substance is the major problem? 
PLEASE CODE AS ABOVE, OR OO=No problem 
55=Alcohol & Drug (Dual addiction) 
66=Polydrug 
WHEN NOT CLEAR, ASK PATIENT 
20. How long was your last period of voluntary abstinence from this 
major substance? ______ (OO=Never abstinent) 
Months 
21. How many months ago did this abstinence end? 
(OO=Still abstinent, 99= No clean period) 
22. How many times have you: 
Had alcohol d.t.'s Chorrors") 
Overdosed on drugs 
23. In the past 30 days, how often did you have anything with alcohol to 
drink like beer, wine, or liquor? 
!=Never 
2= 1 time per month or less 
3=2-3 times per month 
4=1-2 times per week 
5=3--l times per week 
6=nearly every day 
7=0nceaday 
8=Twice a day or more 
23b. On those days, how much did you have usually'? _____ _ 
(NUMBER OF DRINKS) 
24. Doyousmokecigarettes? ___ O=No l=Yes 
25. About how many cigarettes per day did you smoke during the past 30 days? _____ _ 
1.0._ 
26. How many times during the past 30 days did you stay up past 4 am. because you were using drugs or alcohol? 
O=None 3=Three times 
!=Once 
2=Twice 
4=4 or more times 
27. Do you sleep until after 11 am. most days? O=No 1=Yes 
27a IF YES, Is this because of your working hours? ___ O=No !=Yes 
28. How many times in your life have you been treated for: 
Alcohol abuse: 
Drug abuse: 




30. How much would you say you spent during the past 30 days on: 
Alcohol 
Drugs 
31. How many days have you been treated in an outpatient setting for alcohol or drugs in the past 30 days? 
(INCLUDE NA, AA) __ __ . 




FOR QUESTIONS 33 & 34 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE 
33. How troubled or bothered have you been in the past 30 days by these: 
Alcohol problems 
Drug problems 
34. How important to you NOW is treatment for these: 
Alcohol problems 
Drug problems 
INTERVIEWER SEVERI1Y RATING 




Is the above information significantly distorted by: 
36. Patient'smisrepresentation? __ O=No l=Yes 





1. Was this admission prompted or suggested by the criminal justice system 
Gudge, probation/parole officer, etc.)? O=No l=Y~ 
2. Are you on probation or parole now? O=No l=Yes 
How many times in your life have you been ~ed and~ with the following: 
3. shoplifting 
4. vandalism 
S. parole/probation violation 
6. drugcharges 
7. forgery 
8. weapons offense 






IS a prostitution 
ISb.contempt of court 
ISc.other- Specify---------
16. How many of these charges resulted in convictions? --------
How many times in your life have you been charged with the following: 
17. Disorderly conduct, vagrancy, public intoxication? 
18. Driving while intoxicated? 
19. Other major driving violation (reckless driving, speeding, no license, etc.)? 
20. How many months were you incarcerated in your life? 





(USE CODE 3- 15, 17- 19. IF MULTIPLE CHARGES, CODE MOST SEVERE) 
Are you presently awaiting charges, trial or sentence? ___ O=No I =Yes 
24. What for? (If multiple charges, use most severe) _____ _ 
25. How many days in the p~t 30 were you detained or incarcerated? 
26. How many days in the p~t 30 have you engaged in illegal activities for profit? _____ _ 
FOR QUESTIONS 27 & 28 PLEASE ASK PATIENT TO USE PATIENT'S RATING SCALE 
27. How serious do you feel your present legal problems are? (EXCLUDE CIVll.. PROBLEMS) 
28. How important to you NOW is counseling or referral for these legal problems? 
INTERVIEWER SEVERITY RATING 
29. How would you rate the patient's need for legal services or counseling? __ _ 
CONFIDENCE RATINGS 
Is the above information significantly distorted by: 
30. Patient's misrepresentation? ___ O=No I=Yes 




Have any of your relatives had what you would call a significant drinking, 























Direction: Place "0" in relative category where the answer is clearly no for all relatives in the category; "1" where the answer is 
clearly Yes for anv relative within the category; "X" where the answer is uncertain or"! don't know" and "N" where there never 
was a xelatjve from that category. Code most problematic relative in cases of multiple members per category. 
FAMILY /SOCIAL RELATIONSHIPS 







2. How long have you been in this marital status? (IF NEVER MARRIED, SINCE AGE 18) 
3. Are you satisfied with this situation? 
O=No !=Indifferent 2=Yes 
4. Have you been homeless at all in the past 30 days? O=No !=Yes 
4a Where did you mostly stay during that homeless period? 




3=!n a car 6=0ther ______________________ _ 




!=With sexual partner and children 
2=With sexual partner alone 
3=With children alone 
4=With parents 
8=Controlled envirorunent (residential setting like a jail or hospital) 




6. How long have you lived in these arrangements? (IF Willi PARENTS OR FAMILY, AND ALWAYS HAS BEEN, 
SINCE AGE 18) ---- ----
Years Months 
7. Are you satisfied with these arrangements (particularly the people you are living with)? 
O=No l=lndifferent 2=Yes 
8. Do you live with anyone who has a drug and/or alcohol problem? __ _ 
O=No l=Yes 




10. Are you satisfied with spending your free time this way? 
O=No l=lndifferent 2=Yes 
11. How many close friends do you have? 
Direction for 11 a- 20: Place "0" in relative category where the answer is clearly no fOr all relatives in the cate~ory: "1" 
where the answer is clearly yes for aav relative within the category: 'X" where the answer is uncertain or "I don't know" and 
"N" where there never was a relative from that cate~ory. 
11 a. Would you say you have had close, long lasting, personal relationships 
with any of the following people in your life: 




d. Sexual Partner/Spouse 
e. Children 
f. Friends 
12. How much do you feel cared about, liked or loved by the significant 
people in your life (such as family members, friends, and so on)? 
O=Not at all 1= A little 2=Somewhat 
13. To what degree do you feel you need more emotional support? 
O=Not at all 1= A little 2=Somewhat 3=A lot 
197 
IN YOUR LIFE 
3=A lot 
Have you had significant periods in which you have experienced serious problems getting along with: 




17. Sexual Partner/Spouse 
18. Children 
19. Other significant family 
20. Close friends 
21. Neighbors 
22. Co-Workers 
Did any of these people (14-22) or any others (strangers, acquaintances) abuse you: 
O=No I=Yes 
23. Emotionally (make you feel bad through 
harsh words, humiliation, manipulation) 
(DO NQI INCLUDE VERBAL ABUSE BY 
STRANGERS) 
24. Physically (cause or threaten to cause 
physical hann such as: slapping, 
punching, kicking, hitting with an 
object, assaulting with a knife 
or other weapon, etc.) 
25. Sexually (rape, forced sexual advances 
or non-consensual sexual acts) 
26. Sexual Harassment (inappropriate 
physical contact, stalking, 
using threats to secure sexual 
contact, etc.) 
PAST30DAYS IN YOUR LIFE 
27. How many days in the past 30 have you had serious conflicts (problems which threaten your relationship): 
A. with your family? 




FOR QUESTIONS 28 - 31 PLEASE ASK PATIENT TO USE PA TlENT'S RATING SCALE 
How troubled or bothered have you been in the past 30 days by these: 
28. Family problems 
29. Social problems 
How important to you NOW is treatment or counseling for these: 
30. Family problems 
3 I. Social problems 
INTERVIEWER SEVERITY RATING 
32. How would you rate the patient's need for family and/or social counseling'? 
CONFIDENCE RATINGS 
Is the above information significantly distorted by: 
33. Patient's misrepresentation? ___ O=No !=Yes 





l. How many times have you been treated for any psychological or emotional problems? 
a In a hospital 
b. As an outpatient or private patient 
2. Do you receive a pension for a psychiatric disability? ___ O=No 1 =Yes 
Have you had a significant period (that was not a direct result of drug/alcohol use), in which you have: 
O=No l=Yes 
3. Experienced serious depression .. 
4. Experienced serious anxiety or tension 
5. Experienced hallucinations 
6. Experienced trouble understanding, 
concentrating or remembering 
7. Experienced trouble controlling 
violent behavior 
8. Experienced serious thoughts of suicide 
9. Attempted suicide 
10. Been prescribed medication for any 
psychological/emotional problem 
1l. Experienced anorexia, bulimia, or 
other eating disorders 
PAST30DAYS 
12. In the past 30 days, to what degree were you bothered by past experiences involving: 
O=Not at all 1= A little 2=Somewbat 3=A lot 
a Physical abuse 
b. Sexual abuse 
c. Rape 
d. Sexual harassment 
IN YOUR LIFE 
13. How many days in the past 30 have you experienced these psychological or emotional problems? 
200 
J.D._ 
FOR QUESTIONS 14 & 15 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE 
14. How much have you been troubled or bothered by these psychological or emotional problems in the 
past 30 days? __ _ 
15. How important to you NOW is treatment for~ese psychological problems? 
THE FOLLOWING ITEMS ARE TO BE COMPLETED BY THE INTERVIEWER 
At the time of the interview, is patient: 
O=No l=Yes 
16. Obviously depressed/withdrawn 
17. Obviously hostile 
18. Obviously anxious/nervous 
19. Having trouble with reality testing, 
thought disorders, paranoid thinking 
20. Having trouble comprehending, 
concentrating, or remembering 
21. Having suicidal thoughts 
INTERVIEWER SEVERITY RATING 
22 How would you rate the patient's need for psychiatric/psychological treatment? 
CONFIDENCE RATINGS 
Is the above information significantly distorted by: 
23 Patient's misrepresentation? ___ O=No l=Yes 
24 Patient's inability to understand? O=No l=Yes 
COMMENTS 
TIME ENDED: - --:---- I=A.M. 2=P.M. (circle one) 
-tfu.S. GOVERNMENT PlllNTING omcE, J991 • ·1~/60505 
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Appendix I 









NAME---------------------------------- DATE ____________ _ 
SEX: Male® Female@ 
Below is e list of words that describe feelings people have. Please reed each one 
carefully. Then fill in ONE circle under the answer to the right which best describes 
HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK INCLUDING TODAY . 


















0 =Not at all 
1 =A little 
2 = Moderately 
3 = Quite a bit 
4 = Extremely 
~ :I 11.1 ~ ~ 
c 11.1 ~ : ; 
~ ~ ffi ~ .., 
b :; 8 5 ~ 
z c s 0 : 
45. Desperate .® 0 ® CD@ 
Col@ O.P.@ 22. Relaxed . ® 0 ® ® 0 46. Sluggish .® 0 ® 0 0 
.... !:; ... ,.. 23. Unworthy . @ 0 ® 0 0 47. Rebellious .® 0 ® 0@ 
...1 ~ iD ..J c .., c .., 
!c ~ :i ~ ~ 24. Spiteful .@0®00 48. Helpless .®0@00 b ~ g 5 ... 
z c ~ 0 : 
1. Friendly .®0@00 25. Sympathetic .®0®00 49. Weary .®0@00 
2. Tense .®0®0@ 26. Uneasy. .®0®00 50. Bewildered .®0@0@ 
3. Angry .®@00@ 27. Restless .@0@0@ 51. Alert .®0@00 








5. Unhappy . . ~) I: <i1 (~)@ 29. Fatigued .®0®®~· 53. Furious .@0@(!)0 
6. Clear-headed . 2.: 7 i: 0:: ~ 30. Helpful 
7. Lively . . ·2~ ·I· ~- ·:i· ·~. 31. Annoyed 
8. Confused . ~ . .!_. ~ X ~ 32. Discouraged G:· I· G (3'· :4 56. Full of pep .::£: (!:; i ~ 1:· 
•V 9. Sorry for things done . ·~ ·::!. ]. i- ~~ 33. Resentful . ·~) '7' ® C!: ~~ 57. Bad-tempered .'~ 8 :i. :i.' ~\ 
• 
• 10. Shaky . ® 0@ 0 !.!} 34. Nervous . ®• 0 0 0@ 58. Worthless 
• 
• 11. Listless . . ® ::!.'@ 0 ~· 35. Lonely . ~) ~@ G> GJ 59. Forgetful 
• 
12. Peeved 36. Miserable . ® 0 ~) (!) ·~:· 60. Carefree 
• 
• 13. Considerate . ® 8 ® 0 0 37. Muddled .®0@0@ 61. Terrified .®8@:~·~) 
• 
• 14. Sad . ® 8 0@@ 38. Cheerful . ® 0@ 0 (~) 62. Guilty .@ ::i)@ C!:' (~) 
• 




16. On edge . @ S' 0 ~ ~· 40. Exhausted . ® (0 ® ® ~ 64. Uncertain about things .@) 0@ :~ ~) 






18. Blue . !~) G:'· '~ ~ ~· 42. Ready to fight .®0®0@ 
19. Energetic 43. Good natured 
20. Panicky 0 1 z 2 • 44. Gloomy ~ .! 3 i 4 
MAKE SURE YOU HAVE 
ANSWERED EVERY ITEM. 
e POM021 
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Dissertation Abstract 
A COMPARATIVE EVALUATION OF 
COGNITIVE-BEHAVIORAL THERAPY AND INSIGHT-ORIENTED 
PSYCHOTHERAPY IN THE TREATMENT OF COMORBID 
SUBSTANCE ABUSE, ANXIETY, AND DEPRESSION IN SUBSTANCE 
ABUSING FEMALES 
Substance abuse accounts for over 200,000 deaths 
annually in American females - - more than four times 
the number who will die of breast cancer. While female 
addiction is at epidemic proportions, treatment 
continues to focus on males and their substance abuse. 
Furthermore, it is questionable whether treatment 
designed for male substance use can be generalized to 
female substance users. This is compounded by the dearth 
of studies that examine treatment of female substance 
abuse. 
A pretest-posttest comparative experimental design 
was used to evaluate whether Cognitive Behavioral 
Therapy or Insight-Oriented Psychotherapy was more 
efficacious in the treatment of substance abuse in a 
female population. The final sample for this study 
consisted of 17 participants who were randomly assigned 
to the two treatment conditions via a table of random 
numbers. 
Chi-square analysis indicated that there was no 
significant difference between the two treatment 
conditions on any demographic variable. Dependent 
variables include Drug- and Alcohol-Status, Psychosocial 
variables, anxiety and depression. Instruments used 
included the Structured Clinical Interview using the 
DSM, the Addiction Severity Index, and the Profile Of 
Mood States. Each group counseling session lasted for 90 
minutes and convened weekly for a period of eight weeks. 
Statistical analyses included Means, standard 
deviations, effect size, and MANOVA procedures. The 
major findings in this study include: neither IOP or CBT 
was effective in increasing psychosocial functioning of 
the current sample; CBT was over ten times more 
effective than IOP in the reduction of alcohol use; CBT 
was four times more effective than IOP in the reduction 
of drug use; CBT was two times more effective than IOP 
in the reduction of anxiety; and, CBT was three times 
more effective than IOP in the reduction of depression. 
2 
The current findings suggest that (1) IOP treatment 
is not the treatment of choice for females with a 
history of substance abuse who are in the early stages 
of recovery; (2) females can respond well to treatment 
based on a cognitive-behavioral paradigm; (3) treatment 
approaches designed for male veterans can be applied to 
a female population within an outpatient community 
mental health setting. 
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